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Introduction General introduction, aims, and outline
PART I
1
Stroke in young adults 
Stroke affects about 15 million persons worldwide, resulting in death in approximately 
a third of all cases and significant disability in the survivors.1
Stroke is an umbrella term for ischaemic stroke, intracerebral haemorrhage, and a tran-
sient ischaemic attack (TIA). Ischaemic stroke is caused by a sudden occlusion of an ar-
tery in the brain, impairing blood flow and thus oxygen delivery to brain parenchyma. 
In a majority of cases, this occlusion is the result of an embolus originating from the 
systemic circulation (heart, aortic arch, carotid arteries) or a consequence of endothelial 
damage with clotting of blood platelets and other coagulation factors.2, 3 TIA’s have the 
same pathophysiological mechanisms as ischaemic stroke. The only difference is the 
arbitrarily chosen cut-off duration of symptoms of less than 24 hours for a TIA and more 
than 24 hours for an ischaemic stroke. Intracerebral haemorrhages account for approx-
imately 20% of all strokes. They are caused by the rupture of a cerebral blood vessel. 
In the Netherlands, each year approximately 41 000 patients are diagnosed with an 
ischaemic stroke or intracerebral haemorrhage.4 Up to 12% of these strokes occur in 
young adults between 18 and 50 years of age5  — a so-called ‘young stroke’ — and the 
incidence in this age group is rising.6 Stroke is clinically characterised by a sudden onset 
of loss of motor, sensory, visual, speech or language function, depending on the local-
isation of the lesion. Although being an acute event in onset, post-stroke impairments 
can have a more prolonged course and a life-long negative impact on daily life. These 
long-term effects are of particular importance in young patients, since they usually 
have a long life expectancy of decades ahead.
For the studies described in this thesis, we defined ‘young stroke’ as a TIA, ischaemic 
stroke or intracerebral haemorrhage in adults aged 18 through 50 years. 
Long-term neuropsychological and social consequences
The first thing that usually might come to mind considering post-stroke disability is mo-
tor impairment. This is substantiated by the fact that one of the most frequently used 
functional outcome scales after a stroke, the modified Rankin Scale,7 predominantly 
assesses motor performance. In the first weeks after the stroke, patients and caregivers 
mainly focus on these physical impairments and their recovery. However, less visible 
consequences may become apparent only after this time, consisting of subjective and 
objective cognitive impairment, but also fatigue or psychiatric disorders, such as de-
pressive symptoms and anxiety. These consequences have been extensively studied 
in elderly stroke survivors (>60 years of age).8-25 Less research has been performed in 
young stroke patients on these topics,9, 26-34 although stroke survivors and their family 
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rate these topics as high priority in research, since these symptoms usually prevent 
return to pre-stroke life.35 
Findings from studies in older stroke patients cannot per se be generalised to the 
younger population. First, the prevalence of cognitive impairment and other neuropsy-
chological consequences may differ from older persons, as a result of different recovery 
patterns. Age-related neurodegenerative changes, for example amyloid plaques or ac-
cumulating small-vessel disease, may contribute to and exaggerate these neuropsy-
chological consequences in elderly stroke survivors. These changes will play a far less 
pronounced role in the occurrence of neuropsychological symptoms in young stroke 
patients, given their younger age. 
Second, the effects of neuropsychological consequences on daily life are different in 
younger than in older patients, due to different demands from their social environ-
ments. Young patients are in a phase of life during which they have to make important 
life-changing decisions, such as career movements or family planning. Neuropsycho-
logical consequences may possibly have an adverse effect on chances of returning to 
work.36 This will not only result in an individual loss, but also in loss of productivity and 
working years, thereby increasing burden to society.37
Third, most studies only included patients with an ischaemic stroke and excluded pa-
tients with a TIA or intracerebral haemorrhage. However, evidence is accumulating in 
older patients that a TIA might not be as transient as previously thought, with respect 
to less visible symptoms such a cognitive impairment.38, 39 Survival of intracerebral hae-
morrhage patients has increased,40 due to improved intensive and neurological care. 
So, the need for information on long-term consequences in this condition also arises.
Finally, given their usually long life expectancy, especially information on long-term 
consequences is of utmost importance for young stroke survivors. However, to date, 
long-term follow-up studies barely exist.26
Aims of the thesis and study design
The aim of this thesis was to investigate the long-term prognosis with respect to neuro-
psychological and social consequences after a stroke in young adults aged 18 through 
50 years, including post-stroke depressive symptoms, anxiety, fatigue, subjective and 
objective cognitive impairment, and post-stroke unemployment. 
The studies presented in this thesis are based on the ‘Follow-Up of Transient ischaemic 
attack and stroke patients and Unelucidated Risk factor Evaluation’ (FUTURE) study, a 
large cohort study of 1 005 patients, designed to investigate aetiologies and long-term 
consequences of a young stroke. All consecutive patients with a TIA, ischaemic stroke 
or intracerebral haemorrhage between 18-50 years, admitted to the Radboud Universi-
ty Nijmegen Medical Centre, The Netherlands between January 1, 1980 and November 
1, 2010 were included. Patients alive were invited for an extensive follow-up assessment 
between November 1, 2009 and January 1, 2012.
Exclusion criteria were traumatic haemorrhagic stroke, haemorrhage in known cerebral 
metastasis or primary brain tumor, cerebral venous sinus thrombosis, subarachnoid 
haemorrhage or intracerebral haemorrhage attributable to known ruptured aneurysm, 
and retinal infarction. 
In addition, 147 control subjects were recruited from the same environment as patients, 
including spouses, siblings, and other relatives. Controls had to be at least 18 years old, 
without a TIA or stroke in their medical history. They were matched with the patient 
group on age and sex. 
Outline of this thesis
In part I of this thesis, chapter 2 provides a critical review of the literature on risk fac-
tors, aetiology, and long-term prognosis of young stroke, including mortality and risk of 
cardiovascular disease, but also functional outcome and psychosocial consequences. 
The term ‘young stroke’ will be discussed and issues that need more investigation are 
pointed out.
Part II, chapter 3 describes the rationale and design of the FUTURE study.
In part III, chapter 4 reports on the long-term cognitive impairments in young isch-
aemic stroke patients. In chapter 5, the prevalence of subjective cognitive failures is 
reported in patients with a young TIA or ischaemic stroke. Subsequently, we inves-
tigated whether these subjective cognitive failures are related to objective cognitive 
impairment or not. The prevalence of depressive symptoms and anxiety is reported in 
chapter 6 and the prevalence of fatigue in chapter 7, both in young TIA and ischaemic 
stroke patients. The association of these symptoms with a poor functional outcome is 
described in these chapters. In chapter 8, we report on the long-term neuropsycho-
logical problems in the subgroup of intracerebral haemorrhage patients. Chapter 9 of 
this thesis reports on long-term unemployment rates in the young stroke population, 
compared with nationwide controls.
In part IV of this thesis, the main results from the studies in this thesis are summarised 
(Chapter 10) and discussed (Chapter 11), including possible implications for clinical 
practice and directions for future research. Chapter 12 contains the Dutch summary 
of this thesis. 
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Abstract
Contrary to trends in most other diseases, the average age of ischaemic stroke on-
set is decreasing, owing to a rise in the incidence of stroke among ‘young’ individu-
als (under 50 years of age). This review provides a critical overview of the risk factors 
and aetiology of young ischaemic stroke and addresses its long-term prognosis, 
including cardiovascular risk, functional outcome, and psychosocial consequenc-
es. We highlight the diminishing role of ‘rare’ risk factors in the pathophysiology 
of young stroke in light of the rising prevalence of ‘traditional’ vascular risk factors 
in younger age groups. Long-term prognosis is of particular interest to young pa-
tients, because of their long life expectancy and major responsibilities during a 
demanding phase of life. The prognosis of young stroke is not as favourable as 
previously thought, with respect either to mortality or cardiovascular disease or to 
psychosocial consequences. Therefore, secondary stroke prevention is probably a 
life-long endeavour in most young stroke survivors. Due to under-representation 
of young patients in past trials, new randomised trials focusing on this age group 
are needed to confirm the benefits of long-term secondary preventive medica-
tion. The high prevalence of poor functional outcome and psychosocial problems 
warrants further study to optimise treatment and rehabilitation for these young 
patients.
Introduction
Stroke is a devastating disease that affects 15 million patients worldwide each year, re-
sulting in death in about one-third of patients and severe disability in two-thirds of the 
survivors.1, 41 Approximately 80% of all strokes are ischaemic strokes, of which roughly 
10% occur in individuals under the age of 50 years — so-called ‘young stroke’.5 In this 
article, we review the literature on ischaemic stroke in these young patients. Age limits 
defining young stroke differ across studies,5, 27, 42, 43 but we chose to define young stroke 
as an ischaemic stroke in adults aged 18-49 years, as this was the age range generally 
used in large studies.26, 43, 44 For the sake of inclusivity, however, we will also report on 
results from some studies that used upper age limits of 45, 50 or 55 years.42, 45 Risk fac-
tors and management strategies for young stroke differ across the world, depending 
on factors such as genetic differences, environmental influences, and the development 
and accessibility of health services. In this review, we will focus on the situation in West-
ern societies, unless otherwise specified.
In recent years, we have witnessed a remarkable, unprecedented decrease in the av-
erage age of onset of ischaemic stroke in the overall population, which is mainly at-
tributable to an increased incidence of stroke in young adults.6, 46 Ischaemic stroke in 
young adults is often thought to be related to ‘rare’ risk factors and aetiological features 
that are very different from the ‘traditional’ vascular risk factors and aetiology seen in 
older stroke patients. However, the increase in stroke incidence in young adults has 
been found to be associated with a rising prevalence of some important ‘traditional’ 
vascular risk factors, including hypertension, hypercholesterolaemia, diabetes mellitus, 
and obesity, in this age group.6, 47 We will discuss the role of these risk factors from the 
perspective of the increased incidence of young stroke.
In addition to the identification of risk factors and aetiology, long-term prognosis after 
stroke is of particular interest from the perspective of young patients, as they usual-
ly have a life expectancy of several decades. Following a stroke, these individuals are 
suddenly confronted with uncertainties about their future in a period of life during 
which they might be preparing for decisive career moves or planning a family. There-
fore, information on long-term prognosis should include not only the risk of vascular 
and other diseases, but also the expected psychosocial consequences related to life 
after stroke — a topic reported to be among the top 10 research priorities for patients.48
In the first part of this review, we provide a critical overview of the existing literature 
on risk factors and aetiology of young ischaemic stroke. This section will include a 
methodological discussion on the rare risk factors and aetiology that have conven-
tionally been regarded as specific for young stroke, followed by a discussion of the 
20
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growing prevalence of traditional vascular risk factors among younger individuals. We 
will then review the life-long consequences of stroke in young adults, not only in terms 
of cardiovascular disease recurrence, but also with respect to less frequently studied 
but equally relevant consequences, including cognitive and social impairments, mood 
disorders, and fatigue.
Risk factors and aetiology 
The view that ischaemic stroke in young adults is different from ‘old stroke’ with respect 
to risk factors and aetiology originated predominantly from the many publications — 
mainly based on case series from tertiary hospitals — that reported on the high prev-
alence of unusual, rare conditions and risk factors among young patients with stroke.49 
These rare risk factors and aetiologies are extensively summarised in previous reviews 
and textbooks,2, 49 and will not be outlined in detail here. The term ‘risk factor’ is used 
to indicate that a certain factor was found to be associated with stroke in young adults. 
However, the mere identification of a risk factor does not imply that the aetiology is 
fully understood. Sometimes the risk factor is somewhere in the ‘causal pathway’ of 
the disease, and may give rise to a certain aetiology that in turn is associated with the 
disease; for example, hypertension is a risk factor, but atherosclerosis might be the un-
derlying causal aetiology of the stroke. For the purposes of this review, we will catego-
rise the aetiology according to the Trial of Org 10172 Acute Stroke Treatment (TOAST) 
classification, with ‘large-artery atherosclerosis’, ‘small-vessel disease’, ‘cardioembolic’, 
‘other determined’, and ‘cryptogenic’ as important aetiological subgroups.3
‘Rare’ risk factors and aetiologies
In Tables 1 and 2, we summarise data on 5 rare risk factors and 5 rare aetiologies that 
have been linked chiefly to stroke in young patients. The choice was based on the rel-
atively high prevalence of these factors and aetiologies in large, Western young stroke 
cohorts.43, 44 In other populations, the distribution of conditions in the TOAST category 
‘other determined aetiologies’ differs. For example, in Japan, moyamoya disease will be 
diagnosed more frequently in young patients with stroke, because the incidence and 
prevalence of this disease is much higher there than in other parts of the world, such 
as Europe.50
Table 1 Top 5 most prevalent ‘rare’ risk factors for stroke in younga Western populations.
Risk factor
TOAST 
classificationb
Prevalence in 
young patients 
with strokec
Strength of 
association
Highest level 
of evidenced
Migraine51-55e Unknown cause 20-24% Pooled effect 
estimate ~2.056
A1, association 
proven for mi-
graine with aura 
only
Illicit drug use57-61 Other (rare) causes 9-20% OR 2.0 for 
cocaine;57 OR 2.3 
for cannabis;60f 
no significant 
association for 
amphetamines57
A2 for cocaine; B 
for amphetamines, 
cannabis and 
heroin
Patent foramen 
ovale62-65
Possible cardiac 
embolism; low-risk 
source
24%, up to 50% in 
stroke, classified as 
cryptogenic
Hazard ratio ~1.5 
(non-significant)63
A2, contrasting 
with evidence 
from B-level 
studies
Oral 
contraceptives54, 
66-71 
Other (rare) cause/
unknown
10-40% Summary OR 2.167 B
Pregnancy/
puerperium72-76
Other (rare) 
cause/unknown
7.5% in women Relative risk 8.7 
during puerpe-
rium, not during 
pregnancy74
A2, conflicting 
results
a.) Under 50 years of age; b.) TOAST classification, according to Ay et al. (2005)3;  c.) Sum of all prevalences 
exceeds 100%, because data were extracted from different study populations. In addition, conditions are 
not mutually exclusive in an individual patient; d.) Levels of evidence: A1, systematic review, based on at 
least 2 independent A2-level studies; A2, prospective cohort study of sufficient sample size and duration 
of follow-up, adequately adjusted for confounding and selective follow-up sufficiently excluded; B, pro-
spective cohort study, not meeting the criteria of A2, or retrospective cohort study, or case-control study; 
C, non-comparative study; D, expert opinion;  e.) Note that migrainous stroke is very rare;35 however, 
reports on the role of migraine as a risk factor for stroke are abundant;  f.) Not significant after correction 
for tobacco use.
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Table 2 Top 5 most prevalent ‘rare’ aetiologies for stroke in younga Western populations.
Aetiology
TOAST 
classificationb
Prevalence in young 
patients with strokec
Strength of 
association
Highest level 
of evidenced
Non-inflammatory  arteriopathies
Arterial dissection (cervi-
cal or intracranial)77-81
Other (rare) 
causes
10-25% Not reported A2
Reversible cerebral 
vasoconstriction 
syndrome44, 82-84
Other (rare) 
causes
1-5% Not reported B
Inflammatory  arteriopathies
Inflammatory arteriitis85e Other (rare) 
causes
3-5% 
(all autoimmune vasculit-
ides combined)
Not reported B or C, 
depending on 
the underlying 
autoimmune 
disorder
Cardioembolic
Cardiomyopathy43, 44, 86 Cardioem-
bolism, 
high-risk source
2-3% Not reported A2
Prothrombotic state
Coagulation factors87-93 Other (rare) 
cause/un-
known 
Antiphospholipid syn-
drome: 10%f
Factor V Leiden: 3.0-7.5%
Antithrombin III deficien-
cy: 5-8%
Protein C deficiency: 
4-11%
Protein S deficiency: 6% 
(up to 23% in occasional 
studies)
Prothrombin  
mutation: 2-6%
OR 2.294
OR 1.0287
Not reported 
Not reported
Not reported
Not reported
A2 for anti-
phospholipid 
syndrome, 
conflicting 
results; 
B for other 
factors,
conflicting 
results
a) Under 50 years of age;  b) TOAST classification, according to Ay et al. (2005)3; c) Sum of all prevalences 
exceeds 100%, because data were extracted from different study populations. In addition, conditions 
are not mutually exclusive in an individual patient; d) Levels of evidence: A1, systematic review, based 
on at least 2 independent A2-level studies; A2, prospective cohort study of sufficient sample size and → 
←  duration of follow-up, adequately adjusted for confounding and selective follow-up sufficiently ex-
cluded. B, prospective cohort study, not meeting the criteria of A2, or retrospective cohort study, or 
case-control study; C, non-comparative study; D, expert opinion;  e) Including primary vasculitis and vas-
culitis secondary to collagen vascular diseases, and other systemic conditions (excluding those secondary 
to infections)85; f) Up to 46% in selected populations.
Aetiological subgroups, as described in Table 2, vary across sex and age categories. 
Extracranial arterial dissections are the most common ‘rare’ aetiological subgroup. Dis-
sections are found throughout all age categories and account for approximately 20% 
of strokes in patients under 45 years of age, but only for 2% of all ischaemic strokes. The 
highest incidence of dissections lies in the fifth decade; men and women are about 
equally affected, although women are, on average, 5 years younger when the dissec-
tion manifests.77, 78
Inflammatory arteriopathies, such as vasculitis, are a heterogeneous group, mostly con-
sisting of multisystemic inflammatory disorders affecting arteries of all sizes, depending 
on the disease.85 Some of these conditions virtually never occur in young adults; for 
example, giant cell arteriitis almost exclusively affects individuals over 50 years of age. 
However, other conditions, such as Takayasu disease, predominate in young females.85 
Of note, infectious diseases underlie a considerable proportion of cases of secondary 
vasculitis. In the developed world, hepatitis B and C remain the most common under-
lying infections, whereas HIV is a large problem in the developing world.95
Within the subgroup of cardioembolic stroke, cardiomyopathy is one of the most prev-
alent conditions in young patients with ischaemic stroke.43, 44 One would expect cardio-
myopathy to be associated with strokes earlier in life, because this condition often has 
an early age of onset. However, 1 study that stratified young patients with stroke by 
age category found no significant difference in prevalence between patients under 42 
years of age and those aged 42 years or older. In this study, cardiomyopathy was more 
than twice as prevalent in men than in women (15.5% versus 6.1%).44
Antiphospholipid syndrome is an important example of a prothrombotic state that is 
related to stroke in young adults. This condition has predominantly been studied in 
women. An increased risk of ischaemic stroke was found in association with this con-
dition in women under 50 years of age (OR 43.1, 95%-CI 12.2-152.0).96 Although some 
studies showed a clearer relationship in younger women than in older populations, 
another study showed no age differences in a young stroke population.97
Of note, some of the risk factors mentioned in Table 1, such as illicit drug abuse or the 
presence of a patent foramen ovale (PFO), are seen as being quite specific to young 
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adults, but they can actually occur throughout the human life span. In older adults, 
however, the relative presence of these risk factors is much lower than in young adults, 
as the absolute numbers of patients with traditional cardiovascular risk factors and a 
proven aetiology, such as large-artery atherosclerosis, small-vessel disease or cardioem-
bolic stroke, is much higher.
For most of the risk factors in Table 1, only weak associations with respect to young 
stroke have been reported. Moreover, the extent to which a risk factor is judged to be 
causal in the origin of a disease might depend on the quality of the study. To increase 
the likelihood of causality, studies would have to show that the effects of risk factors 
are, among other criteria, dose-dependent and time-dependent.98 Double-blind ran-
domised trials or large, prospective cohort studies would be needed to meet these 
requirements. 
Associations for most of the reported risk factors were derived from case-control stud-
ies or case series, which are prone to various forms of bias because they are hospi-
tal-based and often limited with respect to sample size. First, information bias — in 
particular, recall bias — needs to be considered. Remarkable events in the recent past, 
such as infections, might be more readily remembered by a patient in the aftermath 
of a stroke than by a person who has not experienced a stroke. Acute respiratory tract 
infections have been implicated as trigger factors for stroke, as have chronic infections, 
such as chronic bronchitis.99 The potential role of these infections as trigger factors 
was supported by the fact that their association with stroke was time-dependent and 
dose-dependent. However, the evidence derives mostly from case-control studies with 
methodological limitations.
Second, referral bias could be an issue. Young stroke cases described in the literature 
are often selected from a population that was referred for a second opinion to a ter-
tiary academic centre. These cases usually represent a selection of patients in whom 
no aetiology could be established on the initial investigations. Subsequent additional 
investigations may have revealed incidental or presumed abnormal findings (for exam-
ple, a PFO) that were not necessarily causal factors.
Last, confounding can contribute to bias; for example, in many small studies, traditional 
risk factors were not appropriately adjusted for in the analysis.
Traditional vascular risk factors
Whereas the role of rare risk factors in the pathophysiology of young stroke seems 
overestimated, the role of traditional vascular risk factors may have been underesti-
mated.5, 6, 43, 45, 100-105 The rising incidence of stroke in young adults coincides with an 
increasing prevalence of traditional vascular risk factors in this age group,43, 45, 82, 101 which 
is at least supportive of a relationship between the two, although causality remains to 
be proven. Hypertension is reported in 19-39% of all young patients with stroke, dyslip-
idaemia in 17-60%, diabetes in 2-10%, smoking in 42-57%, and obesity in 10-20%.5, 43, 45, 
100-103 Figure 1 illustrates the increase in prevalence of the traditional vascular risk factors 
with age, indicating a sharp rise in the prevalence of hypertension — and, to a lesser 
extent, hypercholesterolaemia — over the age of 35 years. 
Figure 2 shows that the number of traditional vascular risk factors per patient increases 
with age: in patients over 35 years of age, only a small fraction of patients has no vas-
cular risk factors.
Despite the high prevalence of traditional vascular risk factors in young adults with 
stroke, a proven causal aetiology, such as large-artery atherosclerosis, remains to be 
identified in a large proportion of cases.82 However, improved diagnostics, including 
high-resolution plaque and vessel wall imaging, might increase the likelihood of di-
agnosing a causal aetiology, especially among patients with vascular risk factors, by 
enabling detection of earlier stages of atherosclerosis.106
Given the abundance of traditional vascular risk factors, the proven presence of large-ar-
tery atherosclerosis might obviate the need for further diagnostic work-up, although 
the safety of this strategy requires confirmation in diagnostic studies. In patients with-
out any proven aetiology, ancillary investigations are indicated to further unravel po-
tentially treatable rare risk factors and aetiologies.
Chapter 2
Ischaemic stroke in young adults: risk factors and long-term consequences
PART I
2726
Introduction
2
Figure 1  Prevalence of traditional vascular risk factors in young patients with stroke.
Graphs show the prevalence of various traditional vascular risk factors by age category, for A | men and B 
| women. Data were pooled from the 15 Cities study,101 FUTURE study,102 and SIFAP1 study.45
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Figure 2 Age-specific proportions of patients with traditional vascular risk factors, strati- 
    fied by sex.
Graphs show the prevalence of no, 1, or 2 or more traditional vascular risk factors in different age cate-
gories, for A | men and B | women. Traditional vascular risk factors that were considered were diabetes, 
hypertension, smoking, and hypercholesterolaemia. Data are extracted from the SIFAP1 study.45
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Cardiovascular prognosis
Mortality
Prognosis in terms of mortality was usually considered to be favourable in young pa-
tients with stroke, given the lower short-term mortality rates compared with older pa-
tients.107 However, long-term follow-up studies in young patients found 5-year cumu-
lative mortality ranging from 9-11%, while the 10-year cumulative risk of death ranged 
from 12-17%.27, 103, 108-111 In 30-day survivors of a young ischaemic stroke, 20-year cumula-
tive mortality was reported to be 27%, which is 4 times higher than that of individuals in 
the general population matched for age and sex.110 As Figure 3 shows, excess mortality 
is present across all age groups of young patients with stroke, but especially in those 
over 35 years of age, in whom vascular risk factors are also highly prevalent.
Figure 3 Long-term cumulative mortality in young patients with stroke and the general 
    population with similar age, sex and calendar-year characteristics.
Figure shows the excess mortality of young patients with stroke, compared with the general population, 
stratified by age <35 years or ≥35 years. Based on data from the FUTURE study.110
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In young adults who died during a 5-year109 or a 20-year110 follow-up period after stroke, 
vascular disease was the main cause of death. More than half of the deaths resulting from 
vascular disease were attributable to a vascular cause other than stroke. These findings 
suggest that the underlying (vascular) disease that caused stroke at a relatively young age 
continues to put these patients at an increased long-term risk of vascular disease.
Figure 4 Risk of death or recurrent vascular events, stratified by number of traditional 
    vascular risk factors. 
Figure shows risk of A | mortality and B | recurrent vascular events, stratified by the number of risk factors 
present. Risks are adjusted for age and sex. Traditional vascular risk factors that were considered were 
diabetes, hypertension, smoking, and hypercholesterolaemia. Based on data from the FUTURE study.102, 110
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Figure 4 Continued
Recurrent vascular eventsB
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Recurrent vascular events
In the first few years following a young stroke, patients are at a substantial risk of stroke 
recurrence (annual risk 1-3%)5, 27, 102, 112-114 and, to a lesser extent, other cardiovascular vas-
cular events (annual risk 0.5-1.0%).102, 113, 114 In the decades that follow, the risk of recurrent 
events continues to be elevated, leading to a cumulative risk of 20% for recurrent stroke 
and 17% for other cardiovascular events.102, 103, 113
Identification of high-risk groups 
High-risk groups in terms of recurrent mortality and cardiovascular events were iden-
tified on the basis of the TOAST classification.3 The atherothrombotic stroke category 
was found to have the highest risk of mortality and recurrent stroke, compared with the 
other TOAST categories.35, 102, 110, 115 
Risk factors that were associated with the highest 5-year risk of recurrent stroke pre-
dominantly included the traditional vascular risk factors, including age over 40 years, 
history of transient ischaemic attack, type 1 diabetes, and the use of antihypertensive 
medication.114 The studies available found that the risk of mortality109, 111, 116 and recurrent 
vascular events102, 114 increased in parallel with the number of traditional cardiovascular 
risk factors present (Figure 4). Cardioembolic strokes were also associated with higher 
risks of mortality and recurrent vascular events.102, 110
Racial disparities in cardiovascular prognosis after young stroke have also been ob-
served. In a short-term follow-up study of young stroke patients aged 18-45 years, 
black individuals had the highest 30-day risk of mortality: 10%, about 4 times the risk 
in Asians.117 White individuals had an approximately 3.5-fold increased risk of 30-day 
mortality compared with Asians. These differences were independent of the presence 
of traditional vascular risk factors. 
These findings indicate that prognosis in terms of long-term risk of cardiovascular dis-
ease after a young stroke is not as favourable as previously thought.27, 108, 116, 118 Young 
patients with stroke, especially those who resemble older stroke patients with respect 
to the presence of traditional vascular risk factors and aetiology, also seem to show 
similarity to older patients in terms of long-term cardiovascular mortality and disease.
Of note, the prognosis for stroke patients in the ‘other determined’ category, which 
includes arterial dissection, seemed relatively favourable compared with the other cat-
egories.78, 102, 115 However, one must keep in mind that this category includes a mixture 
of conditions, each with a different disease course and treatment options and, thus, 
variable prognoses. 
Secondary prevention
Young patients with stroke are often under-represented in large secondary prevention 
trials on antiplatelet drugs, statins and blood pressure lowering agents.35 Nonetheless, 
it is common practice to treat young stroke patients in accordance with guidelines 
based on extrapolated data from elderly patients with stroke.119 This might be a sensible 
approach, given that a considerable proportion of these young patients have the risk 
factors that are targeted in these trials, and some of the trials showed greater benefits 
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in younger individuals (under 65 years) than in the older ones (65 years or over).120 These 
conclusions are, however, mainly based on post hoc analyses, as no studies were spe-
cifically designed to investigate secondary prevention strategies in young adults with 
stroke. Although no evidence exists that long-term secondary prevention is particu-
larly harmful in young patients, the question of whether these long-term prevention 
strategies are truly beneficial in all young adults with stroke — for example, in those 
patients in whom no risk factor or presumed aetiology could be found — remains to 
be answered. In addition, treatment strategies without proven benefit are not particu-
larly cost-effective.
Secondary prevention strategies in some subgroups with a specific risk factor or ae-
tiology have been investigated in young adults, for example, those with PFO or an-
tiphospholipid syndrome. For a PFO, current evidence does not show superiority of 
closure, compared with medical treatment, in preventing recurrent strokes in adults 
under 60 years of age.121 Two randomised controlled trials included post hoc subgroup 
analyses in patients aged 45 years or younger (approximately 45% of the study co-
hort), which showed no beneficial effects of closure in this subgroup.122, 123 For patients 
with antiphospholipid syndrome, guidelines from the American Heart Association and 
American Stroke Association recommend treatment with oral anticoagulants, with an 
international normalised ratio (INR) between 2.0 and 3.0.124 However, an expert panel 
could not reach consensus and noted that the evidence supporting higher or lower 
INR intensities or other strategies, such as antiplatelet therapy, was uniformly weak.125
To discover which patients will benefit the most from secondary prevention strategies, 
we suggest that recruitment of patients for future (multicentre) trials should be based 
on aetiological subgroups rather than age, so that younger patients are not excluded.
Physical impairments and complications
The risk factors and aetiology underlying a stroke have a substantial impact on cardio-
vascular mortality and morbidity. With respect to functional outcome and psychoso-
cial consequences, however, the prognosis is more likely to be determined by a combi-
nation of factors, including not only aetiology, but also stroke severity and subsequent 
cerebral damage, co morbidity, demands from the patient’s environment, and the pa-
tient’s coping strategies. The sections that follow provide an overview of prognosis in 
terms of physical problems (functional outcome, pain, and epilepsy) and psychosocial 
consequences (cognitive impairment, depression, anxiety, fatigue, sexual dysfunction, 
and return to work) after a young stroke.
Functional outcome 
Neurological deficits due to a stroke are often registered during hospital admission 
and discharge, as a measure of stroke severity on the NIH Stroke Scale. However, as 
no studies have described these neurological deficits in the years after discharge, the 
frequency of neurological deficit over time is not known.
Functional outcome is assessed in terms of disability, most commonly with the modi-
fied Rankin Scale (mRS), a scale that predominantly assesses motor function. Using this 
scale, functional outcome is usually found to be better in younger than in older adults 
after short-term follow-up.126 For young adults, however, information on long-term 
physical disability is equally important, because of their long life expectancy. Only a few 
studies have reported long-term functional outcomes after young ischaemic stroke. 
Proportions of individuals with poor functional outcome (mRS score >2) among young 
stroke survivors range from 6-20% after a mean follow-up duration of 3-12 years,103, 118, 127, 
128 compared with 40% after short-term follow-up in older stroke survivors.129
Independence with regard to basic activities of daily living may not necessarily mean 
a good outcome for young patients: the ability to live independently as a young adult 
also requires independence in performing more complex tasks. In addition, demands 
from society on these young patients might be higher than in the elderly, because of 
occupational obligations and, in many cases, their role as a caregiver for a young family. 
The studies performed to date have not addressed these issues. Moreover, one must 
keep in mind that young stroke survivors with a poor functional outcome have to cope 
with this consequence for a considerable number of years, given their generally long 
life expectancy.
Epilepsy
Post-stroke epilepsy is reported to affect 2.4-14.4% of young patients with ischaemic 
stroke.103, 113, 118, 130-132 The highest prevalence was found in a study that included patients 
aged 50 years and under;132 most other studies only included patients up to 45 years 
of age. The lowest prevalence was found in a study that only included cryptogenic 
stroke.130 Factors that were associated with epilepsy, either with or without recurrent 
seizures, included a more severe stroke and involvement of cortical structures.113, 132 
A study with a decade of follow-up revealed a long-term association between post-
stroke epilepsy and a poor functional outcome, as measured with the mRS.128
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Pain
The prevalence of post-stroke pain has frequently been studied in the older stroke 
population, and estimates vary considerably, from as low as 1% to as high as almost 
50%.133-136 This broad range is probably explained by the wide variation in methods 
used to assess post-stroke pain. Moreover, post-stroke pain originates from multiple 
sources, including central pain from both thalamic and extrathalamic lesions, and pe-
ripheral pain from musculoskeletal abnormalities, such as joint contractures.133 No stud-
ies have specifically addressed the prevalence of pain after stroke in young adults. A 
recent report suggested a link between post-stroke pain and increased mortality in 
young patients with stroke.137
Psychosocial consequences
Cognitive impairment
Cognitive performance is an important determinant of social functioning in a young 
patient with stroke.138 One year after stroke, up to 60% of young stroke patients had im-
paired cognitive performance compared with stroke-free controls, depending on the 
cognitive domain tested.28, 29 In younger patients in particular, cognitive recovery is like-
ly to continue beyond 1 year after stroke. However, 1 study reported that after a mean 
follow-up of 11 years, 50% of young patients with stroke still had to cope with impair-
ment or below average performance on at least 1 cognitive domain.139 Elderly patients 
with stroke commonly exhibit prominent frontal executive impairment,140 whereas 
young patients generally show deficits in multiple cognitive domains, including visuo-
construction, delayed verbal memory, attention, and executive function. Most of these 
deficits are especially pronounced in patients with left-hemispheric lesions, with the 
exception of visuoconstruction, which seems to be more impaired after right-hemi-
spheric strokes.139 These findings suggest that cognitive impairment in young patients 
with stroke displays a more global pattern than one would expect on the basis of a 
focal lesion,139 perhaps as a result of diffuse network dysfunction remote from the site 
of the lesion.139, 141
Aphasia has not been specifically tested in long-term follow-up studies.139 One study 
that assessed language disturbances in the subacute phase after stroke found that 
young patients (under 51 years) were prone to non-fluent aphasia, whereas older pa-
tients were more likely to exhibit fluent aphasia, probably owing to a higher proportion 
of posterior infarcts in the older age group.142
Cognitive impairment can have life-changing consequences for young adults. For ex-
ample, return to work may be impaired due to memory problems.26 A short-term fol-
low-up study found that the number of cognitive deficits predicted later inability to 
return to work.143 This is not a surprising finding, as disturbances in multiple domains 
might interact, thereby diminishing the ability to compensate for impairments. For ex-
ample, visual field defects can lead to reading disorders, and alexia could exaggerate 
this effect.144
Depression
Depressive symptoms are present in 28-46% of young patients with stroke26, 27, 32 after 
follow-up durations of 6-12 years. Depressive symptoms can have a large impact on 
recovery and daily life after stroke. These symptoms have been associated with poor 
functional outcomes in an unadjusted analysis, but this association might have been 
confounded, for example, by recurrent vascular events.26
Patients with stroke were also found to have an increased risk of suicide (up to 7%), or 
suicidal ideations (6-15%) in both the acute and the chronic phase, especially when 
patients had current or past mood disorders.145, 146 Young adults seemed to be at par-
ticular risk.146
In 1 study conducted in the general population, younger individuals tended to be clas-
sified as having a ‘non-vascular depression’ profile, which was characterised by a higher 
risk of suicide and more psychotic features, whereas older individuals more often dis-
played a ‘vascular depression’ profile, with a higher prevalence of functional disability 
and anhedonia.147 The small study sample resulted in large confidence intervals, and the 
findings need further confirmation in large stroke cohorts. One might expect that the 
proportions of vascular and non-vascular depression profiles would not differ markedly 
between young and older patients in a stroke cohort, since both age groups have vas-
cular lesions. However, elderly individuals might still exhibit a greater propensity towards 
a vascular depression profile owing to accumulation of vascular damage with age.
Depressive symptoms should not be confused with emotionalism (that is, emotional 
expressions outside a patient’s normal control), which was reported in 22.5% of the 
general stroke population the first month post-stroke.148 Although the 2 conditions 
co-occurred in 1 patient, and depressed mood was more likely to be present in patients 
with emotionalism, most patients with emotionalism were found not to be depressed. 
No studies on emotionalism versus depression have been conducted specifically in 
young patients with stroke.
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Anxiety
Anxiety is present in 19% of patients with young ischaemic stroke after 12 years of fol-
low-up,26 but no studies exist on its influence on daily life.
Fatigue
Post-stroke fatigue is present in about 50% of young patients with stroke,33 and seems 
to be associated with poor functional outcome33 and inability to regain pre-stroke ac-
tivities.34, 149 However, most of the studies that assessed this complaint were limited with 
respect to sample size34 or follow-up duration.34, 149
Some short-term follow-up studies in older stroke patients found fatigue to be associ-
ated with certain lesion locations.24, 150 In young patients with stroke, however, fatigue 
could be the result of an imbalance between demands from society and reduced cog-
nitive or physical capacity after stroke. Moreover, factors that underlie fatigue in the 
short term after stroke may differ from those in the long term, but these factors remain 
to be clarified.
Sexual dysfunction
One short-term follow-up study on sexual dysfunction, focusing on young patients 
with stroke (aged 18-45 years), found diminished sexual function in 22.5% of patients.131 
In the general stroke population, sexual dysfunction is caused by multiple factors, vary-
ing from neurological deficits (for example, hemisensory neglect151 or aphasia) to psy-
chological problems such as depression.152 The relative contributions and long-term 
effects of the various factors in a young stroke population are unknown.
Hypersexuality may also be an issue after a young stroke. One study found this problem 
in just 1 of 71 young stroke patients, which may have been an underestimation, as the 
opinion of the patients’ partners was not investigated.131 Hypersexuality is thought to 
result from disinhibition due to lesions in the frontostriatal circuits, and also in the tem-
poral lobe after ischaemic stroke.153
Return to work
Return to work after young stroke is an important determinant of life satisfaction,36, 154 
and might even be a necessity for many people to provide for themselves. In addition 
to the personal implications for patients, inability to return to work after stroke imposes 
an economic burden on society as a whole, owing to loss of productive years of em-
ployment.37 However, only a few studies have addressed this important subject.
Reports to date indicate that 50-80% of stroke patients returned to work after a maxi-
mum follow-up of 4 years.34, 155-158 However, most young patients with stroke will be of 
vocational age for more than a decade of their remaining life, which stresses the need 
for further studies on the very long-term prognosis with respect to return to work. In 1 
study with a follow-up of almost 12 years,26 only 40% of patients had returned to full-
time employment by the end of the study period. However, these data must be regard-
ed with caution, since the study was retrospective with a relatively low response rate.
Screening and treatment
Cognitive impairment, mood disorders, and fatigue seem to be very common in young 
patients with stroke, and functional outcome is poor in a substantial proportion of 
these young adults. If not actively screened for, these consequences often go unno-
ticed by caregivers, possibly leading to frustration in young patients when they are not 
able to return to their pre-stroke activities.159 The first step in treatment of these ‘invisi-
ble’ psychosocial issues, therefore, is their recognition.
The next step is to start treatment for these symptoms. The current treatment strat-
egies, which are suboptimal, consist primarily of occupational therapy160 or medical 
treatment, for example, with antidepressants.161, 162
Directions for future research
Currently, only limited data exist on long-term psychosocial consequences and their 
impact on daily life functioning after stroke in young adults. Future studies should fo-
cus on the influence of these psychosocial factors on daily life and try to find clinical 
and demographic factors that can predict future psychosocial effects. Large, prospec-
tive cohort studies are needed for this purpose. These predictors might, in turn, provide 
insight into the pathophysiological mechanisms that underlie these psychosocial con-
sequences, although imaging studies, postmortem studies or animal models would 
provide us with more fundamental insights.
In addition, treatment strategies should be developed, and their effects quantified, in 
clinical trials. Individuals who experience a stroke at a younger age have different reha-
bilitation goals from their older counterparts,159 and specific programmes need to be 
developed that are adjusted to the specific needs of these young patients.
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Conclusions and recommendations
In the past, stroke in individuals under 50 years of age (‘young stroke’) has been viewed 
as a disease with different risk factors and aetiology — and usually a better prognosis 
— in comparison with stroke in older patients. After a critical review of the available 
literature, however, this view may be challenged.
Traditional vascular risk factors in young adults with stroke have been somewhat ne-
glected in the literature, which seems unjustified given their high prevalence,35 espe-
cially in young patients between 35 and 50 years of age. This high prevalence coincides 
with a rising incidence of stroke in young adults, suggesting that traditional vascular 
risk factors might contribute more to the aetiology of young stroke than was previously 
thought. The presence of these risk factors, however, is not always related to causal ae-
tiologies such as large-artery atherosclerosis, as assessed with current diagnostic tools.
Young patients with stroke are at increased risk of cardiovascular mortality and mor-
bidity compared with the general population, sometimes even approaching the risks 
observed in the older stroke population. The patients whose condition is classified as 
atherothrombotic stroke, with highly prevalent traditional risk factors, have the highest 
risk. In these patients, life-long treatment with secondary prevention seems to be a 
plausible approach. However, further trials are needed to establish which patients will 
benefit from different forms of secondary prevention. Recruitment of patients for these 
trials should be based on aetiological subgroups rather than age.
Although many ‘young’ stroke patients are ‘old’ with respect to aetiology and progno-
sis, they are ‘young’ when psychosocial consequences come into play, as most patients 
have a life expectancy of decades that includes phases of their lives in which important 
life-changing decisions have to be made. To fulfil these needs, treatment strategies 
tailored to the needs of young patients must be developed.
Stroke in young adults is an acute disease, but its life-long consequences are becoming 
increasingly recognised. Treatment and guidance, accompanied by a life-long perspec-
tive, should be offered to each young stroke survivor in order to attain the highest 
possible quality of post-stroke life.
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Abstract
Background and objective 
Young stroke can have devastating consequences with respect to quality of life, 
the ability to work, plan or run a family, and participate in social life. Better insight 
into risk factors and the long-term prognosis is extremely important, especially in 
young stroke patients with a life expectancy of decades. To date, detailed infor-
mation on risk factors and the long-term prognosis in young stroke patients, and 
more specific risk of mortality or recurrent vascular events, remains scarce.
Methods/Design 
The FUTURE study is a prospective cohort study on risk factors and prognosis of 
young ischaemic and haemorrhagic stroke among 1 006 patients, aged 18-50 
years, included in our study database between 1-1-1980 and 1-11-2010. Follow-up 
visits at our research centre take place from the end of 2009 until the end of 2011. 
Control subjects will be recruited among the patients’ spouses, relatives or social 
environment. Information on mortality and incident vascular events will be re-
trieved via structured questionnaires. In addition, participants are invited to the 
research centre to undergo an extensive sub study including MRI.
Discussion 
The FUTURE study has the potential to make an important contribution to increase 
the knowledge on risk factors and long-term prognosis in young stroke patients. 
Our study differs from previous studies by having a maximal follow-up of more 
than 30 years, including not only TIA and ischaemic stroke but also haemorrhag-
ic stroke, the addition of healthy controls and prospectively collect data during 
an extensive follow-up visit. Completion of the FUTURE study may provide better 
information for treating physicians and patients with respect to the prognosis of 
young stroke.
Introduction
Up to 12% of all strokes occur in patients between 18-50 years (‘young stroke’),103 affect-
ing about 5000 patients each year in the Netherlands and about 2 million young people 
each year worldwide. In a substantial proportion of roughly one third the aetiology re-
mains unelucidated. In terms of prognosis a young stroke has a dramatic influence on 
independency and quality of life as it occurs in the period of life that people start to form 
families, make decisive career moves, and have an active social life. Uncertainty about 
long-term prognosis affects choices and planning affiliated with these life events.
Whereas risk factors and prognosis in patients who develop a stroke at higher ages 
(usually over 70 years) are among the best studied topics in clinical medicine, this does 
not hold true for young stroke. At higher ages, almost all risk factors have atheroscle-
rosis in their final common pathway. However, this cannot simply be extrapolated to 
young stroke as the underlying cause of stroke is usually different from that in elder-
ly and may therefore also have a different prognosis both with respect to function-
al stroke outcome as to risks of recurrent stroke or other major vascular events. Even 
more, the identification of risk factors for young stroke so far has often been based on 
the occurrence of presumed risk factors in consecutive series of young stroke patients, 
without methodological sound comparison with controls.
The ‘long-term’ perspective in an on average over 70 years old stroke patient differs 
from that of a 30 years young stroke patient, and particularly studies with a long-term 
follow-up of more than 10 years are lacking in the young stroke field. Studies thus far, 
usually with a mean follow-up duration of less than 7 years, report highly variable post-
stroke mortality and risk of incident vascular disease.5, 103, 112-114, 163 These large differences 
across studies are well explained because young stroke is a heterogeneous disease and 
most studies were small, had different selection criteria, did not investigate patients in 
person but relied on telephone interviews, and outcome assessments and follow-up 
planning was not uniform and often suboptimal. Although stroke includes both isch-
aemic and haemorrhagic stroke, almost all studies have excluded the investigation of 
aetiology and prognosis of young haemorrhagic stroke.
Except for recurrent vascular disease and persistent motor and language impairments, 
post-young stroke quality of life will most likely also be determined by cognitive dys-
function, depressive symptoms, fatigue, and specific post-stroke complications such as 
epilepsy, because those determine the ability to (return to) work and to have a normal 
family and social life. Data on those aspects in the very long-term follow-up of young 
stroke patients are even more scarce.
Although the absolute number of young stroke is lower than stroke among the elderly, 
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the total number of years that young stroke patients as a whole will live with the con-
sequences of the stroke exceeds that of older stroke survivors due to far longer survival.
This justifies a properly designed and executed study on risk factors and prognosis 
of young stroke, compared with controls. We therefore set up the FUTURE study (Fol-
low-Up of Transient ischaemic attack and stroke patients and Unelucidated Risk factor 
Evaluation study), the largest single-centre prospective cohort study on risk factors and 
prognosis of young TIA, ischaemic stroke and haemorrhagic stroke patients (n=1 006) 
and controls.
Methods/Design
The FUTURE study is a prospective cohort study that aims to investigate the causes 
and consequences of a young stroke. The Medical Review Ethics Committee region 
Arnhem-Nijmegen approved the study.
Patients
The department of neurology has a long-standing interest in the aetiology and prog-
nosis of young stroke and therefore maintains a prospective registry of all consecutive 
young stroke patients with a standardised collection of baseline and clinical character-
istics (see ‘baseline’) since the 1970’ies.164 For the current FUTURE study, all consecutive 
TIA, ischaemic stroke patients with presumed arterial origin or those with an intracere-
bral haemorrhage that sought medical attention for these disorders at the department 
of neurology of the Radboud University Nijmegen Medical Centre between 1-1-1980 
and 1-11-2010 will be eligible for participation in the study.
Inclusion criteria
• TIA, ischaemic stroke of presumed arterial origin or intracerebral haemorrhage
• Date of onset between 1-1-1980 and 1-11-2010
• Age 18-50 at onset
Exclusion criteria
• Traumatic haemorrhagic stroke
• Intracerebral haemorrhage in known cerebral metastasis or primary brain tumor
• Ischaemic/haemorrhagic stroke due to cerebral venous sinus thrombosis
• Intracerebral haemorrhage due to ruptured cerebral aneurysm
• Any subarachnoid haemorrhage 
• Retinal infarct
TIA was defined as a rapidly evolving focal neurological deficit with no other than a vas-
cular cause lasting less than 24 hours. Stroke was defined similarly, but with symptoms 
lasting more than 24 hours. On the basis of radiological findings, stroke was further 
subdivided into haemorrhagic and ischaemic stroke.
As the diagnostic process may have changed during a more than 30-year period all ini-
tial diagnoses were reviewed by a panel of 2 experts from a pool of 4 (FEdL, EvD, RA, LJD) 
and in cases of disagreement a consensus meeting was held to adjudicate the event.
1 006 patients who had sought medical attention at our University Medical Centre 
between 1-1-1980 and 1-11-2010 fulfilled inclusion and exclusion criteria for our study. 
Characteristics of our baseline population (at the time of their qualifying event) are 
reported in Table 1.
Table 1 Baseline population characteristics.
 
Total 
population
Time of index event
1980-1989 1990-1999 2000-2010
n 1006 223 249 534
Men, n (%) 470 (46.7) 110 (49.3) 128 (51.4) 232 (43.4)
Age at index event, mean (SD) 40.2 (7.9) 39.3 (8.3) 39.7 (8.6) 40.8 (7.4)
Index event
TIA, n (%) 277 (27.5) 52 (23.3) 40 (16.1) 185 (34.6)
Infarction, n (%) 630 (62.6) 146 (65.6) 189 (75.9) 295 (55.2)
Haemorrhage, n (%) 99 (9.8) 25 (11.2) 20 (8.0) 54 (10.1)
Controls
Control subjects will be recruited among the patients’ spouses, relatives or social en-
vironment. They have to be at least 18 years old without a history of any TIA or stroke 
before the age of 50 at the moment of inclusion.
Baseline
At baseline (during the occurrence of the qualifying event for the study) a minimal 
dataset has been collected that consists of demographics, stroke subtype, risk factors, 
and additional investigations (Table 2). The completeness of the baseline dataset varies 
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among patients due to changes in standard diagnostic procedures over the last 30 years.
Current common rating scales for the severity and cause of stroke did not exist at the 
time when a substantial proportion of our patients experienced their qualifying event. 
Therefore, a rating of both the severity (NIHSS) and cause (TOAST) was done for all cas-
es retrospectively by a validated approach.165
Follow-up
Information on the vital status will be available either from hospital data or through 
coupling of patient records with data from the municipality registry. All patients alive 
will be approached for the follow-up assessment according to a 2-step approach.
First, all patients will be contacted by letter to inform them about the study; subse-
quently they will be contacted by phone. In case the patient has moved, the municipal-
ity register of the last known residence will be contacted to trace the patient. In cases 
of an invalid phone number, a second letter will be sent asking the patient to contact 
our centre to provide a correct phone number. Subsequently, when a patient does not 
respond to the second letter, the last known general practitioner will be contacted 
to provide us with updated contact details. The patient will be considered lost to fol-
low-up when known alive, but when untraceable via the procedure described above.
Subsequently, patients will be given the opportunity to participate in an extensive sub 
study. If they agree to do so, they will be invited to visit our research centre for addi-
tional investigations including a structured interview, cognitive assessment, physical 
and neurological examination, an extensive MRI protocol, an electrocardiogram, and 
an ultrasonography of the carotid arteries (Table 2). In addition, blood samples (serum/
plasma/DNA) will be taken for future analysis. When patients are not able to visit our 
research centre the same investigations will be performed at their homes, except for 
the ultrasonography of the carotid arteries, electrocardiogram, and MRI scan. Controls 
will undergo the same protocol as patients.
The follow-up has started at the end of 2009 and is planned to finish at the end of 2011. 
All these participants signed an informed consent.
Table 2 Schedule of assessments in the FUTURE study.
Assessment  Baseline Follow-up
Demographics
Ethnicity X
Education X
Marital status X
Social/living status X
Stroke Characteristics
Qualifying event X
Symptoms at onset X
Discharge date and destination X
TOAST X
NIHSS at admission and at discharge X
Modified Ranking Scale at discharge X
Medical History
History of any cardiovascular disease X Xa
Cardiovascular risk factors X Xa
Family history of cardiovascular disease X X
Medication use X Xa
Stroke related surgical procedures X Xa
Epilepsy X Xa
Neuropsychological examination
Global cognitive function
        Mini Mental State Examination (MMSE) X X
Verbal memory function
        Rey Auditory Verbal Learning Test X
Visuospatial memory
        Rey's Complex Figure Test X
Speed of information processing
        Symbol-Digit Substitution Task X
        Stroop test X
Working memory
        Paper and Pencil Memory Scanning Tasks X
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Assessment  Baseline Follow-up
Neuropsychological examination
Executive functioning
        Animal Fluency task X
Attention
       Verbal series attention test X
Subjective cognitive failures
      Cognitive failures questionnaire X
Depressive symptoms
Structured questionnaire depressive symptoms Xa
      Mini International Neuropsychiatric Interview (MINI) X
      Centre of Epidemiological Studies Depression Scale (CES-D) X
      Hospital Anxiety and Depression Scale (HADS) X
Physical examination
Length and weight X X
Waist circumference X
Blood pressure X X
Heart rate X X
Neurological examination
Babinski sign X
Sensory system
      Quantitative measurement by vibration tuning fork X
Muscle strength 
      Medical Research Council Scale (MRC) X
Mobility and activities of daily living
TUG-test X
Exercise expressed in metabolic equivalent value Xa
Tinetti test (body balance and gait) X
Modified Ranking Scale (MRS) X X
Barthel Index X
Instrumental activities of daily living questionnaire (IADL) X
Assessment  Baseline Follow-up
Additional questionnaires
Fatigue
     CIS20R X
Health related quality of life
     Short Form 36 X
     EQ-5D X
     Stroke impact scale 3.0 X
Sleep disturbances Xa
List of Threatening Experiences (LTE) Xa
Work Xa
Radiological examination
Confirmation of index event (CT or MRI) X
Angiography X
MRI
     T1 magnetization-prepared rapid gradient echo X
     FLAIR pulse sequences X
     Transversal T2* weighted gradient echo sequence X
     Diffusion Tensor imaging X
     Resting state imaging X
     Time-of-flight angiography X
Ancillary investigation
Electrocardiogram X X
Ultrasonography of the carotid arteries X X
a) Variables were collected both for the period before and after the index event.
Outcome events
The primary outcome of the study will be all-cause mortality and the composite end-
point of death from all vascular causes; non-fatal stroke, non-fatal (silent) myocardial 
infarction, cardiovascular procedures (coronary artery bypass grafting, percutaneous 
transluminal coronary angioplasty, carotid endarterectomy, and other arterial revascu-
larisation procedures), whichever occurred first. We will perform separate analyses for 
the occurrence of fatal or non-fatal stroke. Causes of death will be categorised into 
Table 2  Continued Table 2  Continued
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ischaemic stroke, intracerebral haemorrhage, cardiac causes, other vascular causes or 
non-vascular causes. If we cannot obtain information about the cause of death, the 
event will be classified as unspecified.
Secondary outcomes are seizures (classified according to the ILAE166) and dementia (ac-
cording to DSM-IV).
Whenever an outcome event is suspected with the aid of a standardised, structured 
questionnaire, information retrieved will be verified and adjudicated by physicians from 
the appropriate specialty. In case a patient has died, this information will be retrieved 
from their general practitioner or a relative. If there is no information available, the 
event will be classified as a possible event.
Assessment of variables during follow-up
Demographics and life style
Standardised questionnaires on demographics, education (classified using 7 catego-
ries; ‘1’ being less than primary school and ‘7’ reflecting an academic degree),167 marital 
status, living conditions, and life style habits (alcohol consumption, smoking, exercise) 
will be administered. Alcohol consumption will be defined as units per day and the 
age at which alcohol consumption had started (and ended if stopped) will be noted. 
Cigarette smoking behavior will be defined as never, former, and current. Subsequently, 
former and current smoking behavior will be quantified as the number of pack-years, 
calculated as the number of packs of cigarettes smoked per day multiplied by the 
number of years a participant had smoked. Exercise will be expressed in the metabolic 
equivalent value (MET) according to accepted standards.168
Medical history
Structured, standardised questionnaires will be used to assess participants, history of 
hypertension, diabetes mellitus, atrial fibrillation, TIA, stroke, myocardial infarction, cor-
onary artery bypass grafting, percutaneous transluminal coronary angioplasty, carotid 
endarterectomy and other arterial revascularisation procedures, 169-172 migraine with or 
without aura,173 pregnancy, and malignancy. Whenever a primary or secondary out-
come event is suspected with the aid of this standardised, structured questionnaire, 
information retrieved will be verified and adjudicated by physicians from the appro-
priate specialty (see outcome events). The presence of a family history of myocardial 
infarction, cerebrovascular disease, and diabetes mellitus in next of kin will be recorded.
Epilepsy
Each patient will be evaluated for a history of epilepsy by means of a standardised, 
structured questionnaire. Whenever epilepsy is suspected, information will be retrieved 
from the treating physician and verified and adjudicated by a neurologist (FEdL). Epi-
lepsy will be classified according to the ILAE criteria.166 Post-stroke epilepsy will be sub-
divided into early (≤7 days post-stroke) and late (>7 days) post-stroke epilepsy.
Current medication
Current medication use and the age at which medication use started will be noted 
and classified according to the Anatomical Therapeutic Chemical (ATC) classification 
system (World Health Organization, WHO Collaborating Centre for drug statistics and 
methodology, http://www.whocc.no/atcddd/).
Neuropsychological assessment
We will administer an extensive neuropsychological test battery that encompasses 
items from other large-scale epidemiological studies covering the main cognitive do-
mains.174, 175 Global cognitive function will be assessed using the Mini Mental State Ex-
amination (MMSE).176 Verbal episodic memory function will be assessed by the 3-trial 
version of the Rey Auditory Verbal Learning Test (RAVLT) that also includes a delayed 
free-recall and recognition trial, a test used to evaluate the ability to acquire and retain 
new verbal information.177 Visuospatial episodic memory will be administered by the 
Rey Complex Figure Test (RCFT), that consists of 3 trials: a copy trial, an immediate recall 
trial after 3 minutes and a delayed-recall trial after 30 minutes.178 To evaluate speed of 
information processing and executive function, 2 tests will be used; the abbreviated 
Stroop Color Word Test (3 subtasks, the interference trial measuring response inhibi-
tion)179 and the Symbol-Digit Substitution Task, which is a modified version of the Sym-
bol Digit Modalities Test.180 A verbal fluency task in which as many animals as possible 
have to be named within 60 seconds will be used to test semantic memory and execu-
tive functioning (response generation). To assess working memory, the Paper and Pen-
cil Memory Scanning Task (4 subtasks)181 will be used. To evaluate attention, the verbal 
series attention test (VSAT) will be used. 182 To register subjective cognitive failures we 
will administer the modified Cognitive Failures Questionnaire (CFQ).183 The assessments 
will be carried out under standard circumstances in quiet rooms.
A standardised structured questionnaire used in previous large-scale epidemiological 
studies will be used to assess the history of depressive symptoms; normal reactions 
to stressful events or normal grief will carefully be excluded.184 In case of a depres-
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sive episode, age of onset, the medical advice and medication use will be registered. 
We defined ‘depression’ as those depressive episodes that have required attention of 
a general practitioner, psychologist or psychiatrist. This definition includes minor de-
pression, as well as more severe depression syndromes such as major depression and 
bipolar depression.184
In addition, participants will be screened for current depressive symptoms by means 
of the Mini International Neuropsychiatric Interview (MINI), part A, which is a short di-
agnostic structured interview based on the DSM IV.185 Additionally, presence of actual 
depressive symptoms will be assessed by 2 self report questionnaires, the Centre of 
Epidemiologic Studies Depression Scale (CES-D)186 and the Hospital Anxiety and De-
pression Scale (HADS).187
Physical and Neurological Examination
Height and weight will be measured without shoes in light clothing. The body mass in-
dex (BMI) will be calculated as weight divided by height (in meters) squared. The maxi-
mal waist circumference will be measured without shirt, in standing position, between 
the lowest rib and the iliac crest, at the end of normal expiration.188 Blood pressure and 
pulse rate will be measured in triplicate in supine position after 5 minutes rest. Subse-
quently 1 measurement is performed after 1 minute in upright position.171
The strength of the biceps, hand grip, iliopsoas, quadriceps, and foot extensor muscles 
on both sides will be scored according to the medical research council scale (MRC).
The sensory system will be assessed by a quantitative measurement by vibration tun-
ing fork (Rydel-Seiffer®) on both first toes and both medial malleolus, also registering 
ankle edema and the ankle jerk reflex.
Gait and balance
We will use a widely used modified version of the original Tinetti test with 17 items: 9 
for body balance (score 0-16) and 8 for gait (score 0-12), with a maximum score of 28.189 
It grades balance while sitting, standing with eyes open and closed, nudging and turn-
ing, gait initiation, stride length and width and symmetry. Functional mobility will be 
classified by using the widely-used timed-up-and-go(TUG)-test which is a timed test 
during which the participant is asked to rise from a standard armchair, walk 3 m, turn, 
walk back, and sit down again.190 Each participant will perform the test 3 times.
Functional performance
As a measure of disability the Barthel Index and modified Ranking Scale will be used.191 
The activities of daily living will be assessed by the instrumental activities of daily living 
questionnaire.192
Additional self-report questionnaires
Several primary sleep disorders are addressed using a number of screening ques-
tions. The presence of possible sleep disordered breathing is based on a history of 
snoring, witnessed sleep-related apneas, and non-restorative sleep. Non-REM and REM 
parasomnias are addressed based on a history of sleepwalking or dream-enacting 
behaviour. Excessive daytime sleepiness will be assessed based on the presence of 
continuous feelings of sleepiness, sleep attacks or a combination of both. Finally, the 
presence of sleep-onset and/or sleep-maintenance insomnia is recorded. 
For the assessment of fatigue we will use the Checklist on Individual Strength (CIS20R).193 
The overall health status (quality of life) will be assessed with the Short Form 36 (SF-
36),194, 195 the EQ-5D,196 and the Stroke Impact Scale 3 (SIS-3).197
Adverse life events will be assessed with the 12-item List of Threatening Events (LTE), 6 
months before the index event and subsequently the period after the index event.198
Patients will be asked for their employment status in the month before their index 
event, within the first year after their index event and at time of the follow-up visit. Each 
period includes a description of occupation, working hours a week, adjustments in 
tasks, use of supporting devices and reasons for not working.
Ancillary Investigations
MRI protocol
MRI scanning will be performed on a 1.5-Tesla Magnetom scanner (Siemens, Erlangen, 
Germany). The scanning protocol includes whole brain 3D T1 magnetisation-prepared 
rapid gradient-echo (MPRAGE) sequence (TR/TE/TI 2730/2.95/1000ms; flip angle 7°; vox-
el size 1.0x1.0x1.0mm); FLAIR pulse sequences (TR/TE/TI 12220/85/2200 ms; voxel size 
1.0x1.2x3.0mm; slice gap 0.6 mm); transversal T2-weighted turbo spin echo sequence 
(TR/TE 7440/96ms; voxel size 0.9x0.9x3.0 mm; slice gap 0.6 mm); Multi-slab 3D time of 
flight angiography sequence (TR/TE 24/7ms; voxel size 0.8x0.5x1.0mm) will be made 
of the carotid arteries and the circle of Willis. Gradient echo susceptibility weighted 
imaging sequence (TR/TE 49/40ms; voxel size 0.8x0.7x1.0mm); DTI (TR/TE 9100/98ms; 
voxel size 2.2x2.2x2.2mm; 7 unweighted scans, 61 diffusion weighted scans, with non 
co-linear orientation of the diffusion-weighting gradient, and b value 1000s/mm²) and 
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resting state imaging using a gradient echo EPI (TR/TE 1870/35ms; voxel size 3.5x3.5x3.0 
mm; slice gap 0.5mm). During resting state, participants will be told not to concentrate 
on any particular subject, but just to relax with their eyes closed. The complete scan-
ning protocol takes approximately 60 minutes.
ECG
An electrocardiogram (ECG) will be performed and evaluated by a standardised assess-
ment by an experienced cardiologist, registering frequency, cardiac rhythm, cardiac 
ectopias, cardiac axis, conduction time over the PQ, QRS, and QTC intervals, conduc-
tion disturbances, left ventricle hypertrophy, pathologic Qs, infarction, repolarisation 
disturbances, and acute ischaemia. A final diagnosis is defined as normal, abnormal 
without clinical significance, abnormal with clinical consequences or pathologic ECG 
with immediate consultation of a cardiologist when necessary.
Carotid ultrasound
A carotid ultrasound assessment will be performed at which the intima media thick-
ness (IMT) will be measured in the distal (near the bulbus) left and right common carot-
id artery. All measurements will be performed using a phased array real-time scanner 
(Philips i-u22, The Netherlands) with a 17-5 MHz broadband linear transducer. The IMT 
will be automatically measured by QLab® qualification software (V. 4.2.1.) according to 
previously described procedures.199 All ultrasound measurements will be performed by 
3 experienced and specific trained clinical neurophysiology technicians.
Vena puncture
Fasting blood samples will be taken. Immediate analysis will include glucose, creati-
nine, lipid profile and complete blood count. Additional serum, plasma and DNA will 
be stored (-80°C) for future biochemical and genetic analyses.
Statistical analysis
Cumulative risk of primary and secondary outcomes will be estimated with Kaplan-Mei-
er analysis. In the analysis of vascular events, patients who had died from other than 
the defined fatal endpoints will be censored at the time of death. Cox proportional 
hazard models will be used to calculate the risk of suffering from any of the primary 
or secondary outcomes in the follow-up period, with adjustments for the necessary 
covariates. The relative risk (hazards ratios) will be calculated with their corresponding 
95% confidence intervals.
Cross-sectional analysis (for example in the comparison between patients and controls 
of data acquired during the follow-up) of continuous variables will be done with Stu-
dent’s t-test or analysis of variance or in case of skewed distributions which cannot be 
normalised corresponding non-parametric tests will be used. Chi-squared test will be 
used for cross-sectional analysis of categorical variables.
Discussion
Detailed information on risk factors and the long-term prognosis in young stroke pa-
tients, and more specific the risk of mortality and recurrent vascular events, remains 
scarce. These data are often derived from selected patients (often with the exclusion 
of TIA and haemorrhagic stroke patients) in small sized studies with short follow-up 
without in person assessment of risk factors and outcomes. We therefore performed 
the FUTURE study, designed to investigate risk factors and to prospectively assess prog-
nosis in a large cohort of young stroke patients.
Strong elements of our study are the inclusion of both TIA and haemorrhagic and 
ischaemic stroke patients, the very long follow-up (up to 30 years), its sample size of 
over 1 000 potential participants and the availability of baseline data of all consecutive 
patients in a single university medical centre. In addition, the extensive investigation 
during a follow-up visit, including advanced neuroimaging has the potential of major 
contributions to the field. Our study differs from many other young stroke studies due 
to the inclusion of controls that enable us to compare the frequency of some pre-
sumed, but also unknown, risk factors between patients and controls. Detailed risk fac-
tor analysis can be done, not only for commonly documented risk factors but also for 
those that are rarely documented in medical records, like physical inactivity and sleep 
disturbances. Moreover, the inclusion of healthy controls provides the opportunity to 
distinguish consequences of a young stroke from other factors like ageing effects.
We feel that completion of our study may contribute to a better understanding of the 
aetiology of young stroke and may provide better information for treating physicians 
and patients with respect to the prognosis of young stroke.
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Abstract
Background and objective 
Up to 14% of all ischaemic strokes occur in young adults (<50 years). Post-stroke 
cognitive performance is a decisive determinant of their quality of life. However, 
virtually no studies report on cognition after young stroke, especially not on the 
long term. This long-term perspective is important since young patients have a 
long life expectancy during which they start forming a family, have an active social 
life and make decisive career moves. We aimed to evaluate the long-term cogni-
tive outcome.
Methods
All consecutive patients between January 1, 1980 and November 1, 2010 with a 
first-ever young ischaemic stroke were recruited for cognitive assessment, using a 
matched stroke-free population as a reference. Composite Z-scores for 7 cognitive 
domains were calculated and the ANCOVA model was used (Bonferroni correction). 
A below average performance was defined as >1.0 SD below the age-adjusted 
mean of the controls and cognitive impairment as >1.5 SD.
Results
277 patients and 146 matched controls completed cognitive assessment (mean 
follow-up  11.0 (SD 8.2) years; mean age 50.9 (SD 10.3) years. Long-term cognitive 
outcome after an ischaemic stroke was worse in most cognitive domains com-
pared with a non-stroke population. Up to 50% of the patients had a below aver-
age performance or cognitive impairment. Deficits in processing speed, working 
memory, and attention were most common. 
Conclusions
Even 11 years after ischaemic stroke in young adults, a substantial proportion of 
patients must cope with permanent cognitive deficits. These results have implica-
tions for information given to patients and rehabilitation services.
Introduction
Approximately 10% to 14% of all ischaemic strokes occur in young adults (aged 18-50).43, 
104, 200-204 The incidence of stroke in young adults is rising, which is a major concern.6
Their outcome is usually considered fairly good, since these patients usually have a 
good motor recovery,118, 129 and outcome after stroke is usually assessed with rating 
scales that predominantly measure motor performance.7 However, post-stroke out-
come is also very much dependent on cognitive performance after stroke. Surprisingly, 
there are only a few studies that addressed cognitive outcome on the short term (4-
12 months)28, 29 and none on the long term. Although these short-term studies found 
somewhat lower cognitive performance in ischaemic stroke patients compared with 
controls, that may still very well be compatible with the common observation of grad-
ual cognitive recovery, that may continue for at least 1 year or longer after stroke.205, 206
Since life expectancy of most of these patients exceeds by far 1 year,109 patients need to 
be informed about their cognitive prognosis, not only on the short term, but particu-
larly for the coming decades as they are in a period of life in which they start forming a 
family, have an active social life, and make decisive career moves. It is exactly this long-
term perspective that is currently missing. The aim of the present study was to inves-
tigate the long-term cognitive performance after a first-ever young ischaemic stroke. 
Patients and methods
Study design
This study is part of the ‘Follow-Up of Transient ischaemic attack and stroke patients 
and Unelucidated Risk factor Evaluation’ (FUTURE) study, a large cohort study which 
investigates causes and consequences of stroke in young adults.42 The Medical Review 
Ethics Committee region Arnhem-Nijmegen approved the study and the recruitment 
of controls. The present study comprises all consecutive patients with a first-ever isch-
aemic stroke of presumed arterial origin, aged 18-50 years, admitted to Radboud Uni-
versity Nijmegen Medical Centre from January 1, 1980, until November 1, 2010. This hos-
pital is a large academic centre, receiving patients from both the direct environment 
as well as serving as a tertiary referral centre. Our hospital is the only academic medical 
centre in our region. 
Patients were identified through a prospective registry of all consecutive young isch-
aemic stroke patients that has been kept at the department since the 1970s with a 
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standardised collection of baseline clinical characteristics and neurological exam. Isch-
aemic stroke was defined as focal neurologic deficit persisting more than 24 hours. The 
diagnosis of ischaemic stroke and lesion location were based on medical records and 
radiological findings. 
The diagnostic techniques improved during a 30-year period and to minimise bias all ini-
tial diagnoses were reviewed by a panel of 2 experts from a pool of 4 (FEdL, EvD, RA, LJD) 
and in cases of disagreement a consensus meeting was held to adjudicate the event.
Primary exclusion criteria for ischaemic stroke patients in the FUTURE study were ce-
rebral venous sinus thrombosis and retinal infarction. There were additional exclusion 
criteria for cognitive assessment based on the neurological exam, which was also a part 
of the FUTURE study (Figure 1). 
Controls were recruited among patients’ spouses, relatives, or social environment. They 
had to be at least 18 years old without a history of TIA or stroke. The control group and 
patient group were matched for age, sex, and level of education. Controls were all living 
independently, none fulfilled the clinical criteria of dementia. They were recruited from 
the same environment as patients. 
Written informed consent was obtained from all participants.
Cognitive assessment
Neuropsychological tests were administered between November 2009 and end 2011. 
They covered the main cognitive domains and these tests have been previously ap-
plied in large-scale epidemiological studies in cerebrovascular disease.174, 175 Strict in-
struction protocols were used to assess cognitive performance and researchers were 
trained. The following cognitive domains were examined: Processing speed (the written 
administration of the Symbol-Digit Modalities Test, Abbreviated Stroop Color Word 
Test, parts I and II), Visuoconstruction (Rey-Osterrieth Complex Figure (ROCF) - Copy 
trial), Working memory (Paper and Pencil Memory Scanning Task (PPMST)), Immediate 
memory (ROCF - Immediate recall and the total number of words immediately recalled 
in the 3-trial version of the Rey Auditory Verbal Learning Test (RAVLT)), Delayed memo-
ry (delayed recall on the ROCF and the RAVLT), Attention (Verbal Series Attention Task 
(VSAT)), and Executive functioning (Verbal Fluency and Stroop Interference). To account 
for speed-accuracy trade-off on the Stroop test, PPMST, and VSAT, composite scores 
were calculated (accuracy(%)/reaction time).207 Stroop Interference was computed by 
dividing the composite Stroop part III score by the mean of the composite scores of 
parts I and II. To prevent potential bias in scoring the ROCF, 2 researchers independently 
rated 10% of the complex figures in both patients and controls, with high inter-rater 
reliability using the Spearman’s correlation coefficients (Copy: r
s
=0.90; Immediate recall: 
r
s
=0.97; Delayed recall r
s
=0.95). Detailed information on the neuropsychological exam-
ination is described extensively elsewhere.42
Other measurements
Age, sex, level of education, depressive symptoms, and fatigue were considered pos-
sible confounders. Level of education was scored with a Dutch scoring system (1=less 
than primary school; 7=university degree).208 
Depressive symptoms were assessed using the Hospital Anxiety and Depression Scale 
(HADS),187 and fatigue was assessed using the subscale Subjective Fatigue of the revised 
Checklist Individual Strength (CIS-20R).193, 209 
Marital status (married, divorced, widowed, and never married) at follow-up was re-
ported. Employment status at follow-up was defined as the number of patients who 
worked/studied at the time of their event and were unemployed, still employed or 
retired at follow-up assessment. Employment status of controls was defined as em-
ployed, unemployed, and retired at follow-up assessment. Functional outcome during 
follow-up visit was evaluated using the Barthel Index210 and modified Ranking Scale 
(mRS).7 A good functional outcome was defined as a mRS score of 0-1 and a Barthel 
Index of ≥85.211
Furthermore, assessment of both the aetiology (TOAST)212 and severity (National Insti-
tutes of Health Stroke Scale; NIHSS)213 was performed retrospectively in all cases using a 
validated approach,165, 214 because these scales did not exist at the time when a substan-
tial proportion of the patients experienced their qualifying event.
We assessed vascular risk factors (hypertension, diabetes mellitus, dyslipidaemia, smok-
ing (current/former/never), current alcohol use (>2 units/day)), and vascular disease 
(myocardial infarction and recurrent stroke) on the basis of medical history using a stan-
dardised, structured questionnaire and/or the use of medication. Whenever a myocar-
dial infarction or recurrent stroke was suspected information retrieved was verified and 
adjudicated by physicians. The body mass index (BMI) at follow-up was calculated as 
weight (kilograms) divided by height (meters) squared.
Statistical analysis
Baseline characteristics were presented as means (±SD), median (Q1-Q3) or number of 
cases (%). All statistical analyses were performed with SPSS 20.0 software for Windows. 
Baseline characteristics in young ischaemic stroke participants and ischaemic stroke 
patients who refused cognitive assessment were compared using a Pearson’s chi-
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square test, Mann-Whitney U test, or Student’s t-test when appropriate. To adjust for mul-
tiple comparisons in all analyses a Bonferroni correction was applied (p-values <0.0071 
were considered significant, since there were 7 pairwise comparisons for each analysis).
The mean raw cognitive test scores (±SD) for each test were calculated. The Rey Com-
plex Figure - Copy trial showed a left skewed distribution, therefore this variable was 
transformed (e5) to obtain a normal distribution to use in all subsequent analyses.215 
For the purpose of data reduction, across-domain comparison, and statistical consid-
erations, raw test scores were converted to Z-scores, using the mean and standard de-
viation of the controls. Z-scores of tests assigned to the same cognitive domain were 
averaged and were used in all subsequent analyses as composite Z-score, or domain 
score. If 1 test of a particular domain was missing, the domain score was occasionally 
based on the remaining tests of that domain (always <5.1%).
A 1-way ANCOVA model was used for each cognitive domain with a 2-level factor ad-
justing for age, sex, level of education, depressive symptoms, and fatigue severity. All 
p-values reported were 2-sided and confidence intervals were calculated at the 95%-CI. 
Linear regression was used to explore the effect of differences in follow-up duration and 
performance on cognitive domains adjusting for age, sex, level of education, depres-
sive symptoms, and fatigue. Results were reported as standardised beta coefficients.
Below average performance and cognitive impairment
Due to the long-term follow-up patients differed in age at follow-up cognitive assess-
ment. Obviously, age has an influence on cognitive performance apart from stroke.216 
To account for differences in age, age-adjusted Z-scores for each neuropsychological 
test were calculated using the mean and SD of the controls in 3 different strata of age 
at follow-up: 20-40, 40-60 and 60-80 years. Next, Z-scores of cognitive tests assigned to 
the same cognitive domain were averaged.
The frequency of a below average performance (>1.0 SD below age-adjusted mean of 
controls) and cognitive impairment (>1.5 SD) was determined.140
A Pearson’s chi-square test (or Fisher’s exact test when an expected cell count was less 
than 5) was used to investigate differences between patients and controls in the pro-
portion of participants with cognitive impairment.
Lesion location and cognitive outcome
The frequency of cognitive impairment or a below average performance for each cog-
nitive domain in patients with supratentorial infarction (left vs. right) and infratentori-
al infarction was determined. The proportion of patients with cognitive impairments 
Figure 1 Flowchart of the study population.
*Severe psychiatric disorder (1), inability to communicate in Dutch (1), blind and deaf (1), severe fatigue (1), 
severe aphasia (only sounds) and bilateral hemianopia (1), severe physical disabilities (1).
were compared with controls using a Pearson’s chi-square test (or Fisher’s exact test 
when an expected cell count was less than 5).
Baseline ever ischaemic 
stroke population
n = 606
Deceased
n = 122
Lost to follow‐up
n = 63
Follow‐up survivors
n = 325
Follow‐up study population
n = 543
Exclusion  cognitive 
assessment
1. Severely  disabled patients  
based on the neurological 
Follow‐up cognitive 
assessment  in first ‐ever 
ischaemic stroke  patients
n = 277
exam: n = 6*
2. Participated  in the 
FUTURE study, but refused 
to visit the research centre: 
n = 42
n = 96
Refused to participate  in 
 the FUTURE study
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Recurrent stroke
All above described analyses were conducted including and excluding patients with a 
recurrent stroke to investigate whether patients with recurrent events influenced the 
results.
Results
The study population consisted of 277 ischaemic stroke participants and 146 controls 
(Figure 1). 
Basic demographic and clinical characteristics of the study population are described in 
Table 1 and neuropsychological test scores are presented in Table 2. 
Mean age of patients was 40.0 (SD 7.7) years at stroke onset; 55.6% was female. Mean fol-
low-up of the study population was 11.0 (SD 8.2) years, while 48.0% had a follow-up of 10 
years or longer. Participants did not significantly differ on basic demographical and clin-
ical characteristics from ischaemic stroke patients who refused to participate or who did 
participate in the FUTURE study but did not want to visit the research centre (Table 1).
Ischaemic stroke patients had a worse cognitive performance on 6 cognitive domains 
after a mean follow-up of 11 years compared with controls (processing speed: F(1,406): 
35.4, p<0.0001; working memory: F(1,407): 41.7, p<0.0001; immediate memory: F(1,412): 
14.0, p=0.0002; delayed memory: F(1,408): 17.7, p<0.0001; attention: F(1,396): 28.6, 
p<0.0001; executive functioning: F(1,409): 17.2, p<0.0001) (Figure 2).
Follow-up duration
In ischaemic stroke patients longer follow-up duration was associated with a lower 
immediate memory (β: -0.23, p=0.001), delayed memory (β: -0.30 , p<0.0001) and exec-
utive functioning score (β: -0.22, p=0.004).
Below average performance and cognitive impairment
Ischaemic stroke patients showed a substantial higher proportion of patients with a be-
low average performance (-1.5 SD ≤ composite Z-score <-1 SD) or cognitive impairment 
(>1.5 SD) compared with controls (Figure 3A). Up to 50% of all ischaemic stroke patients 
had a below average performance or cognitive impairment. Cognitive impairments 
were frequent among patients, affecting up to 34.5%. Deficits in processing speed, 
working memory, and attention were most common.
Table 1  Demographic and clinical characteristics of the study population and 
    ischaemic stroke patients who refused cognitive assessment.
Ischaemic stroke
participants Refusalsa p-valueb Controls
(n=277) (n=138) (n=146)
Age at index event (years) 40.0 (7.7) 40.1 (8.0) 0.84c NA
Men 123 (44.4%) 59 (42.8) 0.75d 61 (41.8%)
Follow-up duration 11.0 (8.2) NA NA
      <10 years 144 (51.9%) NA NA
      ≥10 years 133 (48.0%) NA NA
Lesion location
      Supratentorial stroke 218 (79.0%) NA NA
          Left 116 (42.0%) NA NA
          Right 102 (37.0%) NA NA
          Bilateral 7 (2.5%) NA NA
      Infratentorial stroke 51 (18.5%) NA NA
Age at follow-up examination 50.9 (10.3) NA 48.6 (11.7)
Education 5 (4-6) NA 5 (5-6)
NIHSS score at admission 4 (2-8) 4 (2-7.75) 0.79e NA
Barthel Index at follow-up 96.9 (9.7) NA 99.6 (1.5)
     Good outcome (BI ≥85) 262 (94.6%) 146 (100%)
modified Ranking Scale at follow-up 1 (1-2) NA 0 (0-0)
     Good outcome (mRS 0-1) 191 (69.0%) NA 139 (95.2%)
Marital status at follow-up
     Married  180 (65.7%) NA 97 (66.4%)
     Widowed 5 (1.8%) 4 (2.7%)
     Divorced 22 (8.0%) NA 6 (4.1%)
     Never married 67 (24.5%) NA 39 (26.7%)
Employment status at follow-upf
     Working 120 (51.9%) NA 101 (70.1.2%)
     Unemployed 94 (40.7%) NA 35 (24.3%)
     Retired 17 (7.4%) NA 8 (5.6%)
MMSE at follow-up 26.3 (2.6) NA 27.2 (1.9)
HADS - depressive symptoms 4.0 (3.6) NA 2.5 (2.7)
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Ischaemic stroke
participants Refusalsa p-valueb Controls
(n=277) (n=138) (n=146)
CIS-20R - fatigue severity 30.3 (13.9) NA 22.5 (12.8)
TOAST 0.21d
     Large-artery atherosclerosis 66 (23.8%) 42 (30.4%) NA
     Cardiac source of embolism 26 (9.4%) 10 (7.25%) NA
     Small-vessel occlusion (lacune) 38 (13.7%) 16 (11.6%) NA
     Stroke of other determined aetiology 47 (17.0%) 33 (23.9%) NA
     Multiple aetiologies 7 (2.5%) 3 (2.2%) NA
     Stroke of undetermined aetiology 93 (33.6%) 24 (24.6%) NA
Vascular medical history
     Myocardial infarction 16 (5.8%) 3 (2.1%)
     Recurrent stroke 30 (10.8%) NA
Vascular risk factors
     Hypertension 150 (54.2%) 44(30.1%)
     Diabetes mellitus 34 (12.3%) 6 (4.1%)
     Dyslipidaemia 185 (66.8%) 26 (17.8%)
     BMI at follow-up 26.9 (5.1) 26.9 (4.7)
     Smoking
        Current 78 (28.2%) 38 (26.0%)
        Former 129 (46.6%) 55 (37.7%)
        Never 70 (25.3%) 53 (36.3%)
    Alcohol (>2 units/day) 19 (6.9%) 14 (9.6%)
Data are expressed as mean (SD), number (%) or median (Q1-Q3). NIHSS: National Institutes of Health 
Stroke Scale, MMSE: Mini Mental State Examination, HADS: Hospital Anxiety and Depression Scale, CIS-
20R: Checklist Individual Strength, TOAST: Trial of Org 10172 in Acute Stroke Treatment. NA: not applicable. 
Missing data in ischaemic stroke participants: Lesion location: 0.4%, education: 1.1%, NIHSS at admission: 
0.7%, marital status: 1.1%, employment status: 2.5%. MMSE: 2.9%, HADS depression: 1.1%, CIS-20R: 1.1%, 
BMI: 3.2%, alcohol: 0.4%. Missing in the control group: employment status: 1.4%, BMI: 1.4%. Missing in the 
refusals: NIHSS at admission: 1.4%.  a.) Ischaemic stroke patients who refused to participate in the FUTURE 
study (n=96) + patients who participated in the FUTURE study, but refused to visit the research centre 
(n=42); b.)  Comparisons between ischaemic stroke participants and those who refused cognitive →
Table 1  Continued ← assessment; c.)  Student’s t test; d.) Pearson’s chi-square test; e.) Mann-Whitney U test; f.) The propor-
tion of ischaemic stroke patients with baseline employment (n=231) and who were unemployed, still 
employed, or retired at follow-up. Controls: employment status at follow-up.
Table 2  Neuropsychological test scores of patients with a previous young stroke and 
    controls.
Cognitive domain & test Ischaemic stroke Controls
Processing speed
     SDMT 42.6 (13.7) 53.3 (10.2)
     Stroop part Ia 4.0 (1.1) 4.7 (0.8)
     Stroop part IIa 3.2 (0.9) 3.7 (0.6)
Visuoconstruction
     ROCF copy 30.7 (5.4) 32.4 (2.8)
Memory
    Working memory
        PPMST ‘%’a 2.8 (1.0) 3.6 (0.8)
        PPMST ‘S’a 2.4 (0.8) 3.1 (0.7)
        PPMST ‘MP’ a 1.6 (0.5) 2.0 (0.5)
        PPMST ‘DHN’a 1.3 (0.4) 1.6 (0.4)
   Immediate memory
        RAVLT trial 1-3 18.3 (6.3) 22.1 (6.1)
        ROCF immediate recall 16.4 (6.5) 18.3 (5.8)
   Delayed memory
        RAVLT delayed recall 5.3 (2.8) 6.9 (2.8)
        ROCF delayed recall 15.8 (6.3) 18.0 (5.7)
Attention
   VSATa 1.2 (0.5) 1.5 (0.4)
Executive functioning
   Verbal fluency 21.3 (6.8) 24.4 (5.8)
   Interferencea 0.51 (0.1) 0.56 (0.1)
Data are expressed as mean (SD). SDMT: Symbol-Digit Modalities Test, ROCF: Rey-Osterrieth Complex Fig-
ure, PPMST: Paper & Pencil Memory Scanning Test, RAVLT: Rey Auditory Verbal Learning Test, VSAT: Verbal 
Series Attention Test. a.) Speed-accuracy composite score. Higher scores indicate better performance on 
all measures.
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Figure 2 Cognitive performance after first-ever ischaemic stroke in young adults 
    compared with controls.
Figure shows cognitive performance about 11 years after first-ever ischaemic stroke in young adults com-
pared with controls. Adjusted mean composite Z-score (95%-CI) per cognitive domain (adjusted for age, 
sex, education, depressive symptoms, and fatigue). Grey band represents the 95%-CI of the adjusted 
mean composite Z-score of controls. Missing values in different domains: 0.7-6.5%. No missing values in 
the control group.
* Denotes a significant difference between ischaemic stroke patients and controls. p-value <0.0071 was 
considered significant.
Lesion location and cognitive outcome
One patient could not be classified as supratentorial or infratentorial infarction (infarc-
tion in basal ganglia or brainstem). Seven patients with bilateral supratentorial infarc-
tion were excluded from the analysis since the number of patients was too small for 
further analyses. The results showed that patients with a left supratentorial infarction 
had the worst cognitive outcome, up to 45.5% of patients had cognitive impairments 
on the long term (Figure 3B). 
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Recurrent stroke
After exclusion of patients with a recurrent stroke (n=30) there was no longer a signifi-
cant negative relation between follow-up duration and executive functioning score in 
ischaemic stroke patients. 
Figure 3 Below average performance or cognitive impairment in ischaemic stroke pa- 
    tients and controls. 
Figure 3 shows the proportion (%) of ischaemic stroke patients and controls with a below average perfor-
mance (composite Z-score >1.0 SD below the age-adjusted mean of controls) or a cognitive impairment 
(>1.5 SD) about 11 years after stroke A |. The relationship between lesion location and the proportion of pa-
tients with a below average performance or a cognitive impairment compared with controls B |. (page 72)
IS: Ischaemic stroke, Con: Control group, LS: left supratentorial infarction, RS: right supratentorial infarc-
tion, Inf: Infratentorial infarction.  
* Denotes a significantly higher proportion of patients with cognitive impairment compared with con-
trols. p-value <0.0071 was considered significant.
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Discussion
This study showed that a substantial proportion of young ischaemic stroke patients 
after a mean follow-up of 11 years showed a worse cognitive performance on a wide 
range of cognitive domains compared with a matched stroke-free population. Patients 
with a left supratentorial infarction had the worst cognitive outcome.
Strong elements of our study include a large sample size in a single centre, with a high 
response rate.28, 29 We used extensive neuropsychological testing rather than a short 
cognitive screen and we included a representative control group as a reference for 
neuropsychological examination. 
However, some methodological issues need to be addressed. First, the study was not 
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Figure 3 Continued community-based, but hospital-based and therefore our sample may not represent all 
young stroke survivors in our catchment area. However, we think that our stroke popu-
lation is representative to the wider Dutch stroke population. Those who survive usually 
visit a university medical centre during the course of their disease. Furthermore, the age 
and sex standardised prevalence of stroke in our region equals that of the age and sex 
standardised prevalence of stroke in the Netherlands.217 We therefore believe that our 
cohort has a good external validity. This is also underlined by the fact that we included 
all consecutive cases admitted to our hospital.
Second, cognitive data of patients who refused to participate obviously were lacking, 
but their baseline characteristics did not differ from participants in the present study, 
making a selection bias unlikely.
Although we investigated a wide range of cognitive domains, agnosia or language 
comprehension28 were not included in our neuropsychological assessment. Based on 
the neurological exam we considered the proportion of patients with these symptoms 
to be small and therefore we believe that this has not largely influenced cognitive per-
formance. 
We found relatively low MMSE scores in both the patients and the controls, compared 
with others28 and healthy older adults.218 However, all controls lived independently and 
none fulfilled the clinical criteria for dementia. Furthermore, the diagnostic accuracy of 
the MMSE in detecting cognitive impairment is generally poor, especially outside the 
Alzheimer domain219 hence we believe this finding is of little clinical relevance.
Longer follow-up, adjusted for age effects, was associated with a decrease in cogni-
tive functioning in ischaemic stroke patients. Longer time interval might be associated 
with incident co morbidity that could in turn have negatively affected cognitive per-
formance. Another explanation is that these patients are older and that, apart from 
the stroke, neurodegenerative pathology might have emerged that interacts with the 
cerebrovascular disease.220 A better understanding of this interaction is important as 
especially those with the longest follow-up are the oldest patients who might be at 
risk for further cognitive decline, due to this interaction of vascular lesions and neuro-
degenerative pathology. 
Two studies have investigated cognitive performance in 2429 and 4028 young ischaemic 
stroke patients 4-12 months after stroke. Malm and colleagues29 examined 24 patients 
with cerebellar infarcts and cognitive domains most affected were mental speed, cog-
nitive flexibility, and working memory. We also found that an infratentorial infarction 
was associated with impairments in processing speed and working memory. Cao and 
colleagues28 investigated 40 young ischaemic stroke patients and assessed other do-
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mains and found language comprehension, reasoning and verbal memory to be most 
affected. Processing speed was not assessed in these patients.28 Comparing our results 
with these 2 studies, we found similar deficits in verbal memory, working memory, and 
processing speed, but also deficits in executive functioning and attention are common 
on the long term in ischaemic stroke patients. These 2 domains were not addressed in 
reported studies.28, 29 
A substantial proportion of up to 50% of young ischaemic stroke patients had below 
average cognitive performance or impairment, despite the fact that the median of ini-
tial stroke severity was relatively mild. This highlights the influence of cerebrovascular 
lesions on cognitive performance, even decades after the stroke. It could also be that 
a severity rating scale, which includes predominantly motor signs (NIHSS), may under-
estimate the effect of stroke on other than motor symptoms. This would justify a basic 
careful neuropsychological examination of stroke patients in the (sub)acute phase of 
the disease.
Interestingly, a focal stroke on the long term seems to have a widespread impact on 
cognition, affecting multiple cognitive domains. Increasing evidence suggests that 
focal lesions can have a widespread, diffuse impact on brain network organisation,141 
which may explain the cognitive impairments attributable to dysfunction of the brain, 
remote from the site of the infarction.221 
It appears that stroke in young adults seems to have a relatively better cognitive 
prognosis as compared with stroke in the elderly, as we found cognitive deficits in 
20.4-34.8% of our young ischaemic stroke patients, whereas 31-77%222 was reported 
in elderly stroke survivors. This difference in cognitive prognosis is perhaps due to a 
better collateral blood supply with an attendant lower volume of the infarction, a more 
pronounced neuronal plasticity and the absence of neurodegenerative pathology in 
younger adults.223
Summary
To conclude, in young ischaemic stroke patients, with in general a good motor recov-
ery, long-term cognitive impairments are common. Given the importance of cognitive 
performance for post-stroke quality of life cognitive functioning should be monitored 
in clinical practice. This may also yield valuable information for treating rehabilitation 
services and return to work.
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Abstract 
Background and objective
Few studies exist on subjective cognitive failures after a stroke in young adults (≤50 
years) and their relation to objective cognitive performance is unknown. Therefore, 
we investigated the prevalence of subjective cognitive failures in patients with a 
stroke in young adulthood, and their relation with objective cognitive impairment. 
Methods
This study is part of the ‘Follow-Up of Transient ischaemic attack and stroke patients 
and Unelucidated Risk factor Evaluation’ (FUTURE) study, including patients, aged 18 
through 50 years, admitted to our hospital between 1980 and 2010 with a first-ever 
TIA or ischaemic stroke. The prevalence of subjective cognitive failures in patients 
was determined and compared with 146 age- and sex-matched stroke-free con-
trols. The relation of subjective failures with objective cognitive performance was 
investigated with linear and logistic regression analysis. 
Results
160 patients with a TIA and 277 with an ischaemic stroke were included. After a 
mean follow-up of 10.1 (SD 8.3) years, the prevalence of subjective memory failures 
was 86.4% and that of subjective executive failures was 67.4% in patients, versus 
69.7% (p=0.008) and 41.4% (p=0.002) in controls. A weak association between sub-
jective memory failures and objective immediate (ß: -0.12, p=0.011) and delayed 
memory performance (ß: -0.13, p=0.010) was observed in patients. 
Conclusions
Subjective cognitive failures are prevalent after stroke in young adults, but not 
strongly related to objective cognitive impairment. Therefore, extensive neuropsy-
chological assessment is essential for determination of objective cognitive impair-
ment. However, it is important that subjective cognitive failures are recognised as 
they may indicate underlying psychosocial problems. 
Introduction 
Post-stroke subjective cognitive failures are highly prevalent in the general stroke pop-
ulation.8-10 They are related to current or forthcoming objective cognitive impairment, 
in line with findings in the general elderly population.224, 225 Previous studies report-
ed that in patients with a stroke <55 years, these subjective cognitive failures are very 
common as well up to 2.5 years after stroke, but whether these were also related to 
long-term objective cognitive impairment is not known.9, 30, 31 This information can be 
of help to either prevent unnecessary concern or provide reliable insight in actual or 
future cognitive performance and is particularly important in young adults. They are in 
need for long-term information on possible post-stroke consequences, because they 
usually have a life expectancy of decades ahead. 
Stroke is an umbrella term for, amongst others, also patients with a transient ischaemic at-
tack (TIA). Evidence from older stroke cohorts suggests that a TIA is not as transient as pre-
viously thought, with respect to other less visible symptoms, such as mood disorders.226
Therefore, the aim of our study was to investigate the long-term prevalence of subjec-
tive cognitive failures in patients with a TIA or ischaemic stroke at ages 18 through 50 
years, compared with a stroke-free control population and to investigate the relation 
between these subjective cognitive failures and objective cognitive performance. 
Methods
Patients and study design
This study is part of the ‘Follow-Up of Transient ischaemic attack and stroke patients 
and Unelucidated Risk factor Evaluation’ (FUTURE) study, a large cohort study that in-
vestigates causes and consequences of stroke in young adults. Details of the study 
have been described extensively elsewhere.42, 110 The Medical Review Ethics Committee 
region Arnhem-Nijmegen approved the study.
In short, the FUTURE study comprised all consecutive patients aged 18 through 50 years 
with a TIA, ischaemic stroke or intracerebral haemorrhage, admitted to the Radboud 
University Nijmegen Medical Centre from January 1, 1980, until November 1, 2010.110 
For the present study, only first-ever TIA or ischaemic stroke patients were assessed. 
Patients were included prospectively between 1980 and 2010 with a standardised col-
lection of baseline and clinical characteristics.132 TIA was defined as a rapidly evolving 
focal neurological deficit with no other than a vascular cause lasting less than 24 hours. 
Stroke was defined similarly, but with symptoms lasting more than 24 hours.102, 110, 128, 132 
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All patients underwent neurological examination and brain imaging at the time of their 
index event. Radiological findings were used to differentiate between ischaemic and 
haemorrhagic stroke.
The assessment of stroke severity (National Institutes of Health Stroke Scale (NIHSS)213) 
was done for all cases retrospectively by a validated approach,165, 214 as these scales did 
not exist at the time when a substantial proportion of our patients experienced their 
qualifying event.42
Cerebral venous sinus thrombosis was excluded. There were additional exclusion crite-
ria for cognitive assessment based on the neurological exam, which was also a part of 
the FUTURE study. 
Stroke-free control participants were recruited among the patients’ spouses, relatives, 
or social environment, resulting in a sex- and age-matched control group (n=146). They 
had to be at least 18 years old, without a history of TIA or stroke. Controls were all living 
independently, none fulfilled the clinical criteria of dementia.139
Written informed consent was obtained from all patients and control participants.
Follow-up
All patients alive were invited to visit our research centre for a follow-up examination be-
tween November 1, 2009 and January 1, 2012, including assessment of subjective cog-
nitive failures and an extensive neuropsychological investigation in the same session. 
Subjective cognitive failures
The presence of subjective cognitive failures in the past month was assessed, using a 15 
items semi-structured interview based on the Cognitive Failures Questionnaire (CFQ).183 
This version was also used in other large scale epidemiologic research.227, 228 
Our primary outcome measures were the prevalence of subjective memory failures 
and of subjective executive failures. This subdivision of subjective cognitive failures into 
memory failures and executive failures was made, in order to correlate these specific 
failures to the objective cognitive domains of memory and executive functioning, re-
spectively. 
Subjective cognitive failures were considered present when a participant scored a ‘2 
(moderate)’ or higher on at least 1 item with a scale of 0 to 3 or scored a ‘1’ on at least 
1 item with dichotomous answers (failure present or absent). For this study, only items 
specific for memory failures (missing data in 10 subjects (2.3%)) and executive failures 
(missing data in 1 patient (0.2%)) were used. 
Objective cognitive performance
For the present study, the following cognitive domains were examined: Working mem-
ory (Paper and Pencil Memory Scanning Task (PPMST)), Immediate memory (Rey-Oster-
rieth Complex Figure Test (ROCF) - Immediate recall and the total number of words 
immediately recalled in the 3-trial version of the Rey Auditory Verbal Learning Test 
(RAVLT)), Delayed memory (delayed recall on the ROCF and the RAVLT), and Executive 
functioning (Verbal Fluency and Stroop Interference). If 1 test of a particular domain was 
missing, the domain score was based on the remaining tests of that domain (always 
<5.1%). Detailed information on the neuropsychological examination and calculation 
of domain-scores is described extensively elsewhere.42, 139 The MMSE was administered 
as a measure of global cognitive performance. 
Other measures
Other measures were education, depressive symptoms, fatigue, and current level of 
performance (assessed by the modified Rankin Scale). Level of education was scored 
with a widely-used Dutch scoring system (1 = less than primary school; 7 = university 
degree).229
Depressive symptoms and anxiety were measured using the Hospital Anxiety and De-
pression Scale (HADS), with a cut-off value for the presence of depressive symptoms 
or anxiety of >7.230 Fatigue was assessed using the subscale Subjective Fatigue of the 
revised Checklist Individual Strength (CIS-20R).193, 209
We assessed vascular risk factors (hypertension, diabetes mellitus, dyslipidaemia, 
smoking (current/former/never), current alcohol use (>2 U/day)) and vascular disease 
(myocardial infarction and recurrent stroke) on the basis of medical history using a 
standardised, structured questionnaire, and/or the use of medication. Whenever a 
myocardial infarction or recurrent stroke/TIA was suspected, information retrieved was 
verified and adjudicated by physicians. The body mass index at follow-up was calculat-
ed as weight (kg) divided by height (m) squared. 
Statistical analysis
Baseline characteristics were compared between participants, non-participants (those 
patients that refused and patients lost to follow-up), and deceased patients using Stu-
dent’s t-test, Mann-Whitney U test or chi-square-test when appropriate. Age between 
stroke subgroups (TIA or ischaemic stroke) and controls was compared with a Student’s 
t-test and sex with a chi-square test. P-values <0.05 were considered statistically signif-
icant, unless otherwise specified.
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The prevalence of subjective memory failures and of subjective executive failure was 
calculated, defined as the proportion of subjects in whom subjective memory or exec-
utive failures were present. Logistic regression was used to calculate the risk of having 
subjective memory or executive failures as a patient with a stroke ≤50 years, compared 
with stroke-free controls. Subsequently, the distribution of the total scores of subjec-
tive memory and executive failures is reported as a measure of severity of subjective 
failures. Next, we calculated prevalence of subjective memory failures and of subjective 
executive failure, stratified by tertiles of follow-up (first tertile: up to 4.43 years, n=145; 
second tertile: 4.45 to 13.27 years, n=146; third tertile: 13.49 to 30.00 years, n=146)
In addition, we calculated whether fatigue, the presence of depressive symptoms, and 
the presence of anxiety were associated with the presence of subjective memory fail-
ures or with the presence of subjective executive failures.
The association between subjective cognitive failures and objective cognitive perfor-
mance was calculated in 2 ways. First, for each stroke subtype (TIA or ischaemic stroke) 
and controls, correlations between total scores of subjective memory failures and do-
main scores of objective (working, immediate, and delayed) memory and correlations 
between subjective executive failures and the domain score of objective executive 
functioning were determined using linear regression. In this analysis, a correction for 
multiple testing was applied, using the Bonferroni method. Alpha was set at 0.013 (0.05 
divided by 4 (number of cognitive domains)). Second, we tested with a chi-square test, 
whether the presence of subjective memory and executive failures differed between 
cognitively impaired and unimpaired patients on the memory domain and executive 
functioning domain, respectively (cut-off point >1.5 SD below the mean of the control 
group). Controls were excluded from this analysis, because of the small absolute num-
ber of cognitively impaired patients in this group. 
Age at follow-up, sex, NIHSS-score at admission, education, presence of depression, 
and fatigue were considered potential confounders and adjusted for in analyses when 
appropriate. NIHSS-score in controls was set at ‘0’
All statistical analyses were performed with SPSS 20.0 software for Windows.
Results
Study population and demographics
437 patients were included in the analysis for this study (Figure 1), of whom 160 (36.6%) 
had a TIA, and 277 (63.4%) had an ischaemic stroke. 
Demographics and clinical characteristics are listed in Table 1. 
Table 1 Demographic and clinical variables of patients with a stroke at young age 
    and controls.
TIA
(n=160)
IS
(n=277)
Controls
(n=146)
Baseline
Age at index event (years); mean (SD) 40.9 (8.0) 40.0 (7.7) NA
Men, n (%)a 75 (46.9) 123 (44.4) 61 (41.8)
NIHSS-score at admission; median (Q1-Q3) 0 (0-1) 4 (2-8) NA
Follow-up 
Follow-up duration (years)
       Mean (SD) 8.7 (8.3) 11.0 (8.2) NA
       Median (Q1-Q3) 4.8 (4.8-15.4) 9.3 (4.0-16.6) NA
Age at follow-up (years); mean (SD)b 49.7 (11.2) 50.9 (10.3) 48.6 (11.7)
Education; median (Q1-Q3) 5 (5-6) 5 (4-6) 5 (5-6)
MMSE at follow-up; mean (SD) 26.7 (2.3) 26.3 (2.6) 27.2 (1.9)
mRS at follow-up; median (Q1-Q3) 0 (0-1) 1 (1-2) 0 (0-0)
HADS-depressive symptoms; median (Q1-Q3) 3 (1-5) 3 (1-6.25) 2 (0.75-4)
CIS- fatigue; median (Q1-Q3) 30 (17-41) 30.5 (18-43) 19 (12-30)
Incident vascular events
       Incident myocardial infarction; n (%) 7 (4.4) 16 (5.8) 3 (2.1)
       Incident stroke/TIA;  n (%) 25 (15.6) 47 (17.0) NA
Vascular risk factors
       Hypertension; n (%) 86 (53.8) 150 (54.2) 44 (30.1)
       Diabetes mellitus; n(%) 16 (10) 34 (12.3) 6 (4.1)
       Hypercholesterolaemia;  n (%) 105 (65.6) 185 (66.8) 26 (17.8)
       BMI at follow-up; mean (SD) 26.4 (4.2) 26.9 (5.1) 26.9 (4.7)
       Smoking
          Current; n (%) 34 (21.3) 78 (28.2) 38 (26.0)
          Former; n (%) 59 (36.9) 129 (46.6) 55 (37.7)
          Never; n (%) 65 (40.6) 70 (25.3) 53 (36.3)
       Current alcohol  consumption
       (> 2 units/ day); n (%)   
9 (5.6) 19 (6.9) 13 (8.9)
TIA: Transient Ischaemic Attack, IS: ischaemic stroke, NIHSS: National Institutes of Health Stroke Scale, 
MMSE: Mini Mental State Examination, mRS: modified Rankin Scale, HADS: Hospital Anxiety and →
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← Depression Scale, CIS-fatigue: Checklist Individual Strength, fatigue subscale, BMI: Body Mass Index, NA: 
not applicable. a.) no significant difference between the overall patient group and controls, tested with a 
chi-square test, and b.) Student’s t-test. Ischaemic strokes only differed significantly from controls on age 
at follow-up, p=0.039. 
Figure 1 Flowchart of study population.
0-6) in participants, p<0.001 and p<0.001, respectively). Deceased patients were more 
often men (56.4% versus 45.3%, p=0.017) and slightly older than participants at the time 
of their index event (mean 42.6 (SD 6.6) years versus 40.3 (SD 7.8) years, p=0.002). Pa-
tients lost to follow-up were slightly younger than participants at the time of the index 
event (38.1 (SD 8.5) years versus 40.3 (SD 7.8) years, p=0.025). 
Prevalence of subjective cognitive failures
The overall prevalence of subjective memory and executive failures in patients with 
a stroke ≤50 years was 86.4% and 67.4%. Prevalence of subjective cognitive failures 
stratified by stroke subtype is shown in figure 2A and 2B. Figure 2C and 2D show the 
distribution of total scores of subjective memory and executive failures. Patients more 
often had higher total scores of subjective memory failures (73.5% with a score >2) and 
subjective executive failures (51.6% with a score >2) than controls (46.2% (p=0.0004) 
and 20.5% (p=0.00006), respectively). Prevalence of subjective memory and executive 
failures did not differ between the 3 tertiles of follow-up duration, although there was 
a trend towards higher prevalence of subjective memory failures among patients in the 
tertile with the longest follow-up (OR 2.7, 95%-CI 1.0-7.1). 
The risk of having subjective memory failures was higher in ischaemic stroke patients 
(OR 3.0, 95%-CI 1.5-5.9) than in controls, but did not differ significantly between TIA-pa-
tients (OR 1.6, 95%-CI 0.9-2.9) and controls. The risk of having subjective executive fail-
ures was higher in ischaemic stroke patients (OR 2.9, 95%-CI 1.7-5.1) than in controls, but 
did not differ significantly between TIA-patients (OR 1.6, 95%-CI 1.0-2.7) and controls.
In the patients, the severity of fatigue (OR 1.1, 95%-CI 1.0-1.1, per point of the subscale 
Severe Fatigue of the CIS20R-questionnaire), the presence of depressive symptoms (OR 
12.7, 95%-CI 1.7-94.3), and the presence of anxiety (OR 4.5, 95%-CI 1.6-13.1) were all asso-
ciated with the presence of subjective memory failures in univariate logistic regression 
analysis. When these 3 variables were put together in a multivariate logistic regression 
model, only fatigue was independently associated with the presence of subjective 
memory failures (OR 1.1,95%-CI 1.0-1.1, per point of the subscale Severe Fatigue of the 
CIS20R-questionnaire).
In the patients, the severity of fatigue (OR 1.1, 95%-CI 1.0-1.1, per point of the subscale 
Severe Fatigue of the CIS20R-questionaire), the presence of depressive symptoms (OR 
5.1, 95%-CI 2.2-11.6), and the presence of anxiety (OR 3.8, 95%-CI 2.1-7.1) were all associ-
ated with the presence of subjective executive failures in univariate logistic regression 
analysis. 
 
 
n = 868
Lost to follow‐up
n = 73
Deceased
n = 145
Refused to  participate
n = 139
Exclusion for cognitive 
assessment
n = 74
1. Severely  disabled,  based 
on the neurological exam:   
n = 6
2. Participated in part  of the 
    
     
Follow‐up survivors
n = 511
n = 68
Follow‐up study participants
n = 437
Baseline ever ischaemic
stroke or TIA
FUTURE study, but refused
to visit the research centre:
Patients who refused to participate did not differ from participants with respect to type 
of index event, sex, age at index event, and NIHSS-score at admission. Deceased pa-
tients and patients who were lost to follow-up more often had an ischaemic stroke 
than a TIA as index event than participants. They also had higher NIHSS-scores at ad-
mission than participants (median 5.5 (Q1-Q3: 2-12) and 4 (Q1-Q3: 1-11) versus 2 (Q1-Q3: 
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Figure 2 Prevalence and severity of subjective cognitive failures.
TIA: Transient ischaemic attack, IS: ischaemic stroke. Missing data in part A and C: 3 in TIA group, 7 in IS 
group. Missing data in part B and D: 1 in TIA group. * p<0.01, ** p<0.001.
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When these 3 variables were put together in a multivariate logistic regression mod-
el, only fatigue was independently associated with the presence of subjective mem-
ory failures (OR 1.1, 95%-CI 1.0-1.1, per point of the subscale Severe Fatigue of the 
CIS20R-questionnaire).
In controls, the severity of fatigue was (OR 1.1, 95%-CI 1.0-1.1, per point of the subscale 
Severe Fatigue of the CIS20R-questionnaire) associated with the presence of subjec-
tive memory failures and executive failures. The presence of depressive symptoms or 
anxiety was not related to the presence of subjective memory failures and executive 
failures, in the univariate nor in the multivariate model.
Relation between subjective cognitive complaints and objective
cognitive performance 
Table 2 shows that there was a statistically significant association between subjective 
memory failures and cognitive domain scores of immediate memory (ß: -0.12, p=0.011) 
and delayed memory (ß: -0.13, p=0.010) in the overall stroke population. 
In ‘Online resource 1’, a scatter plot shows that effect sizes of this relation were small, 
with an R2 of 0.06 and 0.05, respectively. The statistically significant difference disap-
peared after stratification by stroke subtype, taking into account the Bonferroni cor-
rection. Subjective executive failures and objective executive performance were not 
associated. 
In controls, no significant associations between subjective cognitive failures and objec-
tive cognitive performance were found. 
In patients with an ischaemic stroke or TIA, the prevalence of subjective cognitive fail-
ures did not differ between patients with or without cognitive impairment (defined as 
>1.5 SD below the mean of the control group) (Figure 3).
Table 2 Relation between subjective cognitive failures and objective cognitive perfor- 
    mance.
Working 
memory
Immediate
memory
Delayed
memory
Executive
functioning
Subjective memory failures
    Participants, overall -0.03 -0.12a -0.13a NA
          TIA -0.08 -0.06 -0.09 NA
          Ischaemic stroke -0.01 -0.15 -0.15 NA
    Controls 0.03 -0.10 -0.05 NA
Subjective executive failures
    Participants, overall NA NA NA 0.00
          TIA NA NA NA -0.04
          Ischaemic stroke NA NA NA 0.01
    Controls NA NA NA 0.04
Table 2 shows correlations between total score of subjective cognitive failures and z-scores of objective 
cognitive performance, calculated with linear regression analysis (numbers in table are adjusted beta’s). 
NA: correlation not determined. a.) p<0.013 (indicating statistical significance after Bonferroni correction).
Online resource 1  →  Page 90
Relation between subjective memory failures and objective memory performance.
A | Subjective memory performance and objective immediate memory performance. 
B | Subjective memory performance and objective delayed memory performance.
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Figure 3 Subjective cognitive failures, stratified by presence of objective cognitive 
    impairment.
TIA: Transient ischaemic attack, IS: ischaemic stroke, SMF: subjective memory failures, SEF: subjective ex-
ecutive failures.
No statistically significant differences between ‘No cognitive impairment’ and ‘Cognitive impairment’ in 
any of the subgroups or cognitive domains.
Missing data in part C: TIA, n=2, IS, n=7; and in part D: IS, n=6.
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Figure 3 Continued Discussion
Subjective memory and executive failures were highly prevalent in our study popula-
tion. We found a statistically significant, yet weak association between the subjective 
cognitive failures and objective cognitive performance in the overall population with a 
stroke at young age, but this association disappeared when stratified by stroke subtype 
after correction for multiple testing. 
A strength of our study is the large sample size with inclusion of all consecutive cases, 
admitted to our hospital. Since in the Netherlands all patients with a stroke at young 
age who survive usually visit a university medical centre during the course of their 
disease, we believe that our study population is a representative cohort for a Dutch 
population with a stroke at young age. In comparison with other studies on patients 
with stroke at a young age, we found similar prevalence of diabetes mellitus and hy-
pertension, a little higher prevalence of hypercholesterolaemia and a somewhat lower 
prevalence of alcohol consumption and smoking.43, 231 However, overall, we conclude 
that the contribution of traditional vascular risk factors was rather comparable to other 
studies on patients with a stroke at young age. Therefore, our results are generalisable 
to other cohorts with patients with stroke at young age in Western societies. Another 
strong element is the inclusion of stroke-free controls. The prevalence of subjective 
memory failures and subjective executive failures among stroke-free controls was high. 
This may be due to several reasons. First, the high prevalence in controls may be a 
reflection of the high prevalence of subjective cognitive failures in the general pop-
ulation. The strict cut-off value from the Cognitive Failures Questionnaire (CFQ) — 1 
positive answer already results in classification as ‘subjective cognitive failures present’ 
— makes it a very sensitive method for assessing subjective cognitive failures, but may-
be not very specific. One population-based study, using the CFQ with the same strict 
cut-off value found subjective memory failures present in 72%.227 However, participants 
in this study were on average 72 years old. Younger individuals may report subjective 
memory complaints less often; unfortunately this has never been formally assessed 
with the CFQ. Second, although controls did not suffer from a stroke themselves, they 
all had a spouse or close relative with a stroke at young age (as controls were recruited 
from the patients social environment). This might have been a stressful life event to 
the controls as well, that could have resulted in psychological vulnerability, that on its 
turn might have contributed to the emergence of subjective memory complaints.232 
However, the presence of depressive symptoms or anxiety was not related to the pres-
ence of subjective cognitive failures in our control group. Moreover, prevalence did 
not differ between controls with a relative who had a stroke <2 years ago and controls 
C
D
Delayed memory
 
Executive functioning
No cognitive impairment  Cognitive impairment  
%
 w
ith
 SM
F
    
 
  
%
 w
ith
 SE
F
  
70
80
90
100
50
60
0
40
n=123 n=35 n=211 n=59
  ISTIA
n=134
 
n=26 n=205 n=66
70
80
90
100
0
40
50
60
  ISTIA
9594
Long-term neuropsychological and social consequences after stroke in young adults
PART III Chapter 5
Subjective cognitive failures after young TIA and ischaemic stroke
5
with our finding that, after long-term follow-up, fatigue, depressive symptoms, and 
anxiety were associated with the presence of subjective memory and executive fail-
ures in the univariate model. Only fatigue was associated with subjective memory and 
executive failures in the multivariate model, independent from depressive symptoms 
and anxiety. The fact that depressive symptoms were not independently (from fatigue 
and anxiety) associated with subjective memory failures in the multivariate model, may 
however been the result of limited power, suggested by the large confidence intervals. 
A meta-analysis in elderly concluded that the presence of subjective memory com-
plaints was related to future mild cognitive impairment or dementia.224 This contradic-
tion with our findings may be because older patients, in addition to the similar cerebral 
ischaemia as in young patients, may also suffer from co-existing neurodegeneration, 
such as amyloid pathology. 
Future research in patients with a stroke at young age should focus on effective cop-
ing strategies with difficulties they are confronted with in daily life, including proper 
knowledge on factors as the presence of depression, fatigue, or work-related issues. 
Unraveling these factors will give the opportunity to effectively adjust rehabilitation 
programmes to these young patients’ specific needs.
In conclusion, our study showed that subjective cognitive failures are highly prevalent 
in patients after a stroke at young age, but these were not strongly related to objective 
cognitive impairment. Given the rising incidence of stroke in young adults, in com-
bination with a usually long life expectancy in these young survivors, the number of 
patients confronted with long-term consequences, such as the highly prevalent sub-
jective cognitive failures, will increase. This study provides insight in how these sub-
jective cognitive failures need to be interpreted by the clinician, and how patients can 
be informed accordingly. For instance, it clearly shows that for the determination of 
objective cognitive impairment, one should not rely on these self-report measures of 
subjective cognitive failures, but a more extensive neuropsychological examination is 
essential. However, it is important that subjective cognitive failures are recognised in 
these patients, because they might indicate other underlying psychosocial problems 
that need guidance or psychological problems that need treatment.
who had a relative with a stroke >2 years ago, a period after which the recovery period 
of neurological deficits in patients is usually considered to be stabilised. However, the 
presence of a higher degree of fatigue was associated with the presence of subjective 
cognitive failures in our control group. The underlying reasons for the presence of fa-
tigue in the control group are unknown. It may be related to co morbidities other than 
stroke, that were not an exclusion criterion in controls. However, these co morbidities 
were neither an exclusion criterion in patients. Comparison with this reference group is 
therefore essential for a realistic comparison with our patient group and a meaningful 
interpretation of findings.
There are some methodological issues that need to be addressed. First, selection bias 
might have occurred, due to patients who refused to participate, patients lost to fol-
low-up, and patients who were deceased. However, patients who refused to partic-
ipate did not differ from participants in baseline clinical and demographic variables 
(index event, sex, age at index event, and stroke severity), making selection bias un-
likely. Patients who were lost to follow-up and deceased patients more often had an 
ischaemic stroke than a TIA. As the prevalence of subjective cognitive failures was very 
high in ischaemic stroke patients, this would only have underestimated the overall high 
prevalence of subjective cognitive failures and would not have altered our conclusions. 
Information bias in collecting data on cognitive functioning might have occurred, be-
cause researchers were not blinded to which group a patient belonged (stroke subtype 
or control), due to the presence of visible physical disabilities. However, strict instruc-
tion protocols were used to assess subjective and cognitive performance by trained 
researchers. 
Potentially, recall bias might have occurred, especially among those with the most out-
spoken cognitive impairment. However, as we assessed the current subjective cogni-
tive failures, we believe that our results are not largely influenced by recall bias. 
Finally, confounding is another bias to be considered. However, we tried to overcome 
this by adjusting for several confounding factors in our analysis. 
The highly prevalent subjective cognitive failures we found in our study were not 
strongly related to objective cognitive impairment. Two previous studies investigated 
the relation between subjective cognitive complaints and objective cognitive func-
tioning in stroke patients in the subacute phase after the stroke9 and after 3 months 
of follow-up.8 Although they reported some contradictory results on the association 
between subjective cognitive failures and objective cognitive impairment, they both 
suggested that the subjective cognitive failures are at least in part the result of other 
factors than objective cognitive impairment, for example mood disorders. This is in line 
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Abstract
Background and objective 
Few studies exist on long-term post-stroke depressive symptoms and anxiety in 
young adults, although these young patients have a particular interest in their 
long-term prognosis, given their usually long life expectancy, being in the midst of 
an active social, working, and family life.
The aims of this study are to investigate the prevalence of depressive symptoms 
and anxiety and their association with clinical and demographic variables and with 
functional outcome after stroke in young adults. 
Methods 
Long-term prevalence of depressive symptoms and anxiety was calculated in 511 
patients with a TIA or ischaemic stroke, aged 18-50 years, using the Hospital Anx-
iety and Depression-scale, compared with 147 controls. Functional outcome was 
assessed with the modified Rankin Score (mRS) and Instrumental Activities of Daily 
Living (IADL). 
Results 
16.8% of patients had depressive symptoms and 23.0% had anxiety, versus 6.1% 
(p=0.001) and 12.2% (p<0.001) in controls. In ischaemic stroke patients, depressive 
symptoms and anxiety were associated with poor functional outcome (mRS>2 or 
IADL<8). 
Conclusion 
Even after a decade after stroke at young age, depressive symptoms and anxiety 
were prevalent and associated with poor functional outcome. Therefore, even in 
the long term, treating physicians should be aware of the long-term presence of 
these symptoms, as their recognition may be the first step in improving long-term 
functional independence.
Introduction 
Many studies investigate the prevalence of post-stroke depressive symptoms and 
anxiety in stroke populations, usually with a mean age over 70 years.11-16 Studies that 
assess the effect of these symptoms on functional outcome suggest a negative influ-
ence on functional outcome after a few months or years.17-20 Patients with a stroke at a 
young age (≤50 years) have a particular interest in factors that influence their long-term 
outcome, as they usually have a life expectancy of decades ahead. Possible adverse 
effects of depressive symptoms or anxiety on functional outcome in these patients 
may be more profound, because they are in a vulnerable period of life with respect to 
socio-economic consequences. However, few studies reported on the long-term prev-
alence of depressive symptoms and anxiety in this specific age-group.26, 27, 32 Only 1 of 
these related them to functional outcome, measured with the modified Rankin Scale, 
which includes little information on more complex tasks in daily living.26 Furthermore, 
no studies exist on depressive symptoms and anxiety in young patients with a transient 
ischaemic attack (TIA). However, increasing evidence from other stroke studies sug-
gests that less visible symptoms, such as cognitive impairment or mood disorders, may 
persist after the resolution of the focal neurological deficits caused by the TIA.38, 39, 226 
Therefore, we investigated the prevalence of depressive symptoms and anxiety and 
demographic and clinical variables associated with these symptoms, as well as the re-
lation between these symptoms and long-term functional outcome in patients with a 
TIA or ischaemic stroke at a young age. 
Methods
Patients and study design
This study is part of the ‘Follow-Up of Transient ischaemic attack and stroke patients 
and Unelucidated Risk factor Evaluation’ (FUTURE) study, a cohort study that investi-
gates causes and consequences of stroke in young adults. Details of the study have 
been described elsewhere.42, 110 The Medical Review Ethics Committee region Arn-
hem-Nijmegen approved the study.
In short, the FUTURE study comprises 1 005 consecutive patients with a TIA, ischaemic 
stroke (excluding cerebral sinus thrombosis) or intracerebral haemorrhage, aged 18 
through 50 years, admitted to the Radboud University Nijmegen Medical Centre be-
tween January 1, 1980 and November 1, 2010. For the present study, only first-ever TIA 
and ischaemic stroke patients were assessed. Patients were identified through a pro-
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spective registry with a standardised collection of baseline and clinical characteristics 
(including demographics and stroke subtype). TIA was defined as a rapidly evolving 
focal neurological deficit without positive phenomena such as twitches, jerks or myo-
clonus, with no other than a vascular cause lasting less than 24 hours. Stroke was de-
fined similarly, but with symptoms lasting more than 24 hours. All patients underwent 
neurological examination and brain imaging at the time of their index event. Radiolog-
ical findings were used to differentiate between ischaemic and haemorrhagic stroke. 
The assessment of stroke severity (National Institutes of Health Stroke Scale (NIHSS)213) 
was done for all cases retrospectively by a validated approach.165, 214 NIHSS-score in con-
trols was set at ‘0’. Lesion location was based on review of presenting clinical signs and 
symptoms and radiological findings, categorised into supratentorial left, supratentorial 
right, bilateral, and infratentorial.
Control participants were recruited from the same environment as the patients, among 
the patients’ spouses, relatives, or social environment (n=147). The patient group and 
control group were matched for age and sex. Controls had to be at least 18 years old, 
without a history of TIA or stroke. They were all living independently. 
Written informed consent was obtained from all participating patients and controls.
Follow-up
All patients alive were invited to visit our research centre for a follow-up examination 
between November 1, 2009 and January 1, 2012. If patients consented to participate, 
but were not able to visit our research centre, data were collected by means of a stan-
dardised, structured questionnaire on paper. 
Depressive symptoms and anxiety 
Our primary outcome measure was the prevalence of depressive symptoms or anxiety, 
operationalised as a score higher than 7 on either the depression or the anxiety items 
of the Hospital Anxiety and Depression Scale (HADS).230 This is a self-administered ques-
tionnaire used to evaluate depressive symptoms and anxiety in the past week and is 
well validated in stroke patients233 and in large population-based studies.184 The cut-off 
value we used is considered to be suggestive of the presence of depressive symptoms 
or anxiety.230, 233  Information on the HADS was missing in 12 participants (2.4%). 
Functional outcome
Functional outcome was assessed with the modified Rankin Scale (mRS) and the In-
strumental Activities of Daily Living-scale (IADL).192 The mRS predominantly measures 
outcome based on motor function. The IADL complements this with the assessment of 
more complex tasks necessary for independent living in a community.128 
In the 68 patients who only filled out questionnaires (because they were not able to 
participate in person), IADL was not assessed. Information on mRS was missing in 2 
participants (0.4%) and on IADL in 5 participants (1.1%).
Assessment of incident vascular events and vascular risk factors
We assessed vascular risk factors (hypertension, diabetes mellitus, dyslipidaemia, cur-
rent smoking, current alcohol use (>2 U/d)) and vascular disease (myocardial infarction 
and recurrent stroke) on the basis of medical history taking using a standardised, struc-
tured questionnaire, and/or the use of medication. Whenever a myocardial infarction 
or recurrent stroke/TIA was suspected, medical records were reviewed for verification 
of the event by physicians from the appropriate specialty, that is, either a cardiologist or 
a neurologist.102 The body mass index (BMI) at follow-up was calculated as weight (kg) 
divided by height (m) squared.139 
In the patients who only filled out questionnaires only (n=68), vascular risk factors (di-
abetes mellitus, dyslipidaemia and hypertension) were considered present when di-
agnosed by a physician. In these 68 patients, BMI, smoking, and alcohol consumption 
were not assessed.
Other measurements
Educational level, a history of depression, and unemployment at follow-up (excluding 
retirement) were considered possible confounders.
Level of education was scored with a widely-used Dutch scoring system (1 = less than 
primary school; 7 = university degree).229 
A history of depression before index event was assessed by asking the patient if there 
had ever been a period of depression, verified by additional questions about treatment 
or professional counseling. ‘History of depression before index event’ in controls was 
defined as ‘history of depression ever’.
Employment status was assessed in a self-questionnaire, during the follow-up visit.
In the 68 patients who only filled out questionnaires (because they were not able to 
participate in person), a history of depression before index event and employment sta-
tus were not assessed.
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Statistical analysis
Baseline characteristics were compared between participants, non-participants (pa-
tients who refused and patients lost to follow-up), and deceased patients, using Stu-
dent’s t-test, Mann-Whitney U test or chi-square-test when appropriate. Sex and age 
were compared between patients and controls, using a chi-square-test and a Student’s 
t-test, respectively. 
The prevalence of depressive symptoms and anxiety was calculated and compared 
with controls with a chi-square test. Logistic regression, stratified on sex, was used 
to calculate the risk of having depressive symptoms or anxiety as a TIA- or ischaemic 
stroke patient compared with controls.
Age at follow-up, sex, education, NIHSS-score at admission, observation time, and a 
history of depression before the index event were considered potential confounders 
and adjusted for in all analyses when appropriate.
Since the present study features a long inclusion period (1980-2010), TIA- and ischaemic 
stroke patients were stratified into tertiles of observation time (n=170/171 per tertile). 
A chi-square test was used to test differences in the prevalence of depressive symp-
toms or anxiety between lesion locations. 
The following analyses were performed only in ischaemic stroke patients, because of 
too small numbers in TIA-patients to perform meaningful logistic regression analysis.
First, 2 multiple logistic regression models were constructed, 1 with the presence of 
depressive symptoms as dependent (dichotomous) variable and 1 with the presence of 
anxiety as dependent (dichotomous) variable. These models contained demographic 
and clinical factors that may theoretically be associated with depressive symptoms and 
anxiety as independent variables. Age at follow-up, sex, education, and NIHSS-score at 
admission were forced into the model. Observation time, recurrent stroke, a history of 
depression before the index event, current alcohol use (>2 U/day), and unemployment 
were put into the model with the backward logistic regression method. These variables 
were removed from the model when they did not significantly alter the model. 
Second, the association between the presence of depressive symptoms or anxiety and 
a poor functional outcome in ischaemic stroke patients was calculated with logistic re-
gression analysis. Poor functional outcome was defined as a mRS>2 or an IADL<8. Sep-
arate analyses were performed for each of these 2 dependent dichotomous outcomes, 
with the presence of depressive symptoms or anxiety as the independent variable and 
age at follow-up, sex, education, NIHSS-score at admission, and observation time as 
confounders. 
All statistical analyses were performed with SPSS v20.0 software for Windows.
Results
Study population and demographics
For the present study, 511 patients were included, of whom 186 (36.4%) had a TIA and 
325 (63.4%) had an ischaemic stroke (Figure 1). Their baseline characteristics are pre-
sented in Table 1. 
Patients who refused to participate did not differ from participants with respect to in-
dex event, sex, age at index event, and NIHSS-score at admission. The proportion of 
patients with an ischaemic stroke was higher among deceased patients and patients 
who were lost to follow-up compared with participants. These 2 groups had higher 
NIHSS-scores at admission than participants (deceased: median 5 (Interquartile range 
(IQR) 2-12), p<0.001, lost to follow-up: median 4 (IQR 1-11.5), p<0.001, participants: me-
dian 2 (IQR 0-6). Deceased patients more often were men (55.8% versus 44.9%, p=0.01). 
Deceased patients and patients who were lost to follow-up were older than partici-
pants at the time of the index event (mean 42.5 (SD 6.7) years, p=0.002 and 38.2 (SD 8.6) 
years, p=0.04, versus 40.2 (SD 7.8) years). 
Figure 1 Flowchart of study population.
TIA: Transient Ischaemic Attack
  
n = 868
Lost to follow‐up
n = 73
Deceased
n = 145
Refused to participate
n = 139
Follow‐up survivors,
visited our clinic
n = 443
Follow‐up survivors
n = 723
Follow‐up survivors,  
questionnaire  only
n = 68
Baseline ever ischaemic
stroke or TIA
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Table 1 Description of demographic and clinical variables in patients and controls.
TIA
n=186
Ischaemic stroke
n=325
Controls
n=147
Baseline 
Age (years) at index event, median (IQR) 42.9 (34.8-47.2) 41.2 (35.7-46.5) NA
Age (years) at index event, mean (SD) 40.5 (8.0) 40.0 (7.8) NA
NIHSS score at admission, median (IQR) 0 (0-1) 4 (2-9) NA
Depression ever before index event, n (%) 33 (20.8) 50 (18.1) 60 (41.1)
Follow-up
Men, n (%)a 83 (44.6) 143 (44.0) 63 (42.9)
Observation time (years), median (IQR) 4.7 (2.5-14.4) 8.5 (3.0-16.6) NA
Observation time (years), mean (SD) 8.3 (8.1) 10.6-8.4 NA
Age (years) at follow-up, median (IQR) 49.2 (40.7-54.1) 50.0 (44.6-57.6) 48.5 (43.0-55.6
Age (years) at follow-upb, mean (SD) 48.9 (11.3) 50.7 (10.4) 48.7 (11.7)
Education, median (IQR) 5 (5-6) 5 (4-6) 5 (5-6)
mRS at follow-up, median (IQR) 0 (0-1) 1 (1-2) 0 (0-0)
mRS>2, n (%) 12 (6.5) 41 (12.6) 1 (0.7)
HADS – d, median (IQR) 3 (1-5) 3 (1-7) 2 (0-4)
HADS – a, median (IQR) 5 (2-7) 4 (2-7) 4 (2-6)
IADL<8, n (%) 17 (10.8) 41 (14.6) 1 (0.7)
Unemployment (excluding retirement), n (%) 33 (24.2) 100 (41.8) 35 (23.8)
Current use of antidepressants, n (%) 12 (7.6) 34 (12.1 ) 9 (6.1)
Incident vascular events
Incident stroke, n (%) 32 (17.2) 58 (17.8) NA
Incident myocardial infarction, n (%) 9 (4.8) 19 (5.8) 3 (2.0)
Vascular risk factors
Diabetes mellitus, n (%) 19 (10.3) 43 (13.3) 6 (4.1)
TIA
n=186
Ischaemic stroke
n=325
Controls
n=147
Hypercholesterolaemia, n (%) 116 (63.0) 199 (61.6) 27 (18.4)
Hypertension, n (%) 97 (52.4) 175 (54.2) 45 (30.6)
Body Mass Index, mean (SD) 26.3 (4.2) 26.2 (5.2) 26.8 (4.7)
Current smoking, n (%) 35 (22.0) 79 (28.2) 38 (25.9)
Current alcohol consumption (>2 U/d), n (%) 7 (4.5) 13 (4.7) 14 (9.5)
TIA: Transient Ischaemic Attack, IS: ischaemic stroke, NIHSS: National Institutes of Health Stroke Scale, mRS: 
modified Rankin Scale, HADS-d: Hospital Anxiety and Depression Scale, depressive symptoms, HADS-a: 
Hospital Anxiety and Depression Scale, anxiety, IADL: instrumental activities of daily living, NA: not appli-
cable. 
a.) Pearson chi-square, no significant differences between TIA or ischaemic stroke and controls; 
b.) Student’s t-test, no significant differences between TIA or ischaemic stroke and controls.
Missing data: 1.4% for depression before index event, 13.3% for employment status, 0.9% for diabetes mel-
litus, 0.9% for hypercholesterolaemia, 0.9% for hypertension, 2.0% for body mass index, 0.9% for smoking 
0.9%, and 2.7% for regular alcohol consumption.
Depressive symptoms
The overall prevalence of depressive symptoms in patients with a stroke at young age 
(TIA and ischaemic stroke together) was 16.8% versus 6.1% in controls. The risk of having 
depressive symptoms was higher in both TIA-patients (OR 2.8, 95%-CI 1.2-6.6, p=0.02) 
and ischaemic stroke patients (OR 4.7, 95%-CI 2.0-11.0, p=0.003) compared with con-
trols. Prevalence of depressive symptoms stratified by stroke subtype (TIA or ischaemic 
stroke) and sex is shown in Figure 2A. Prevalence of post-stroke depressive symptoms 
by tertiles of follow-up is shown in Figure 3A. 
Prevalence of depressive symptoms did not differ between different stroke locations. 
In the multiple regression model, ischaemic stroke patients with a lower educational 
level had higher risk of having depressive symptoms (OR 4.3, 95%-CI 2.0-9.0, p<0.001). 
Longer observation time was associated with a lower risk of having depressive symp-
toms (OR 0.9, 95%-CI 0.9-1.0 per year, p=0.03). Furthermore, unemployed patients had a 
higher risk of depressive symptoms (OR 3.8, 95%-CI 1.9-7.7, p<0.001). Current alcohol use 
was not associated with the presence of depressive symptoms. 
Table 1 Continued
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Figure 2 Prevalence of depressive symptoms and anxiety, stratified by stroke subtype 
    and sex.
Figure shows prevalence of depressive symptoms and anxiety on average 10 years after the event, 
stratified by stroke subtype and sex. Legend: TIA: Transient ischaemic attack, IS: Ischaemic stroke.
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Figure 3 Prevalence of depressive symptoms and anxiety, stratified by tertiles of 
    observation time after stroke.
1st tertile: 0.2-4.1 years of observation time, 2nd tertile: 4.1-12.8 years of observation time, 3rd tertile: 12.8-31.0 
years of observation time. * p<0.05.
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Anxiety 
The overall prevalence of anxiety in patients with a stroke at young age (TIA and isch-
aemic stroke together) was 23.0% versus 12.2% in controls. The risk of having anxiety was 
higher in both TIA-patients (OR 3.0, 95%-CI 1.6-5.8, p=0.001) and ischaemic stroke pa-
tients (OR 2.9, 95%-CI 1.5-5.8, p=0.002) compared with controls. The prevalence of anx-
iety stratified by stroke subtype (TIA or ischaemic stroke) and sex is shown in Figure 2B. 
Prevalence of post-stroke anxiety by tertiles of follow-up is shown in Figure 3B. 
Prevalence of anxiety did not differ between different stroke locations.
In the multiple regression model, ischaemic stroke patients with a lower educational 
level (OR 3.3, 95%-CI 1.5-7.4, p=0.003) and a history of depression (OR 4.3, 95%-CI 2.1-8.8, 
p<0.001) had a higher risk of anxiety. Younger age was associated with a lower risk of 
anxiety (OR 1.0, 95%-CI 0.9-1.0, p=0.04). Furthermore, unemployment (OR 2.3, 95%-CI 
1.1-4.8, p=0.03) and current alcohol use (OR 4.1, 95%-CI 1.1-15.9, p=0.04) were associated 
with the presence of anxiety. 
Association between depressive symptoms or anxiety and 
functional outcome
Depressive symptoms were associated with a poor functional outcome, as assessed by 
both the mRS (OR 11.2, 95%-CI 4.2-29.9, p<0.001) and the IADL (OR 3.8, 95%-CI 1.7-8.9, 
p=0.002), with adjustment for age at follow-up, sex, education, NIHSS-score at admis-
sion, and observation time.
Anxiety was associated with a poor functional outcome, as assessed by both the mRS 
(OR 6.4, 95%-CI 2.5-16.7, p<0.001) and the IADL (OR 2.4, 95%-CI 1.0-5.6, p=0.04), with 
adjustment for age at follow-up, sex, education, NIHSS-score at admission, and obser-
vation time.
Discussion
We showed that patients with a TIA or ischaemic stroke at a young age have an up to 
approximately 5 times higher risk of depressive symptoms and anxiety than stroke-free 
controls. Even after on average a decade after the stroke, these symptoms were associ-
ated with poor functional outcome. 
Prognosis in patients with a stroke at young age is generally considered to be better 
than in elderly stroke patients with respect to mortality and cardiovascular risk.129 Our 
findings indicate that this is apparently not true for depressive symptoms, as the prev-
alence of depressive symptoms we found in our young study population, were in the 
range of numbers given in older stroke survivors (12-60%).11-14 Other studies in young 
patients with stroke found an even higher prevalence of depressive symptoms than we 
found, up to 28%.26, 27, 32 The difference is probably explained by the different methods 
used to assess depressive symptoms. 
The finding that the prevalence of depressive symptoms and anxiety was higher in 
patients than in stroke-free controls, might suggest that these symptoms are attribut-
able to the stroke at young age. However, we found that neither a more severe stroke 
nor recurrent strokes were associated with a higher risk of depressive symptoms and 
anxiety, as would be expected if stroke and depressive symptoms are directly associat-
ed. Some other studies found recurrent strokes to be associated with depression.184, 234 
An explanation for these opposite findings might be that it is not the degree of brain 
damage that gives a higher risk of depressive symptoms, but merely the location of 
the lesion and associated network destruction.235 However, we found no differences 
in prevalence of depressive symptoms or anxiety between different lesion locations. 
Therefore, other factors than lesions of brain structure or function may play a role in the 
presence of depressive symptoms and anxiety after a stroke at young age, for example 
psychosocial issues. 
We found an association between depressive symptoms or anxiety and a poor long-
term functional outcome. Our study described this association with long-term poor 
functional outcome in patients after a stroke at young age, not only defined as poor 
motor recovery (as 1 previous study has done26), but also as a poor outcome on the IADL. 
Because this questionnaire describes more complex tasks in daily living, it is more recog-
nisable to patients when they are informed on long-term consequences of their stroke. 
The relation between psychological symptoms and poor functional outcome may be 
reciprocal. Possibly, psychological symptoms lead to a more passive lifestyle, which re-
sults in more functional dependency in daily life activities. Or maladaptation to func-
tional post-stroke disabilities leads to depressive symptoms or anxiety. A lower edu-
cational level might exaggerate this reciprocal relation, due to less effective coping 
strategies.236 This is indeed suggested by our finding that a lower educational level was 
associated with more depressive symptoms and anxiety. The vulnerability of patients 
with a lower educational level for depressive symptoms and anxiety may be partly 
explained by other related factors, such as alcoholism and unemployment. Therefore, 
these factors may be important targets for treatment and guidance in rehabilitation 
programs, to annihilate their negative effects on mood. 
Strengths of our study include the large sample size and long observation time, with 
inclusion of both ischaemic stroke and TIA-patients. Furthermore, the single centre 
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design allowed us to collect information systematically, limiting information bias. In 
addition, since in the Netherlands all survivors of a stroke at young age usually visit a 
university medical centre during the course of their disease, our study population is a 
representative cohort for a Dutch population of patients with a stroke at young age. 
However, some methodological limitations need to be addressed. Selection bias might 
have occurred due to patients who refused to participate or were lost to follow-up. 
However, as participants and patients who refused to participate did not differ in base-
line clinical and demographic variables (index event, sex, age at index event, and stroke 
severity), we have no reason to assume that these patients differed from participants 
with respect to the prevalence of depressive symptoms and anxiety or their association 
with functional outcome. Patients who were lost to follow-up and deceased patients 
more often had an ischaemic stroke than a TIA. As depressive symptoms were most 
prevalent in ischaemic stroke patients, this might have resulted in an underestimation 
of our prevalence figures, but would not have altered our conclusions. 
Recall bias probably influenced the reported history of depression. Patients who had 
their index event in the first decade of the inclusion period reported a history of de-
pression less frequently than patients who had their index event in the second or third 
decade. However, it is unlikely that recall bias has influenced our primary outcome 
measure, as the HADS-questionnaire assesses depressive symptoms and anxiety in the 
past week.
Confounding is another bias to be considered. We tried to overcome this by adjusting 
for previously reported confounding factors in the analysis when appropriate.237 There 
may be some residual confounding, especially in the association between depressive 
symptoms or anxiety and functional outcome. In the group with the longest obser-
vation time, there is a risk that co morbidities or other complaints, such as incident 
vascular disease or pain, may have led to both the depressive symptoms or anxiety and 
to a poor functional outcome. Future larger studies should take these factors further 
into account.
In conclusion, the findings of our study indicate that even after more than 10 years 
after the stroke at young age, lives of the survivors are very much influenced by the 
psychological consequences of the stroke. These negative effects may be influenced 
by changing lifestyles and learning better coping strategies. Therefore, even in the 
long term, treating physicians should be aware of the long-term presence of these 
symptoms, as its recognition may be the first step in improving long-term functional 
independence. 
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Introduction
Post-stroke fatigue is a frequent symptom in the elderly stroke population (>60 
years).21-24 A previous study found that fatigue was associated with a poorer progno-
sis after 3 years of follow-up.25 In young patients with stroke (≤50 years), post-stroke 
fatigue and its negative effects on prognosis may be even more profound, since these 
patients are confronted with higher demands from their social environment, with a 
young family to take care of and responsibilities at work. In addition, if fatigue nega-
tively influences functional outcome, this effect may be long-lasting, as most of these 
patients still have a long life expectancy. Therefore, young patients with stroke form a 
distinct group and results from the older stroke population cannot just be extrapolated 
to these young patients. 
However, there are only few studies on post-stroke fatigue and its influence on dai-
ly functioning in this specific age group.33, 34, 149, 238 Those that have been performed, 
were limited with respect to sample size33, 149, 238 or follow-up duration.34 Furthermore, 
no studies addressed the occurrence of post-stroke fatigue in young patients with a 
transient ischaemic attack (TIA). Increasing evidence suggests that, after a TIA as well as 
after an ischaemic stroke, despite the first being a transient neurological condition by 
definition, patients suffer from persistent residual symptoms that may not be directly 
visible, for example depressive symptoms or anxiety.239 In patients with stroke, these 
symptoms were found to be associated with post-stroke fatigue.240 
Therefore, we investigated the long-term prevalence of post-stroke fatigue in patients 
with a TIA or ischaemic stroke aged 18 through 50 years, demographic and clinical risk 
factors that may be associated with fatigue, and the association between fatigue and 
functional outcome, including cognitive performance.
Methods
Patients and study design
This study is part of the ‘Follow-Up of Transient ischaemic attack and stroke patients 
and Unelucidated Risk factor Evaluation’ (FUTURE) study, a large cohort study that in-
vestigates causes and consequences of stroke in young adults. Details of the study 
have been described elsewhere.42, 110 The Medical Review Ethics Committee region Arn-
hem-Nijmegen approved the study.
In short, the study comprises all patients with a TIA, ischaemic stroke or intracerebral 
haemorrhage, aged 18-50 years, admitted to Radboud University Nijmegen Medical 
Abstract
Background and objective 
Post-stroke fatigue negatively influences short-term functional outcome in older 
stroke survivors. In young adults, in the midst of their active working and family life, 
this influence may even be more pronounced. However, there are only few studies 
on this topic in young patients with stroke. Therefore, we investigated the long-
term prevalence of post-stroke fatigue in patients with a young TIA or ischaemic 
stroke and its association with functional outcome. 
Methods 
This study is part of a large cohort study among 511 stroke survivors with a first-ev-
er TIA or ischaemic stroke, aged 18-50 years. After a mean follow-up of 9.8 (SD 
8.4) years, we assessed the presence of fatigue with the fatigue subscale of the 
Checklist Individual Strength questionnaire and functional outcome. Prevalence 
of fatigue between young patients with stroke and 147 stroke-free sex-matched 
and age-matched controls was compared. Odds ratios (OR’s) for poor functional 
outcome on modified Rankin Score (mRS>2) and Instrumental Activities of Daily 
Living (IADL<8) and cognitive performance were calculated using logistic regres-
sion analysis. 
Results
Of the young patients with stoke, 41.0% experienced symptoms of fatigue, versus 
18.4% in controls (p=0.0005). Fatigue was associated with a poor functional out-
come, as assessed by the mRS (OR 4.0, 95%-CI 1.6-9.6), IADL (OR 2.2, 95%-CI 1.1-4.6), 
and impairment in speed of information processing (OR 2.2, 95%-CI 1.3-3.9). 
Conclusion 
Fatigue was very common in young stroke survivors and was associated with a 
poor functional outcome, even after almost a decade of follow-up.
117116
Long-term neuropsychological and social consequences after stroke in young adults
PART III
Fatigue after young TIA and ischaemic stroke
Chapter 7
7
Functional outcome
Functional outcome was assessed with the modified Rankin Scale (mRS) and the Instru-
mental Activities of Daily Living-scale (IADL).192 The mRS predominantly measures out-
come based on motor function. The IADL complements this with the assessment of more 
complex tasks necessary for independent living in a community. In the patients who did 
not visit our research centre, IADL was not assessed. Information on mRS was missing in 2 
patients (0.4%) and on IADL in 5 patients who visited our research centre (1.1%).
Cognitive performance
Neuropsychological tests covered the main cognitive domains and these tests have 
been previously applied in large-scale epidemiological studies in cerebrovascular 
disease.174, 175 
The following cognitive domains were examined: Processing speed (the written admin-
istration of the Symbol-Digit Modalities Test, Abbreviated Stroop Color Word Test, parts 
I and II), Visuoconstruction (Rey-Osterrieth Complex Figure (ROCF) - Copy trial), Working 
memory (Paper and Pencil Memory Scanning Task (PPMST)), Immediate memory (ROCF 
- Immediate recall and the total number of words immediately recalled in the 3-trial 
version of the Rey Auditory Verbal Learning Test (RAVLT)), Delayed memory (delayed 
recall on the ROCF and the RAVLT), Attention (Verbal Series Attention Task (VSAT)), and 
Executive functioning (Verbal Fluency and Stroop Interference). To account for speed-ac-
curacy trade-off on the Stroop test, PPMST, and VSAT, composite scores were calculat-
ed (accuracy(%)/reaction time).207 Stroop Interference was computed by dividing the 
composite Stroop part III score by the mean of the composite scores of parts I and II.139 
Per cognitive domain, the prevalence of cognitive impairment (>1.5 SD below the mean 
domain score of controls) was assessed. If 1 test of a particular domain was missing, the 
domain score was occasionally based on the remaining tests of that domain.139
Detailed information on the neuropsychological examination is described extensively 
elsewhere.42, 139
In the patients who did not visit our research centre, cognitive performance was not 
assessed. Data on cognitive impairment was missing in 1.4% to 7.7% in patients who 
visited our research centre, depending on the domain tested.
Other measurements at follow-up
Educational level, depressive symptoms and, anxiety were assessed at follow-up. Level 
of education was scored with a widely-used Dutch scoring system (1 = less than prima-
ry school; 7 = university degree).229 The Hospital Anxiety and Depression scale (HADS) 
Centre in the Netherlands between January 1, 1980 and November 1, 2010. For the 
present study, only first-ever TIA and patients with ischaemic stroke were assessed. 
Patients were identified through a prospective registry with a standardised collection 
of baseline and clinical characteristics (including demographics and stroke subtypes). 
TIA was defined as a rapidly evolving focal neurological deficit, with no other than a 
vascular cause lasting less than 24 hours. Stroke was defined similarly, but with symp-
toms lasting more than 24 hours. All patients underwent neurological examination 
and brain imaging at the time of their index event. Radiological findings were used to 
differentiate between ischaemic and haemorrhagic stroke. The assessment of stroke 
severity (National Institutes of Health Stroke Scale (NIHSS)213) was performed for all cases 
retrospectively by a validated approach.165, 214 Lesion location was based on review of 
presenting clinical signs and symptoms and radiological findings.
Patients with cerebral sinus thrombosis were excluded. 
Control participants were recruited from the same environment as the patients, among 
the patients’ spouses, relatives, or social environment (n=147). The patient group and 
control group were matched for age and sex. Controls had to be at least 18 years old, 
without a history of TIA or stroke and were all living independently.
Written informed consent was obtained from all participants and controls.
Follow-up 
All patients alive were invited to visit our research centre for a follow-up examination 
between November 1, 2009 and January 1, 2012. If patients consented to participate, 
but were not able to visit our research centre, data were collected by means of a stan-
dardised, structured questionnaire, which was filled out at home. 
Fatigue 
Our primary outcome measure was the prevalence of fatigue in young patients with 
stroke. The presence of fatigue was assessed with the fatigue subscale of the Checklist 
Individual Strength questionnaire (CIS).193, 241 This screening instrument is well validated 
in patients with stroke and has been used in a previous stroke cohort.24 The fatigue 
subscale contains 8 items on the level of fatigue perceived over the past 2 weeks. All 
items are scored on a range from 1 to 7, with higher scores representing more fatigue. 
The total score ranges from 8 to 56, a score above 35 is considered indicative of severe 
fatigue.193, 241 Data on the presence of fatigue were missing in 13 participants (1.9%).
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logistic regression analysis, using either mRS>2, IADL<8, or cognitive impairment on 
the 7 cognitive domains (>1.5 SD below the mean domain score of controls) as the 
dependent variable indicating poor functional outcome. For the 7 cognitive domains, 
a Bonferroni correction was used to define results as statistically significant (p 0.05/7 
cognitive domains= 0.007). Sex, age at follow-up, NIHSS-score at admission, presence of 
depressive symptoms and anxiety, duration of follow-up, and recurrent cerebrovascular 
events were considered possible confounders and adjusted for in these analyses.
Cases were excluded from the analysis when 1 or more of the used variables contained 
missing data. This was only the case in 0.4-3.5%, depending on the variable. 
All statistical analyses were performed with SPSS 20.0 software for Windows.
Results
Study population
511 Patients were included in the present study of whom 186 had a TIA and 325 had 
an ischaemic stroke (Figure 1). Their baseline characteristics are presented in Table 1.
Figure 1 Flowchart of study population.
  
  
n = 868
Lost to follow‐up
n = 73
Deceased
n = 145
Refused to participate
n = 139
Follow‐up survivors,
visited our clinic
n = 443
Follow‐up survivors
n = 723
Follow‐up survivors,  
questionnaire  only
n = 68
Baseline rst-ever ischaemic
stroke or TIA
was used for assessing depressive symptoms and anxiety.230, 233
Information on recurrent cerebrovascular events (TIA’s, and both ischaemic and haemor-
rhagic strokes, defined as any stroke between the qualifying event and time of follow-up), 
myocardial infarction, and (cardio)vascular risk factors was collected, using a structured 
questionnaire. Whenever a recurrent event was suspected, information retrieved was ver-
ified and adjudicated by physicians from the appropriate specialty.
Diabetes mellitus, hypercholesterolaemia, and hypertension were considered present 
when diagnosed by a physician or when participants were taking medication for these 
conditions. Furthermore, body mass index (BMI) (weight/(length2)), current smoking, and 
regular alcohol consumption defined as >2 U/day was assessed. In the patients who did 
not visit our research centre, BMI, smoking, and alcohol consumption were not assessed.
Statistical analysis
Baseline characteristics were compared between participants, non-participants (pa-
tients that refused and patients lost to follow-up), and deceased patients using a Stu-
dent’s t-test, Mann-Whitney U test or chi-square-test when appropriate. Sex and age 
were compared between patients and controls, using a chi-square-test and a Student’s 
t-test, respectively. 
The prevalence of fatigue was defined as the proportion of participants in whom these 
symptoms were present (CIS-fatigue subscale >35). Logistic regression was used to cal-
culate the risk of fatigue in a patient with TIA or ischaemic stroke compared with con-
trols, adjusted for age, sex, NIHSS-score at admission, and the presence of depressive 
symptoms and anxiety. 
Since the present study features a long inclusion period (1980-2010), the prevalence of 
fatigue was also calculated as a function of follow-up duration (in tertiles; n= 62 per 
tertile in patients with TIA and n=108/109 per tertile in patients with ischaemic stroke) 
and compared with a chi-square test. A similar analysis was performed for the different 
lesion locations (left hemispheral, right hemispheral, bilateral or infratentorial).
We calculated whether clinical and demographic factors were associated with the 
presence of fatigue with multiple logistic regression, using the presence of fatigue as 
the dependent variable and including sex, current age, NIHSS at admission, education, 
follow-up duration, depressive symptoms and anxiety (per point on the HADS), and 
recurrent cerebrovascular events as independent variables. BMI and alcohol consump-
tion were additionally evaluated for their association with fatigue. 
Subsequently, the association between the presence of fatigue and a poor functional 
outcome was calculated for TIA and patients with ischaemic stroke combined, with a 
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TIA
n=186
Ischaemic stroke
n=325
Controls
n=147
         Executive functioning 26 (16.3%) 66 (24.4%) 11 (7.5%)
Incident vascular events
        Incident stroke 32 (17.2%) 58 (17.8%) NA
        Incident myocardial  infarction 9 (4.8%) 19 (5.8%) 3 (2.0%)
Vascular risk factors
        Diabetes mellitus 19 (10.3%) 43 (13.3%) 6 (4.1%)
        Hypercholesterolaemia 116 (63.0%) 199 (61.6%) 27 (18.4%)
        Hypertension 97 (52.4%) 175 (54.2%) 45 (30.6%)
        Body Mass Indexd 26.3 (4.2) 26.9 (5.2) 26.8 (4.7)
        Current smokingd 35 (22.0%) 78 (28.2%) 38 (25.9%)
        Current regular alcohol consumptiond 7 (4.5%) 13 (4.7%) 14 (9.5%)
Data are mean (SD), number (%), or median (Q1-Q3). TIA: Transient Ischaemic Attack, NIHSS: National Insti-
tutes of Health Stroke Scale, MMSE: Mini Mental State Examination, HADS: Hospital Anxiety and Depression 
Scale, CIS: Checklist Individual Strength, IADL: Instrumental activities of daily living, NA: not applicable. 
a.) Pearson chi-square, no significant differences between TIA or ischaemic stroke and controls; b.) un-
certainty based on clinical grounds and (lack of) radiological findings; c.) Student’s t-test, no significant 
differences between TIA or ischaemic stroke and controls; d.) The following variables were only obtained 
at follow-up visit and not in the follow-up questionnaire group (n=68): MMSE, IADL, cognitive perfor-
mance, body mass index, smoking, and regular alcohol consumption. Proportions and means are of the 
follow-up visit participants only. 
Patients who refused to participate did not differ from participants with respect to in-
dex event, sex, age at index event, and NIHSS-score at admission. The proportion of 
patients with an ischaemic stroke was larger among deceased patients and among 
patients who were lost to follow-up compared with participants. These 2 groups had 
higher NIHSS-scores at admission than participants (deceased: median 5 (IQR 2-12), 
p<0.001, lost to follow-up: median 4 (IQR 1-11.5), p<0.001, participants: median 2 (IQR 
0-6)). Deceased patients more often were men (55.8% versus 44.9%, p=0.01). Deceased 
patients and patients who were lost to follow-up differed in age from participants at 
the time of the index event (deceased: mean 42.5 (SD 6.7) years, p=0.002, lost to fol-
low-up: mean 38.2 (SD 8.6) years, p=0.04, and participants: mean 40.2 (SD 7.8) years).
Table 1 ContinuedTable 1 Description of demographic and clinical variables in young patients with 
    stroke and controls.
TIA
n=186
Ischaemic stroke
n=325
Controls
n=147
Baseline 
Age at index event (years) 40.5 (8.1) 40.1 (7.8) NA
Sexa  (proportion men) 83 (44.6%) 143 (44.0%) 63 (42.9%)
NIHSS score at admission 0 (0-1) 4 (2-9) NA
Localisation of index event       NA
          Supratentorial left 81 (43.5%) 141 (43.4%)
          Supratentorial right    56 (30.1%) 116 (35.7%)
          Infratentorial 28 (15.1%) 60 (18.5%)
          Bilateral 1 (0.5%) 7 (2.2%)
          Could not be establishedb 20 (10.8%) 1 (0.3%)
Follow-up
Follow-up duration (years)
         Mean (SD) 8.3 (8.1) 10.6 (8.4) NA
         Follow-up > 15 years 44 (23.7%) 105 (32.3%) NA
         Follow-up > 20 years 29 (15.6%) 56 (17.2%) NA
Age at follow-up examination (years)c 48.9 (11.3) 50.7 (10.4) 48.7 (11.7)
Education 5 (5-6) 5 (4-6) 5 (5-6)
MMSEd  26.7 (2.3) 26.3 (2.6) 27.2 (2.0)
CIS - fatigue 30.0 (13.4) 30.7 (14.2) 22.5 (12.7)
Modified Rankin Scale 0 (0-1) 1 (1-2) 0 (0-0)
Modified Rankin Scale >2 12 (6.5%) 41 (12.6%) 1 (0.7%)
IADL-questionnaired 8 (8-8) 8 (8-8) 8 (8-8)
IADL <8d 17 (10.8%) 41 (14.6%) 1 (0.7%)
Cognitive impairmentd
         Speed of information processing 30(19.1%) 91 (33.8%) 9 (6.2%)
         Visuoconstruction 21 (13.6%) 54 (20.1%) 11 (7.5%)
         Working memory 16 (10.0%) 83 (30.0%) 13 (8.9%)
         Immediate memory 33 (20.6%) 66 (23.8%) 10(6.8%)
         Delayed memory 35 (22.2%) 59 (21.9%) 8 (5.5%)
         Attention 24 (15.9%) 60 (23.3%) 9 (6.2%)
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Figure 3 Prevalence of fatigue, stratified by follow-up.
TIA: transient ischaemic attack, IS: ischaemic stroke. 
TIA: 1st tertile: 0.3-3.1 years, 2nd tertile 3.3-7.8 years, 3rd tertile 7.9-30.4 years. (n per tertile = 62). 
IS: 1st tertile: 0.2-5.0 years, 2nd tertile 5.0-14.6 years, 3rd tertile 14.9-31.0 years. (n per tertile =108-109-108).
No significant differences between tertiles of follow-up existed after adjustment for age, sex, NIHSS at 
admission, and presence of depression and anxiety.
Risk factors associated with fatigue
In patients with an ischaemic stroke, the number of depressive symptoms (OR 1.4, 95%-
CI 1.3-1.6, per each point increase on the HADS-d), the number of symptoms of anxiety 
(OR 1.1, 95%-CI 1.0-1.2, per each point increase on the HADS-a), and recurrent cerebro-
vascular events (OR 2.4, 95%-CI 1.2-5.0) were associated with the presence of fatigue 
(Table 2)
In patients with a TIA, the number of depressive symptoms (OR 1.8, 95%-CI 1.4-2.2, per 
each point increase on the HADS-d), the number of symptoms of anxiety (OR 1.2, 95%-
CI 1.0-1.4, per each point increase on the HADS-a), and female sex (OR 2.9, 95%-CI 1.1-7.6) 
were associated with the presence of fatigue (Table 2). 
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Prevalence of fatigue
The overall prevalence of fatigue was 41.0% in young patients with stroke (after a mean 
follow-up of 9.8 (SD 8.4) years versus 18.4% in controls (p=0.0005). Figure 2 shows the 
prevalence of fatigue, stratified by stroke subtype.
The risk of fatigue was significantly higher in patients with TIA (OR 2.9, 95%-CI 1.6-5.1) 
and in patients with ischaemic stroke (OR 2.2, 95%-CI 1.2-4.0) than in controls.
The prevalence of fatigue was not influenced by the duration of follow-up (Figure 3). 
The prevalence of fatigue did not differ between different stroke localisations. 
Figure 2 Prevalence of fatigue.
TIA: Transient Ischaemic Attack, IS: ischaemic stroke, CIS: Checklist Individual Strength.
* p=0.0003, ** p=0.01, adjusted for age at follow-up, sex, NIHSS at admission, presence of depression and 
anxiety.
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 ←  severity (National Institutes of Health Stroke Scale), duration of follow-up, presence of depressive 
symptoms and anxiety, and recurrent cerebrovascular events. 
Association between fatigue and functional outcome
In patients with a TIA and ischaemic stroke, fatigue was associated with a poor func-
tional outcome, as assessed by the mRS (OR 4.0, 95%-CI 1.6-9.6) and the IADL (OR 2.2, 
95%-CI 1.1-4.6). Odds ratios are presented after adding the variable ‘recurrent cerebro-
vascular events’ to the model, and adjustment for NIHSS at admission, duration of fol-
low-up, the presence of depressive symptoms and anxiety.
Table 3 displays the associations between fatigue and cognitive impairment.
Discussion
We found that fatigue was a very common symptom in young patients with stroke. 
Even after almost a decade of follow-up, fatigue was associated with a poor functional 
outcome. 
Strengths of our study include the large sample size and long follow-up, with inclusion 
of patients with both ischaemic stroke and TIA and the comparison with a stroke-free 
control group. Furthermore, the single centre design allowed us to collect information 
systematically, limiting information bias. Being a tertiary referral centre, our cohort is a 
representative sample of a Dutch young stroke population, since those young patients 
with stroke who survive usually visit a university medical centre during the course of 
their disease.
However, some limitations need to be addressed. Selection bias might have occurred 
due to patients who refused to participate, patients lost to follow-up, and patients who 
were deceased. It might be that higher levels of fatigue were an important reason for 
patients to refuse to participate. This would result in an underestimation of the preva-
lence of fatigue in our cohort. However, including these patients would then only have 
magnified the differences we found between patients and controls, and not alter our 
conclusions. 
Patients who were lost to follow-up and deceased patients more often had an isch-
aemic stroke than a TIA and higher NIHSS-scores. These variables were however not 
associated with a higher prevalence of fatigue. Furthermore, we have no reason to as-
sume that the nature of the relation between fatigue and functional outcome differs 
in participants from that in any of the 3 groups of non-participants (eg., refusers, lost to 
follow-up, and deceased).
Table 2 Risk factors for the presence of fatigue.
Risk factor
TIA Ischaemic stroke
OR (95%CI) p-value OR (95%CI) p-value
Female sex 2.9 (1.1-7.6) 0.03 1.3 (0.7-2.2) 0.45
Age, per year 1.0 (0.9-1.0) 0.47 1.0 (1.0-1.0) 0.10
Lower educational level 1.0 (0.3-3.4) 0.96 1.1 (0.5-2.5) 0.78
NIHSS at admission, per point 1.1 (0.9-1.3) 0.36 1.0 (1.0-1.1) 0.59
Follow-up duration, per year 1.0 (0.9-1.0) 0.37 1.0 (0.9-1.0) 0.45
Depressive symptomsa 1.8 (1.4-2.2) 0.00001 1.4 (1.3-1.6) <0.000001
Anxietyb 1.2 (1.0-1.4) 0.03 1.1 (1.0-1.2) 0.02
Recurrent cerebro-vascular eventsc 2.3 (0.8-7.1) 0.13 2.4 (1.2-5.0) 0.02
Multiple logistic regression analysis with factors associated with fatigue. All variables were entered simul-
taneously into the model. Body Mass Index and alcohol consumption did not significantly alter the model 
and were removed from the model. Legend: NIHSS: National Institutes of Health Stroke Scale.  a.) per 
point on Hospital Anxiety and Depression Scale, items on depressive symptoms; b.) per point on Hospital 
Anxiety and Depression Scale, items on anxiety; c.) TIA’s, ischaemic and haemorrhagic strokes combined.
Table 3 Association between fatigue and cognitive impairment.
Cognitive domain
Association between impairment and fatigue
OR (95%-CI) p-value
Speed of information processing 2.2 (1.3-3.9) 0.006
Visuoconstruction 1.5 (0.8-2.8) 0.18
Working memory 2.3 (1.3-4.3) 0.007
Immediate memory 1.5 (0.8-2.9) 0.17
Delayed memory 0.7 (0.4-1.3) 0.25
Attention 1.6 (0.9-2.9) 0.12
Executive functioning 1.0 (0.6-1.9) 0.94
Multiple logistic regression analysis, showing associations between fatigue and cognitive impairment on 
7 cognitive domains. With Bonferroni correction, p<0.007 was considered statistically significant. Odds 
Ratios (OR) with 95%-Confidence Intervals (95%-CI) and p-values were adjusted for age, sex, stroke →
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ences in prevalence during different tertiles of follow-up.
Our findings that stroke subtype (TIA or ischaemic stroke), lesion localisation and recur-
rent cerebrovascular events were not unequivocally related to the presence of fatigue, 
suggest that other factors may play an important role, for example psychosocial factors. 
In our study, depressive symptoms and anxiety were associated with the presence of 
fatigue. These symptoms often co-occur.243 A study in patients with a mean age of 68 
years found that fatigue was associated with poor physical health 1.5 years after a stroke, 
independent of depressive symptoms.244 However, younger patients might have to cope 
with higher demands than older stroke survivors, due to active work participation and 
a young family. Therefore, results from studies in older stroke survivors cannot neces-
sarily be extrapolated to young patients with stroke. Our study shows that fatigue was 
related physical health in young stroke survivors, measured with a motor performance 
scale (mRS), independently from depressive symptoms or anxiety. Moreover, we found 
that fatigue was also associated with impairment of speed of information processing and 
showed a trend towards a significant association with impaired working memory. One 
previous study in older patients with stroke found no longitudinal relationship between 
fatigue and mental health.244 This differs from the findings from our study, but this is prob-
ably explained by the fact that we assessed each cognitive domain separately, instead of 
1 global score for cognitive performance. Although we found that fatigue was associated 
or showed a trend towards an association with only 2 cognitive domains (speed of infor-
mation processing and working memory), impairment in these domains may very much 
interfere with regaining pre-stroke activities, for example returning to work.245 
One other study also found a relation between fatigue and poor functional physical 
outcome in young patients with ischaemic stroke.33 Since our study shows that this 
association also holds true for cognitive impairment, our study underlines the fact that 
the less visible (psychological) post-stroke consequences are at least as important to 
address in rehabilitation programmes as are the more visible motor symptoms.
Our findings can be used to properly inform young stroke survivors and caregivers, 
which may be a first step in optimising rehabilitation programmes.246 Although dif-
ferent kinds of treatments for post-stroke fatigue are in development for the general 
stroke population,247, 248 no treatments have been proven unequivocally successful in 
clinical trials in these patients,249-251 let alone in specific young stroke cohorts. 
In conclusion, even after almost a decade of follow-up after a stroke at young age, 
fatigue was present in approximately 40% of patients. This fatigue was associated with 
a poor functional outcome. Therefore, reducing fatigue can be an important tool in 
increasing functional independence in young stroke survivors.
Confounding is another bias to be considered. The most important confounders in 
the relation between fatigue and functional outcome are the presence of depressive 
symptoms and anxiety. We tried to overcome this bias by making adjustments for the 
presence of depressive symptoms and anxiety in our analyses. 
Statistical power was limited in patients with TIA, so we had to include the variables 
‘depressive symptoms’ and ‘anxiety’ as continuous scores on the HADS in the model 
investigating their association with fatigue. They were found to be independently relat-
ed to fatigue, with modestly elevated odds ratios per point on the HADS-score. If there 
were more patients in the TIA-group, and we could have included depressive symp-
toms and anxiety as dichotomous variables, we expect that this would have resulted 
in larger odds ratios, showing even more clearly that these symptoms are interrelated. 
Therefore, this probably would not have altered conclusions. 
One previous study in young patients with stroke reported a prevalence of fatigue of 
51.3% versus 31.6% in controls.33 These figures were higher than we found (41.0% versus 
18.4%). This difference may be explained by the different methods that were used to as-
sess fatigue. It might be that the threshold of detecting fatigue with our questionnaire 
is higher, but we are not aware of studies that directly compare the 2 different methods 
that assess fatigue (Fatigue Severity Scale (FSS) and CIS). 
A surprising finding of our study was that fatigue was equally common in young patients 
with TIA as in young patients with ischaemic stroke. This may suggest that the size of the 
structural lesion caused by the initial TIA or stroke does not play a role in the presence 
of fatigue after long-term follow-up. In addition, we did not find any difference in preva-
lence of fatigue in different lesion localisations. Our findings are in contrast with previous 
short-term follow-up studies. One study found that fatigue was more common after a 
minor stroke than after a TIA.242 Other short-term follow-up studies found that the lesion 
localisation, namely infratentorial or in the basal ganglia, was associated with the pres-
ence of fatigue.24, 150 Our findings indicate that on the long term, initial stroke characteris-
tics (eg., volume of brain damage or lesion localisation) are not an important determinant 
of the presence of fatigue, in contrast to previous studies that found stroke characteristics 
to be associated with fatigue shortly after the stroke. 
Whereas the initial stroke may not have a large role in long-term post-stroke fatigue 
anymore, accumulating structural brain damage over the years may have. This is in-
deed suggested by our finding that recurrent cerebrovascular events were associat-
ed with the presence of fatigue (in patients with an ischaemic stroke). However, one 
would then also expect that the prevalence of fatigue would rise with longer follow-up, 
during which recurrent cerebrovascular events occur. We did however not find differ-
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Introduction
Approximately 10% to 14% of all strokes occur in patients under 50 years of age,5 of 
which 20% are intracerebral haemorrhages (ICH).252 The survival of ICH patients has in-
creased due to improved intensive and neurological care.40 Furthermore, once a patient 
survives the first 30 days, long-term mortality is comparable to the general population 
in patients aged 18-40 years,253 resulting in an increasing number of very long-term sur-
vivors after an ICH in young adults. Therefore, the need for information on long-term 
sequelae of this condition arises. Moreover, young adults are in a demanding phase of 
life, because of their role as a caregiver for a young family or the presence of occupa-
tional responsibilities. This stresses the need for reliable information on possible factors 
that might interfere with post-ICH activities of daily life.
To date, only limited data exist on long-term consequences of ICH in young adults <50 
years,16, 108, 254 especially with respect to less visible symptoms, such as mood disorders, 
fatigue or cognitive impairment.255 Data cannot be extrapolated from findings in el-
derly patients,18, 256-258 since patients are much younger and for example have better re-
covery than elderly. On the other hand, young adults may experience more difficulties 
as they are more likely to encounter demanding situations in their daily life. Findings 
from studies in ischaemic stroke patients may neither necessarily be generalisable to 
patients with an ICH. Although often lumped under the term ‘stroke’, these are 2 com-
pletely different diseases, each with different causes and recovery.23, 259, 260
Therefore, we aimed to investigate the long-term prevalence of neuropsychological 
consequences in a population of ICH-survivors, aged 18 through 50 years, including 
depressive symptoms, anxiety, fatigue, subjective cognitive failures, and objective cog-
nitive impairment, compared with an age-, sex-, and education-matched, stroke-free 
control group.
Methods
Patients and study design
This study is a part of the ‘Follow-Up of Transient ischaemic attack and stroke patients 
and Unelucidated Risk factor Evaluation’ (FUTURE) study, a prospective cohort study 
designed to investigate the aetiologies and consequences of a young stroke. Details of 
the study have been described elsewhere.42, 110 In short, the FUTURE study comprised all 
consecutive patients aged 18 through 50 years with a transient ischaemic attack (TIA) 
or stroke admitted to the Radboud University Medical Centre Nijmegen from January 
Abstract
Background and objective 
The survival of patients with an intracerebral haemorrhage (ICH) has increased due 
to improved intensive and neurological care. Data on the long-term cognitive and 
behavioural prognosis of these patients is scarce, especially in young patients (<50 
years). Therefore, the aim of this study was to investigate this long-term prognosis. 
Methods 
All patients, aged 18-50 years, admitted to our hospital between January 1, 1980 
and November 1, 2010 who survived an ICH (n=45, mean age: 35.3 (SD 8.5) years), 
were recruited. We assessed depressive symptoms and anxiety with the Hospital 
Anxiety and Depression-scale. Fatigue was assessed with the Checklist Individual 
Strength questionnaire and subjective cognitive failures with the Cognitive Fail-
ures Questionnaire. Cognitive performance was examined, using an extensive 
neuropsychological examination. Prevalence of these symptoms was compared 
with 45 sex-, age-, and education-matched controls.
Results
After a mean follow-up of 9.8 (SD 8.0) years, fatigue showed a trend towards a 
significantly higher prevalence in patients compared with controls (40.5% ver-
sus 22.2%, p=0.07). Subjective cognitive failures were more prevalent in patients 
than in controls (93.9% versus 73.0%, p=0.02). Higher frequencies of cognitive im-
pairment on the domains ‘speed of information processing’ (33.3% versus 5.4%, 
p=0.003), ’working memory’ (29.4% versus 10.8%, p=0.049), ‘immediate memory’ 
(26.5% versus 8.1%, p=0.04), and ‘delayed memory’ (20.6% versus 2.7%, p=0.02) 
were observed. We found no difference in prevalence of depressive symptoms 
and anxiety between patients and controls.
 
Conclusion
Even after almost 10 years of follow-up, neuropsychological problems are preva-
lent after ICH in young adults. Patients should be informed on these possible long-
term consequences of an ICH.
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symptoms or anxiety,230, 233 and is well validated in stroke patients233 as well as in large 
population-based studies.184 Data on the HADS were missing in 6.7% of the patients.
Fatigue
The presence of fatigue in the past 2 weeks was assessed with the fatigue subscale of 
the Checklist Individual Strength questionnaire (CIS).193, 241 The fatigue subscale contains 
8 items on the level of perceived fatigue, with a scoring range from 1 to 7, with higher 
scores representing more fatigue. The total score ranges from 8 to 56, a score above 
35 is considered indicative for severe fatigue.193, 241 This screening instrument is well val-
idated in stroke patients and has been used in a previous stroke cohort.24 Data on the 
presence of fatigue were missing in 6.7% of the patients.
Subjective cognitive failures
The presence of subjective cognitive failures in the past month was assessed, using a 
semi-structured interview based on the Cognitive Failures Questionnaire (CFQ).183 This 
questionnaire contains 5 items with a scoring range from 0 to 3 (none-mild-moder-
ate-severe) and 10 items with a scoring of 0 or 1 (item absent or present). Subjective 
cognitive failures were considered present when a participant scored a ‘2 (moderate)’ 
or higher on at least 1 item with a scale of 0 to 3 or scored a ‘1 (present)’ on at least 1 
item with dichotomous answers. This version was also used in other large scale epide-
miologic research.227, 228 Subjective cognitive failures were assessed in the patients who 
visited our research centre for an in-person neuropsychological investigation, n=37. 
Data were missing in 10.8 % of these patients.
Cognitive performance
Neuropsychological examination covered the main cognitive domains and these tests 
have been previously applied in large-scale epidemiological studies in patients with 
cerebrovascular disease.174, 175 The following cognitive domains were examined: Process-
ing speed (Symbol-Digit Substitution Task, Abbreviated Stroop Color Word Test, parts I 
and II), Visuoconstruction (Rey-Osterrieth Complex Figure (ROCF) - Copy trial), Working 
memory (Paper and Pencil Memory Scanning Task (PPMST)), Immediate memory (ROCF - 
Immediate recall and the total number of words immediately recalled in the 3-trial 
version of the Rey Auditory Verbal Learning Test (RAVLT)), Delayed memory (delayed 
recall on the ROCF and the RAVLT), Attention (Verbal Series Attention Task (VSAT)), and 
Executive functioning (Verbal Fluency and Stroop Interference). To account for speed-ac-
curacy trade-off on the Stroop test, PPMST, and VSAT, composite scores were calculat-
1, 1980 until November 1, 2010. For the present study, only patients with an ICH were 
included. Patients were identified through a prospective registry that has been main-
tained at the Department of Neurology of the Radboud University Nijmegen Medical 
Centre, since the late 1970’s with a standardised collection of baseline and clinical char-
acteristics (including demographics and stroke subtype).42 
Stroke was defined as a focal neurological deficit persisting for more than 24 hours.261, 
262 Stroke was subdivided into ischaemic or haemorrhagic based on radiological 
findings. To minimise bias resulting from changing diagnostic techniques, the World 
Health Organization definition for stroke was used.261, 262 ICH location was determined 
by neuroimaging reports and medical history. Assessment of stroke severity (National 
Institutes of Health Stroke Scale (NIHSS)213) was performed retrospectively in all cases 
using a validated approach as previously described,165, 214 because this scale did not exist 
when a substantial number of our patients experienced their index event. 
Exclusion criteria were traumatic haemorrhagic stroke, haemorrhage in known cerebral 
metastasis or primary brain tumor, subarachnoid haemorrhage or ICH attributable to 
known ruptured aneurysm. 
Control participants were recruited from the same environment as the patients, among 
the patients’ spouses, relatives, or social environment. Each patient was matched with 1 
control participant for age, sex, and education. Controls had to be at least 18 years old, 
without a history of TIA or stroke. They were all living independently.
The Medical Review Ethics Committee region Arnhem-Nijmegen approved the study.
Written informed consent was obtained from all participants and controls.
Follow-up assessment
All patients alive were invited for a follow-up assessment between November 1, 2009 
and January 1, 2012. If patients consented to participate, but were not able to visit our 
research centre, a standardised, structured questionnaire was sent out by mail to these 
participants, including the questionnaires on depressive symptoms, anxiety, and fa-
tigue. The presence of subjective cognitive failures and cognitive impairment was not 
assessed in these patients.
Depressive symptoms and anxiety
Depressive symptoms and anxiety in the past week were assessed with the Hospital Anx-
iety and Depression Scale (HADS). Depressive symptoms were considered present with a 
score higher than 7 on either the depression or the anxiety items of this questionnaire.230 
The cut-off value we used is considered to be indicative of the presence of depressive 
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Figure 1 Flowchart of study population.
Table 1 Description of demographics and clinical variables in ICH-patients.
ICH
n=45
Baseline
Men, n (%)a 26 (57.8)
Age at index-event, years (SD) 35.3 (8.5)
NIHSS score at admission, median (IQR) 11 (3-15.5)
Location
Supratentorial, n (% of total) 36 (80.0)
Hemisphere, n (% of all supratentorial locations)
Left 13 (36.1)
Right 20 (55.6)
Bilateral 3 (8.3)
Localisation, n (% of all supratentorial locations)
Deep 8 (22.2)
Lobar 15 (41.7)
Ventricular 3 (8.3)
Intraventricular extension 10 (27.8)
Baseline intracerebral 
haemorrhage
n = 98
Lost to follow‐up
n = 9
Deceased
n = 28
Refused to participate
n = 16
Follow‐up survivors,
visited our clinic
n = 37
Follow‐up survivors,  
questionnaire only
n = 8
ed (accuracy(%)/reaction time).207 Stroop Interference was computed by dividing the 
composite Stroop part III score by the mean of the composite scores of parts I and II. 
Cognitive performance was assessed in the patients who visited our research centre 
for an in-person neuropsychological investigation, n=37. Data on cognitive impairment 
were missing in 8.1-10.8% of these patients, depending on the domain tested. If 1 test 
of a particular domain was missing, the domain score was occasionally based on the 
remaining tests of that domain. Detailed information on the neuropsychological exam-
ination is described extensively elsewhere.42, 139 
Statistical analysis
The prevalence of depressive symptoms, anxiety, fatigue, and subjective cognitive fail-
ures was compared with controls, using a chi-square test. 
Cognitive impairment for each cognitive domain was defined as >1.5 SD below the 
mean of the control group. Next, the prevalence of cognitive impairments for each 
cognitive domain between patients and controls was compared by means of a chi-
square test. Subsequently, we tested the ‘forgetting rate’ after 30 minutes by subtract-
ing delayed recall on the RAVLT from the third trial of the RAVLT.
A sensitivity analysis was performed to account for the relatively large percentage of 
missing data in the 7 cognitive domains, using the automatic multiple imputation 
methods in SPSS. 
Two-sided p-values of less than 0.05 were considered to indicate statistical significance. 
All statistical analyses were performed with SPSS 20.0 software for Windows.
Results
Study population and demographics
45 patients with an ICH and 45 healthy controls were included in this study (Figure 1). 
Demographics and clinical variables of patients are presented in Table 1. Controls did 
not differ from patients with respect to sex, age, and education.
Deceased patients were older than participants at the time of the index event (41.2 
(SD 7.7) years versus 35.3 (SD 8.5) years, p=0.04) and had a more severe stroke (median 
NIHSS 17.5 (IQR 11-23) versus median NIHSS 11 (IQR 3-15.5), p=0.0001), but no differences 
were observed with respect to sex. 
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Neuropsychological outcomes
After a mean follow-up of 9.8 (SD 8.0) years (with 17 of patients (37.8%) with a follow-up 
duration of >10 years), subjective cognitive failures were more prevalent in patients 
than in controls (93.9% versus 73.0%, p=0.02). Fatigue was present in 40.5% of patients 
and showed a trend towards a significant difference compared with controls (22.2%, 
p=0.07). No differences in the prevalence of depressive symptoms and anxiety were 
observed in patients compared with controls (7.1% versus 4.4%, p=0.59 and 11.9% ver-
sus 6.7%, p=0.40). 
Table 2 shows the neuropsychological test scores of patients and controls.
Figure 2 shows that the prevalence of patients with cognitive impairment (>1.5 SD be-
low mean performance of controls) differed significantly from controls on the domains 
‘speed of information processing’ (33.3% versus 5.4%, p=0.003), ’working memory’ 
(29.4% versus 10.8%, p=0.049), ‘immediate memory’ (26.5% versus 8.1%, p=0.04), and 
‘delayed memory’ (20.6% versus 2.7%, p=0.02). 
After performing a sensitivity analysis with the multiple imputation method, the signif-
icant difference in ‘working memory’ impairment changed into a trend (p=0.06) and 
the non-significant difference in ‘attention’-impairment became a trend (p=0.08).The 
differences in other domains remained significant.
The large proportion of patients with impairment in delayed memory is mainly attrib-
utable to a worse performance in the initial learning trials of the test, as patients did not 
show a rapid forgetting rate after 30 minutes compared with controls. 
ICH
n=45
Infratentorial, n (% of total) 9 (20.0)
Cerebellum, n (% of all infratentorial locations) 3 (33.3)
Brainstem, n (% of all infratentorial locations) 6 (66.7)
Etiology, n (%)
Hypertension 10 (22.2)
Arteriovenous malformation 14 (31.1)
Cavernous angioma 1 (2.2)
Coagulopathy
Medication use 2 (4.4)
Bleeding disorder 2 (4.4)
Septic embolism 1 (2.2)
Unknown
Cryptogenic 11(24.4)
Multiple causes 2 (4.4)
Incomplete evaluation 2 (4.4)
Follow-up
Mean duration of follow-up, years (SD) 9.8 (8.0)
Follow-up >10 years, n (%) 17 (37.8)
Age at follow-up, years (SD)b 45.1 (10.4)
Education, median (IQR)c 5 (5-6)
Recurrent strokes, n (%) 5 (11.1)d
Abbreviations: ICH: Intracerebral haemorrhage; NIHSS: National Institute of Health Stroke Scale; IQR: in-
terquartile range.
a.) In controls: 25 (55.6), p=0.83; b.) In controls: 45.1 (10.7), p=1.00; c.) In controls: 5 (5-6), p=0.63; d.) Of which 
1 ischaemic stroke and 4 intracerebral haemorrhages. Missing data: educational level was missing in 1 
patient. Level of education was scored with a widely-used Dutch scoring system (1 = less than primary 
school; 7 = university degree).229
Table 1 Continued
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Figure 2 Proportions of patients and controls with cognitive impairment (<1.5 SD below 
    the mean performance of controls) on 7 cognitive domains.
ICH: intracerebral haemorrhage; SOIP: Speed of information processing; VC: visuoconstruction; WM: work-
ing memory; IM: immediate memory; DM: delayed memory; EF: executive functioning.
*p<0.05
**p<0.01
Discussion
This study showed that up to one third of patients who survived an ICH have cognitive 
impairment after almost 10 years of follow-up. In addition, subjective cognitive fail-
ures and fatigue were also very common symptoms. Depressive symptoms and anxi-
ety were much less prevalent and did not differ between ICH-patients and stroke-free 
controls.
One strength of our study is the long-term follow-up, which provides unique informa-
tion on possible long-term neuropsychological consequences a young survivor of an 
ICH may be confronted with. Another strength of our study is the comparison with a 
closely matched control sample. This provides insight into the excess risk of neuropsy-
chological problems, attributable to the ICH.
However, our results need to be interpreted with caution. Because of the small sample 
size, statistical power is limited, which may have introduced bias.
 ICH  Controls 
30
35
40
**
*
*
10
15
20
25
*
*
0
5
SOIP             VC            WM             IM               DM        Attention         EF
Pr
op
or
tio
n w
ith
 co
gn
iti
ve
 im
pa
irm
en
t
Cognitive domains
Table 2 Neuropsychological test scores of patients with an ICH and controls.
Cognitive domain and test
ICH
N=37
Controls
N=37 p-value
Processing speed
    SDMT 45.8 (10.8) 53.9 (8.6) 0.001
    Stroop part Ia 4.4 (1.3) 4.6 (0.7) 0.23
    Stroop Part IIa 3.2 (1.1) 3.6 (0.7) 0.04
Visuoconstruction
    ROCF copy 31.7 (3.7) 32.2 (2.7) 0.57
Memory
    Working memory
       PPMST ‘%’a 2.9 (1.2) 3.6 (1.0) 0.01
       PPMST ‘S’a 2.5 (0.9) 3.0 (0.6) 0.03
       PPMST ‘MP’a 1.7 (0.6) 1.8 (0.4) 0.39
       PPMST ‘DHN’a 1.5 (0.4) 1.6 (0.4) 0.12
   Immediate memory
       RAVLT trial 1-3 19.9 (7.0) 22.7 (5.6) 0.07
       ROCF immediate recall 14.2 (5.4) 19.5 (5.7) 0.0002
   Delayed memory
       RAVLT delayed recall 6.2 (2.8) 7.3 (3.0) 0.12
       ROCF delayed recall 13.6 (5.6) 19.3 (5.7) 0.0003
Attention
       Total score of the VSATa 1.3 (0.5) 1.5 (0.4) 0.35
Executive functioning
       Verbal fluency 23.9 (8.5) 24.4 (6.9) 0.81
       Interferencea 0.5 (0.1) 0.5 (0.1) 0.74
Data are expressed as mean (SD). PPMST: paper and pencil memory scanning test; RAVLT: Rey audito-
ry verbal learning test; ROCF: Rey-Osterrieth complex figure; SDMT: symbol-digit modalities test; VSAT: 
verbal series attention test. S, MP, DHN: these (combination of) letters had to be memorised and found 
among 120 distracting letters.
a.) Speed-accuracy composite score. Higher scores indicate better performance on all measures.
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edema, causing secondary hypoxia,265 although these mechanisms may be partially 
reversible.260, 266 
Future studies are needed to confirm this suggestion, using DTI-techniques to measure 
changes in integrity of subcortical fiber networks over time during and after the clinical 
recovery phase and taking incident co morbidities into account. 
Findings from our study can be used to inform young patients on possible long-term 
neuropsychological consequences of an ICH, although larger studies are needed to 
confirm our results and to elucidate underlying mechanisms. These patients are in a 
period of their lives during which important, possibly life-changing decisions have to 
be made, for example on career movements or family planning.
In conclusion, even after almost 10 years of follow-up, a large proportion of young 
adults who survive an ICH are confronted with cognitive impairment, next to fatigue 
and subjective cognitive failures. Knowing what difficulties may be encountered, will 
create opportunities for better preparation and adjustments, increasing the chances of 
functional independence.
First, selection bias is an issue. Our study included only the long-term survivors of an 
ICH. Patients who were deceased suffered from a more severe stroke. Therefore, it might 
be expected that these patients would also have been more cognitively impaired than 
the participants, resulting in larger differences when included in the analyses, but not 
in different conclusions. 
Second, information bias may have occurred. Researchers who assessed neuropsycho-
logical functioning were not blinded to which group a patient belonged (ICH or con-
trol), due to presence of possible visible physical disabilities. However, strict instruction 
protocols were used and researchers were trained. 
Third, because of the small sample size, we were not able to adjust for confounders. 
However, we tried to overcome this by matching controls on some of the important 
confounding factors, namely age, sex, and education. Recurrent ischaemic strokes or 
ICH, that might have led to cognitive impairment, were not considered in our analy-
ses because of low numbers. These should be considered in future studies with larger 
sample sizes.
Our most important finding is that patients with an ICH showed more cognitive im-
pairment than controls, especially on the domain of ‘speed of information processing’. 
This impairment might interfere with other complex tasks, such as working memory or 
episodic memory performance. As for episodic memory performance, mental slowing 
might have led to impaired learning trials, resulting in a worse recall ability and thereby 
lower scores on tests on delayed memory. One would also expect that ICH-patients 
showed more impairment on the domain of ‘attention’, because this may also be influ-
enced by mental speed. Possibly, our tests were not sensitive enough to find a differ-
ence between patients and controls in our small study sample. 
Mental slowness may also result in experienced fatigue or subjective cognitive failures. 
These symptoms can be caused by an imbalance between high demands from a pa-
tients’ environment (especially in young adults) and impaired coping strategies due to 
the cognitive impairment. 
A possible underlying pathophysiological mechanism for impaired mental speed may 
be the destruction of subcortical fiber networks,263 since mental slowness is usually 
considered to be due to subcortical disfunctioning. Previous studies hypothesised that 
an ICH may cause more reversible damage, because the blood would only displace 
fibers, not destroy them.257 However, our study suggests that an ICH might lead to 
subcortical fiber network destruction, with consequent long-term cognitive impair-
ment. Possible mechanisms may be the mass effect of the volume of the haemorrhage 
itself, causing a raised intracranial pressure264 and tissue necrosis, or the surrounding 
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Introduction 
Approximately 10% of strokes occur in patients under 50 years of age (‘young stroke’), 
but proportions between 20% and 30% are reported, although these higher figures 
mostly come from studies in developing countries.5, 267 At this socioeconomically de-
manding phase of life, post-stroke disability may affect the probability to return to work 
after stroke,268 an important determinant of life satisfaction.36, 154 This is not only an indi-
vidual loss, but also an economic burden to society, as the expected number of loss of 
years of employment is high in these young patients.37 
Assessment of the magnitude of this problem is the first step towards optimising reha-
bilitation of young stroke survivors. This knowledge is currently hampered by the fact 
that previous studies on post-stroke employment usually were limited in follow-up du-
ration155-157, 269 or sample size.158 One study reported on long-term post-stroke employ-
ment after 12 years, but this study was retrospective with a relatively low response rate.26 
In addition, most studies reported only crude numbers of unemployment within the 
young stroke population. A more meaningful approach would be to compare these 
numbers with that of the general population, to reveal the excess in unemployment 
attributable to the young stroke. 
The aim of this study was to investigate the prevalence and excess risk of unemploy-
ment in patients aged 18 through 50 years with a transient ischaemic attack (TIA), isch-
aemic stroke or intracerebral haemorrhage (ICH), compared with a nationwide control 
group. Also, we investigated whether demographic and clinical variables were associ-
ated with long-term unemployment, including baseline skills level.
Methods
Patients and study design
This study is a part of the ´Follow-Up of Transient ischaemic attack and stroke patients 
and Unelucidated Risk factor Evaluation´ (FUTURE) study, a prospective cohort study 
designed to investigate the aetiologies and consequences of stroke in a population of 
individuals aged 18 through 50 years.110 Details of the study were described extensive-
ly42 and in summary,102, 110, 128, 132 and are detailed briefly here.
The FUTURE study comprised all consecutive patients aged 18 through 50 years with 
a TIA, ischaemic stroke or ICH admitted to the Radboud University Nijmegen Medical 
Centre from January 1, 1980, until November 1, 2010.110 For the present study, only pa-
tients with first-ever TIA, ischaemic stroke or ICH were assessed. Patients were included 
Abstract
Objective
To investigate the prevalence, excess risk, and risk factors of unemployment in pa-
tients after a transient ischaemic attack, ischaemic stroke or intracerebral haem-
orrhage at ages 18 through 50 years of age, compared with nationwide controls. 
Methods
We performed a hospital-based cohort study among 694 patients, aged 18-50 
years, with a first-ever transient ischaemic attack, ischaemic stroke or intracerebral 
haemorrhage. 
After a mean follow-up duration of 8.1 (SD 7.7) years, we used logistic regression 
analysis to calculate odds ratios (ORs) with 95% confidence intervals (95%-CI) for 
being unemployed as a young stroke patient, compared with the Dutch popula-
tion of vocational age (n = 7 803 000), with subsequent assessment of risk factors 
of unemployment. 
Results
Young stroke patients had a higher risk of being unemployed than their peers in 
the Dutch population: women: OR 2.3, 95%-CI 1.8-2.9, men: OR 3.2, 95%-CI 2.5-4.0. 
A higher NIHSS-score at admission (OR 1.1, 95%-CI 1.0-1.1) and a longer follow-up 
duration (middle tertile: OR 2.8, 95%-CI 1.7-4.7, upper tertile: OR 3.4, 95%-CI 1.9-6.1) 
were associated with a higher risk of being unemployed. 
Conclusion
Young stroke patients had a 2 to 3 times higher risk of unemployment after 8 years 
of follow-up. Return-to-work programmes should be developed, adjusted and 
evaluated in order to diminish the negative effects that unemployment can have 
on patients’ life satisfaction and to limit the socio-economic consequences. 
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Being retired at follow-up was an additional exclusion criterion for this particular study. 
Data on receiving a disability payment were missing in 77 patients of the original co-
hort of 1 005 patients (7.7%). 
Other measurements
Apart from baseline demographic clinical variables (age, sex, and stroke severity (NIHSS 
score)), we collected occupation prior to the index event by structured questionnaires 
and review of medical records. We subsequently categorised occupations into 4 lev-
els of baseline skills, based on required educational levels for that occupation (rang-
ing from first = primary education only, to fourth = tertiary education with university 
degree or equivalent), according to the International Standard Classification of Occu-
pations-88.273 This classification is designed by the International Labour Organization 
(ILO), a United Nations agency concerned with international labour standards.273 Data 
on baseline skills level were missing in 12.2% of patients.
Appendix 1 Short explanation of the Dutch disability benefit system. 
In the Netherlands, 4 types of disability benefits exist, depending on the employer (self-
employed or not), age, and the proportion of disability. The proportion of disability is 
based on the proportion of a persons’ last-known salary, that one is still able to earn (in the 
same or another occupation). The 4 types of disability benefit are: 1.) WAO (Occupational 
Disability Insurance Act), for employees with chronic disease or disability, utilised until 
2005; 2.) WIA (Work and Income according to Labour Capacity Act), comparable with 1.), 
but partly replacing it, enacted from 29th of December 2005. This benefit consists of 2 
parts, 1 for persons who are permanently disabled for at least 80% (IVA) and 1 for persons 
who are between 35% and 80% disabled or more than 80% but not permanently (WGA); 
3.) WAZ (Occupational Disability Insurance Act for self-employed persons); and 4.) Wajong 
(Occupational Disability Insurance Act in young persons), for those already disabled before 
turning 18. 
When a person is partially disabled, it is possible to be part-time employed at the same 
time, for example being 70% disabled and 30% employed. However, the sum of these 2 
parts cannot be more than 100%. If a patient is able to regain (partial) employment, the 
disability benefit will be cancelled or adjusted accordingly. 
prospectively between 1980 and 2010 with a standardised collection of baseline and 
clinical characteristics and all patients underwent neurological examination and brain 
imaging at the time of their index event.132 
TIA was defined as a rapidly evolving focal neurological deficit without positive phe-
nomena such as twitches, jerks or myoclonus, with no other than a vascular cause last-
ing less than 24 hours.132 Stroke, divided into ischaemic and ICH categories on the basis 
of radiological findings, was defined as focal neurologic deficit persisting for more than 
24 hours.110 We assessed stroke severity retrospectively in all cases with the NIH Stroke 
Scale (NIHSS)213 by a validated approach.165, 214 
Exclusion criteria were as follows: previous stroke or TIA, traumatic haemorrhagic stroke, 
haemorrhage in known cerebral metastasis or primary brain tumor, cerebral venous 
sinus thrombosis, subarachnoid haemorrhage or ICH attributable to known ruptured 
aneurysm, and retinal infarction.110 
Standard protocol approvals, registrations, and patient consents
The Medical Review Ethics Committee region Arnhem-Nijmegen approved the study.
We obtained written informed consent from all participants.
Assessment of unemployment
In the Netherlands, a national registry of Dutch citizens who receive a disability pay-
ment is kept by the Central Bureau of Statistics (CBS), a government agency that is 
responsible for collecting statistical information on the Dutch population. We could 
establish anonymously which patients in our study population received a disability 
payment on the basis of the registry on disability benefits, provided by the CBS. Our 
study participants were assigned unique numbers by the CBS, to guarantee anonymity. 
As most of our follow-up data were collected in the year 2010, we chose to collect data 
on disability payment from the CBS-registry of 2010. 
Data on disability payments of the general Dutch working population (stratified by sex 
and age category) are freely available on the website of the CBS and were used as the 
control group.270 
In appendix 1 on the Neurology® website at Neurology.org, the Dutch system of disabil-
ity benefits is explained.271, 272 
The 4 types of disability payments that exist in the Netherlands were combined into 
1 variable. This variable was used to calculate our primary outcome, unemployment 
after stroke, defined as the proportion of patients receiving any of these 4 disability 
payments in 2010.
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Results
Study population and demographics
We included 694 patients in this study (Figure 1). There were 215 (31%) patients with a TIA, 
425 (61.2%) patients with an ischaemic stroke and 54 (7.8%) patients with an ICH. Table 1 
lists baseline characteristics of all stroke subgroups. Mean follow-up duration was 8.1 (SD 
7.7) years. Of the 694 patients, 33.6% had a follow-up of ≥10 years and 21.5% of ≥15 years. 
Deceased patients (n=120) and patients who were lost to follow-up (n=77) more often 
had an ischaemic stroke or ICH than the 694 participants, with higher NIHSS-scores (me-
dian 10 (3.5-14) and 5 (1-11) versus 3 (0-7) in participants, p<0.0001). The proportion of men 
was higher among deceased patients and among patients who were lost to follow-up 
than among participants (57.1% and 55.8% versus 42.7%, respectively, p=0.007 and 
p=0.02). Patients who died during the course of the follow-up were older at the time of 
their index event than participants (42.6 (SD 6.8) years versus 39.1 (SD 8.1) years, p<0.0001).
Figure 1 Flowchart of study population.
Baseline stroke population
n = 1005
Lost to follow‐up
n = 77
History of  TIA or stroke
n = 46
Deceased
n = 120
Retired
n = 68
Follow‐up study population
n = 694
Statistical analysis
We compared age and sex between stroke subtypes using a Student’s t-test and Pear-
son chi-square test, respectively. 
We calculated the prevalence of unemployment, defined as the proportion of patients 
receiving a disability payment after the index event, for men and women separately. 
We calculated prevalence of unemployment in the 3 stroke subtypes (TIA, ischaemic 
stroke or ICH) similarly and compared differences in prevalence between stroke sub-
types with a chi-square test. NIHSS-score at admission, sex, current age, and duration of 
follow-up were considered possible confounders and adjusted for.
We assessed the risk of unemployment in a young stroke patient, compared with the 
Dutch population by logistic regression, stratified by sex and age. The Central Bureau 
of Statistics stratified age groups as follows: <25, 25-34, 35-44, 45-54, and 55-65 years. 
This was done in an identical manner for young stroke patients. Patients residing in the 
age groups <25 and 25-34 years were combined, because there were only few cases in 
each group. We weighted overall proportions of unemployment in men and women in 
the Dutch working population by age groups. Similar analyses were done for only fully 
unemployed patients (eg., including only patients who are disabled for at least 80% 
(defined as being able to earn less than 20% of the last earned salary), as these patients 
are classified as fully disabled according to the Dutch disability benefit system), and 
ischaemic stroke and ICH patients only (excluding TIA patients). 
We used a multiple logistic regression model to estimate the association (OR with 95%-
CI) between unemployment and sex, current age, follow-up duration divided in tertiles 
(first tertile: up to 3.17 years, n=231; second tertile: 3.20 to 10.05 years, n=232; third ter-
tile: 10.06 to 30.00 years, n=231), stroke severity (NIHSS-score at admission), index event, 
and baseline skills level. The 2 lower and 2 intermediate skills levels were combined for 
comparison with the highest skills level. 
Two-sided P-values <0.05 were considered statistically significant. We performed statis-
tical analysis, using IBM (Armonk, NY) SPSS Statistics version 20.
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Table 1  Baseline demographic and clinical variables, stratified by stroke subtype .
TIA
n=215
IS
n=425
ICH
n=54
Baseline 
Men, n (%)a 88 (40.9 ) 182 (42.8) 26 (48.1)
Age (years) at index event 39.7 (8.0) 39.1 (8.1) 36.2 (8.8)
NIHSS score at admission 0 (0-1) 4 (2-8.5) 10.5 (2.8-15.0)
Skills level at baseline, n (%) NA
      None 28 (14.3) 52 (14.1) 3 (6.8)
      Primary education only  21 (10.7) 54 (14.6) 6 (13.6)
      High school education 73 (37.2) 149 (40.4) 17 (38.6)
      Tertiary education, not 
      equivalent to university degree
65 (33.2) 96 (26.0) 15 (34.1)
      Tertiary education, (equivalent to ) 
     university degree
9 (4.6) 18 (4.9) 3 (6.8)
Follow-up
Follow-up duration (years)
      Mean (SD) 6.0 (6.9) 9.1 (7.9) 8.9 (7.7)
      Median (IQR) 3.6 (1.2-7.4) 7.2 (2.1-14.9) 5.5 (3.3-15.2)
Age (years) at follow-upb 45.7 (9.3) 48.2 (9.0) 45.1 (10.8)
Data are expressed as mean (SD) or median (Q1-Q3), unless otherwise specified.
Abbreviations: TIA: Transient Ischemic Attack, IS: Ischemic stroke, ICH: intracerebral hemorrhage, NIHSS: 
National Institutes of Health Stroke Scale. 
a.) No differences between stroke subtypes, tested with Pearson chi-square test. 
b.) Difference between TIA- and ischemic stroke patients, tested with Student’s t-test (p: 0.004)
Missing data: NIHSS: 0.6%; skills level at baseline:12.2% (Of note, proportions were calculated by dividing 
the number of cases by the total number of patients in the TIA or ischemic stroke group, excluding cases 
with missing values for baseline skills level (n=19 in TIA group, n=56 in ischemic stroke group, and n=10 
in ICH-group).
Unemployment
A total of 202 young stroke patients (29.1%) were unemployed in 2010. Table 2A shows 
that young stroke patients had a higher risk of having a disability payment than the 
nationwide controls in all age groups in both men and women, except for women 
between 55 and 65 years of age and men <35 years of age. In both women and men, 
patients between 35 and 44 years had the highest risk (women: OR 4.7, 95%-CI 3.0-7.0, 
men: OR 9.4, 95%-CI 5.6-15.3).
Of the 202 unemployed patients, 170 patients (84.2%) were fully unemployed. Unem-
ployment rates of these patients only, stratified by age category are also reported in 
Table 2A.
Table 2B shows the unemployment rates, stratified by age categories, for ischaemic 
stroke patients and ICH patients only, excluding the TIA-patients.
Table 2 Post-stroke unemployment after stroke in young adults, compared to total 
    Dutch working population.
Part A
Unemployment 
in Dutch
population 
(n=7 803 000)
Alla post-stroke 
unemployment 
in young stroke 
population 
(n=694)
OR
(95%-CI)
Fullb post-stroke 
unemployment 
in young stroke 
population only
(n=694)
OR
(95%-CI)
Women
(overall) n (%) 14.2%c xx 2.3 (1.8-2.9)d,e xx 1.8 (1.4-2.2)d,e
<35 years xx xx 3.8 (1.7-7.8)f xx 3.8 (1.7-7.8)f
35-44 years 69015 (7.3) 30 (26.8) 4.7 (3.0-7.0)e 24 (21.4) 3.5 (2.2-5.4)e
45-54 years 106140 (11.9) 44 (25.9) 2.6 (1.8-3.6)e 37 (21.8) 2.1 (1.4-2.9)g
55-65 years 150093 (36.7) 28 (40.0) 1.2 (0.7-1.9) 21 (30.0) 0.7 (0.4-1.2)
Men
(overall) n (%) 12.5% c xx 3.2 (2.5-4.0)d,e xx 2.6 (2.0-3.3)d,e
<35 years xx xx 3.0 (0.7-9.4) xx 3.0 (0.7-9.4)
35-44 years 56743 (5.0) 23 (32.9) 9.4 (5.6-15.3)e 20 (28.6) 7.7 (4.5-12.8)e
45-54 years 106023 (9.4) 37 (26.6) 3.5 (2.4-5.0)e 31 (22.3) 2.8 (1.8-4.1)e
55-65 years 205203 (29.6) 29 (43.9) 1.9 (1.1-3.0)h 26 (39.4) 1.5 (0.9-2.5) 
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Part B
Unemployment 
in Dutch
population 
(n=7 803 000)
All post-stroke 
unemployment 
in young stroke 
populationi 
(n=479)
OR
(95%-CI)
Women
(overall) n (%) 14.8% c xx 2.9 (2.2-3.7)d, e
<35 years xx xx 3.6 (1.1-9.9)h
35-44 years 69 015 (7.3) 24 (31.2) 5.8 (3.5-9.3)e
45-54 years 106 140 (11.9) 38 (32.2) 3.5 (2.4-5.1)e
55-65 years 150 093 (36.7) 24 (46.2) 1.5 (0.8-2.6)
Men
(overall) n (%) 13.3% c xx 4.0 (3.0-5.3)d,e
<35 years xx xx 4.5 (1.0-15.0)h
35-44 years 56 743 (5.0) 21 (45.7) 16.1 (8.9-28.9)e
45-54 years 106 023 (9.4) 31 (33.0) 4.8 (3.1-7.3)e
55-65 years 205 203 (29.6) 24 (45.3) 2.0 (1.1-3.4)f
Table 2 shows the number (proportion) of patients and controls who are unemployed, for patients de-
fined as the number (proportion) receiving a disability payment after the index event. Part A: all partici-
pants were included (with TIA, ischaemic stroke or intracerebral haemorrhage); part B: patients with TIA 
were excluded. 
xx: Number and proportions not shown for men and women <35 years of age; according to CBS (Central 
Bureau of Statistics)-guidelines, anonymity of data cannot be guaranteed in case of too small absolute 
numbers.
a.) All post-stroke unemployment includes patients with full and partial unemployment;
b.) Full post-stroke unemployment includes only patients who are disabled for at least 80% (defined as 
being able to earn less than 20% of the last earned salary). These patients are classified as fully disabled 
according to the Dutch disability benefit system; c.) percentage weighted by age groups; d.) OR (95%-CI) 
weighted by age groups; e.) p<0.0001; f.) p<0.01; g.) p<0.001; h.) p<0.05; i.) All post-stroke unemployment 
includes patients with full and partial unemployment, for patients with an ischaemic stroke or intracere-
bral haemorrhage only, excluding patients with a TIA.
Table 2 Continued Risk factors for being unemployed
A higher NIHSS-score at admission (OR 1.1, 95%-CI 1.0-1.1, per point increase of the NI-
HSS) and a longer duration of follow-up (OR 2.8, 95%-CI 1.7-4.7, for the middle follow-up 
tertile and OR 3.4, 95%-CI 1.9-6.1, for the upper follow-up tertile) were associated with a 
higher risk of being unemployed (Table 3).
There was no difference in post-stroke unemployment between TIA-patients and isch-
aemic stroke patients after adjustment for confounding, but patients with an ICH had a 
higher risk of post-stroke unemployment (Figure 2). 
Table 3 Odds ratios for factors associated with post-stroke unemployment.
Risk factor
Unemploymenta in 2010
OR (95%-CI)                               p-value
Female sex 1.0 (0.6-1.4) 0.84
Age, per year 1.0 (1.0-1.0) 0.70
NIHSS, per point 1.1 (1.0-1.1) <0.0001
Follow-up duration
               1st tertile 1 -
               2nd tertile 2.8 (1.7-4.7) <0.0001
               3rd tertile 3.4 (1.9-6.1) <0.0001
Skills level at baseline
              None or primary school
              only 
1.2 (0.4-3.3) 0.80
              High school with or
              without extra education
              not equal to university
              degree
1.9 (0.7-5.3) 0.19
              University degree 1 -
Index event
              TIA 1 -
              Ischaemic stroke 1.4 (0.9-2.3) 0.18
              Intracerebral haemorrhage 2.2 (0.9-4.9) 0.07
Multiple logistic regression analysis. 
a.) Unemployment, defined as the proportion receiving a disability payment after the index event.
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Figure 2 Unemployment rates, stratified by stroke subtype.
Figure shows proportions of unemployment rates (proportion of patients receiving a disability payment), 
stratified by stroke subtype. Column of controls (Dutch working population) was added for illustrative 
purposes.
TIA: Transient ischaemic attack, IS: ischaemic stroke, ICH: Intracerebral haemorrhage. 
*TIA versus ICH p=0.02; TIA versus IS p=0.06; (p-value adjusted for sex, age, NIHSS at admission, and fol-
low-up duration).
Discussion
Even after a mean follow-up of 8 years, we found an up to approximately 9 times higher 
risk of unemployment for young stroke patients, compared with the general population. 
A more severe stroke (indicated by a higher NIHSS-score at admission) and a longer fol-
low-up duration were associated with an increased risk of being unemployed. Ischaemic 
stroke and ICH patients as well as TIA patients had a high unemployment rate, although 
the rate in TIA patients was comparable with that of the general population.
An important finding from our study was that even after on average 8 years of fol-
low-up, the unemployment rate after a stroke at young age was still between 25.9% 
and 43.9%, and full unemployment rates between 21.4% and 39.4%. This is in line with 
previous studies with a short-term follow-up, that also reported that 30-50% of young 
stroke survivors did not return to full-time employment.156, 157 
The combination of an up to 9 times excess risk of unemployment after a young stroke 
and the prospect of decades of unemployment results in a considerable social and 
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economic burden by payments of the disability payments. Therefore, the findings of 
our study are relevant for policymakers. 
Previous short-term follow-up studies found lower educational level an independent 
predictor of returning to work during the first post-stroke years.156, 157 It may be that 
higher educated patients use better coping strategies to compensate for post-stroke 
disabilities.236 However, we found that a lower baseline skills level was not associated 
with a higher risk of unemployment. This is somewhat contradictory to the previous 
studies, assuming that skills level is related to educational level. It may be that patients 
with both lower and higher skills levels are confronted with difficulties in returning to 
work, albeit different difficulties. For example, patients with a lower skills level may get 
fewer opportunities to adjust their work to possible impairments, but patients with a 
higher skills level may face higher demands from their colleagues or employer. There-
fore, personalised chronic care during almost the course of a life should be emphasised.
Strengths of our study include a large sample size and the fact that we included pa-
tients with ischaemic stroke, ICH, and those with a TIA. Since in the Netherlands all 
young stroke survivors usually visit a university medical centre during the course of 
their disease, our study population is representative for a Dutch young stroke popu-
lation. Therefore, we used the Dutch working population as a reference group. This 
makes it possible to assess the excess risk of unemployment due to young stroke. 
However, some methodological issues need to be addressed. Selection bias might 
have occurred. We may have underestimated unemployment risks, due to missing data 
on 77 unregistered patients who had a more severe stroke. However, this underestima-
tion would not have altered our conclusions. In addition, it might be that the retired 
patients we excluded were also prematurely unemployed because of the stroke, again 
leading to an underestimation of unemployment rates. However, we found that only 3 
of the 68 excluded retired patients received a disability benefit in the past. Therefore, 
including these patients would not have largely influenced our results.
Information bias is not likely to be an issue in this study, as the primary outcome variable 
of both the participants and the controls (Dutch population) was obtained from the 
same national registry. However, our outcome measure ‘unemployment after stroke’, 
defined as the proportion of patients receiving any of the 4 possible disability payment 
after the stroke may lead to an overestimation of unemployment, due to several reasons. 
First, it also includes patients who can still be partially employed, when only partially 
disabled. However, we intentionally chose ‘receiving a disability payment’ as a measure 
for excess unemployment in patients with a stroke at young age, as it measures only 
involuntary unemployment, due to disability, not including voluntary unemployment. 
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Second, we do not have data on the permanent or temporary status of the unemploy-
ment in 2010. Some patients may still be in their recovery phase and may return to 
work in 2011, leading to an overestimation of long-term unemployment. However, the 
majority (>90%) of unemployed patients in our study were followed-up for more than 
2 years after stroke, after which further recovery is usually considered unlikely. 
Confounding is another source of bias to be considered in our study. First, we could 
not establish whether incident diseases or co morbidities that occurred after the index 
event rather than the qualifying young stroke, might have led to the unemployment, 
because these data could not be linked at an individual level to the anonymous data of 
the Central Bureau of Statistics. Especially in TIA-patients, with signs and symptoms by 
definition being resolved within 24 hours, the long-term risk of unemployment might 
be a reflection of the risk of incident disease, for example vascular events.102 Although 
we cannot establish a direct causal relation between the young stroke and the unem-
ployment, this does not change our observation that young stroke survivors have a 
much higher risk of being unemployed on the long-term than the general population; 
if not caused by the index stroke itself, then maybe by a long-term higher risk of inci-
dental disease or co morbidities after stroke. 
Second, educational levels could be an important confounder. We adjusted for baseline 
skills levels, used as a proxy of education level, based on patients’ jobs. As skills levels 
were similarly distributed in our study cohort and in the Dutch population,274 we do not 
expect this confounding factor to largely influence our results or alter our conclusions. 
In addition, misclassification may play a role as also in the general population, there will 
be a few patients with a young stroke in their medical history of whom some receive a 
disability payment. However, given the size of our control sample, this misclassification 
of only a few controls would not largely influence our results or conclusions. 
Future research is needed to further determine the reasons for being unemployed so 
many years after the young stroke, which may include impaired motor function, cogni-
tive impairment, or incident diseases. One previous study assessed return-to-work and 
associated factors after 12 years of follow-up.26 However, memory problems, anxiety, 
and depression were assessed with only 1 question each. A more thorough assessment 
is necessary to reveal more detailed information and strengths of associations. This in-
formation can be used to optimise advice and rehabilitation programmes to patients’ 
individual needs.
Earlier short-term follow-up studies found high rates of unemployment after stroke.156, 
157 Our study showed that, even after 8 years of follow-up, young stroke patients still had 
an up to 9 times higher risk of unemployment. Given that these young individuals usu-
ally have a long lifespan, long-term unemployment places a disproportionate burden 
upon stroke survivors in particular and society as a whole. Improving the rehabilitation 
of survivors after a young stroke and developing policies that assist their reintegration 
into the work force should be high priorities for health care policy. This would be the 
first step in diminishing the negative effects that unemployment can have on patients’ 
life satisfaction and to limit the enormous socio-economic consequences. 
Acknowledgements
We thank the Central Bureau of Statistics in the Netherlands for providing the anony-
mous registry on disability payments in our study population.
158 159
 part iv
Summary and
general discussion
161
10
Summary
163162
Summary
Chapter 10
Summary and general discussion
PART IV
10
Summary
Stroke is one of the leading causes of death and disability worldwide. The traditional 
view is that stroke is mainly a disease of the elderly. However, approximately 10% of all 
strokes occur in young adults, under the age of 50 years. Despite this considerable pro-
portion, there are only limited data available with respect to their long-term prognosis. 
However, it is particular this long-term prognosis that matters most for these young 
patients, since they usually have a long life expectancy and are in a demanding phase 
of life, during which life-changing decisions have to be made on for example career 
moves or planning of a family life.
In part I, chapter 2 of this thesis, we provide a critical review of the literature on causes 
and consequences of an ischaemic stroke in young adults. Previous literature mainly 
focused on rare risk factors or diseases as the aetiology of a young ischaemic stroke. 
However, the evidence for these rare conditions as a cause of stroke is relatively limited. 
Evidence is accumulating that traditional vascular risk factors are increasingly prevalent 
in these young patients. Therefore, we challenged the concept of ‘young stroke’ as 
a different disease entity opposed to ‘old stroke’. We suggested that with respect to 
aetiology, the ‘young stroke’ population is rather heterogeneous, with a subgroup of 
truly young adults (<35 years of age) with rare causes, older young adults (35-50 years) 
approaching ‘old stroke’ in prevalence of traditional cardiovascular risk factors, and a 
group in whom no causal factor can be found at all. 
Long-term prognosis in terms of mortality and cardiovascular morbidity is worse than 
previously thought in these young patients. Although mortality is lower than in older 
stroke patients, cumulative mortality was 2-4 times increased, compared with nation-
wide data from an age- and sex- matched population. The long-term risk of recurrent 
cardiovascular events also remained high. 
Cognitive impairment, depressive symptoms, anxiety, and fatigue seem common after 
a stroke at young age. However, only few studies on these outcomes exist to date, most 
of them with limited lengths of observation time or with small study samples. Moreover, 
only limited data exist on the impact of these symptoms on daily life functioning. 
Therefore, we performed the FUTURE study. In part II, chapter 3, we describe the ratio-
nale and design of this study; a prospective cohort study designed to investigate ae-
tiologies and long-term consequences of a TIA, ischaemic stroke or intracerebral hae-
morrhage in 1 005 adults, aged 18-50 years (‘young stroke’), admitted to the Radboud 
University Medical Centre Nijmegen between January 1, 1980 and November 1, 2010. In 
this thesis, the focus lies on the long-term neuropsychological and social consequenc-
es of a young stroke and their impact on functional outcome.
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Long-term neuropsychological and social consequences 
after stroke in young adults
In part III, chapter 4, we report on the cognitive performance of young ischaemic 
stroke patients. Compared with 146 stroke-free age- and sex-matched controls, patients 
performed worse on most cognitive domains. After a mean follow-up of 11.0 (SD 8.2) 
years, up to 50% of the patients had a below average performance or cognitive impair-
ment. A longer follow-up duration was associated with lower scores on the immediate 
memory, delayed memory, and executive functioning domains. Deficits in processing 
speed, working memory, and attention were most common. Patients with a left hemi-
spheral stroke had the worst cognitive outcome. In chapter 5, we report on a higher 
prevalence of subjective memory failures and subjective executive failures in young 
stroke patients (86.4% and 67.4%) than in controls (69.7% and 41.4%). These failures were 
not strongly related to objective memory performance or executive functioning, as-
sessed with an extensive neuropsychological examination. We found that the presence 
of these subjective cognitive failures in patients and controls were merely significantly 
associated with the presence of fatigue. This fatigue was assessed with the Checklist of 
Individual Strength questionnaire, which consists of items measuring both physical as 
mental fatigue. 
Subsequently, the long-term prevalence of depressive symptoms and anxiety (chapter 
6) and of fatigue (chapter 7) was described. All of these symptoms were very common 
in patients with an ischaemic stroke or a TIA (depressive symptoms: 16.8%, anxiety: 
23.0%, fatigue: 41.0%), and more prevalent than in controls. These symptoms did not 
differ by stroke localisation. Depressive symptoms and anxiety were prevalent in the 
first few years after stroke, and became less apparent after longer time after stroke. 
The prevalence of fatigue also showed this trend, but differences were not statistically 
significant after adjustment for age at follow-up, sex, education, severity of stroke, and 
a history of depression. In ischaemic stroke patients, depressive symptoms, anxiety, and 
fatigue were all associated with a poor functional outcome, measured with the mRS 
and the IADL. Fatigue was also associated with impairment on the cognitive domain of 
processing speed and working memory. 
In chapter 8, prevalence of cognitive impairment, subjective cognitive failures, depres-
sive symptoms, anxiety, and fatigue in 45 patients with an intracerebral haemorrhage 
was investigated and compared with 45 age-, sex-, and education-matched controls 
after a mean follow-up of 9.8 (SD 8.0) years. Subjective cognitive failures were more 
prevalent in patients than in controls (93.9% versus 73.0%, p=0.02), as was cognitive 
impairment on the following cognitive domains: ‘speed of information processing’ 
(33.3% versus 5.4%, p=0.003), ’working memory’ (29.4% versus 10.8%, p=0.049), ‘imme-
diate memory’ (26.5% versus 8.1%, p=0.04), and ‘delayed memory’ (20.6% versus 2.7%, 
p=0.02). Prevalence of fatigue showed a trend towards a significant difference between 
patients and controls (40.5% versus 22.2%, p=0.07).
No significant differences were found between patients and controls with respect to 
the presence of depressive symptoms and anxiety. 
In chapter 9, we report on the proportion of unemployment in all consecutive patients 
with a first-ever TIA, ischaemic stroke or intracerebral haemorrhage, defined as the pro-
portion of patients receiving a disability benefit. Between 25.9% and 43.9% of patients 
between 35 and 65 years of age were unemployed after a mean follow-up of 8.1 (SD 7.7) 
years. Overall, patients had a higher risk of being unemployed than their peers in the 
Dutch population of vocational age (women: OR 2.3, 95%-CI 1.8-2.9, men: OR 3.2, 95%-
CI 2.5-4.0). A more severe stroke and longer follow-up duration were associated with a 
higher risk of unemployment. The patients of 35-44 years of age had the highest risk of 
being unemployed (women: OR 4.7, 95%-CI 3.0-7.0, men: OR 9.4, 95%-CI 5.6-15.3).
Conclusion
The studies in this thesis describe that in patients who suffer from a stroke at young 
age (18 through 50 years), neuropsychological and social problems are very common, 
even up to a decade after the young stroke. This is in contrast with the general feeling 
of a rather favourable prognosis. Since these symptoms are associated with functional 
dependence and a high risk of not returning to pre-stroke activities, for example return 
to work, they lead to a significant individual loss for the patient, but also to a burden for 
society as a whole. 
The results from the studies in this thesis enable physicians and other stroke caregivers 
to better inform patients on these possible long-term consequences they can be con-
fronted with in the future. More studies are needed to further unravel the underlying 
pathophysiological mechanisms and develop treatment strategies.
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General discussion and future perspectives
Long-term prognosis after a stroke in young adults is not only determined by the pres-
ence of focal, visible neurological deficits, such as a hemiparesis, but even more by 
non-visible symptoms, such as subjective cognitive complaints or even cognitive im-
pairment or mood disorders, and also social consequences.275 However, to date, only 
few studies exist that evaluated the presence and magnitude of these non-visible 
symptoms after a stroke at young age.
Therefore, we wanted to investigate long-term neuropsychological and social conse-
quences after a stroke at young age. Our general aim was to provide reliable informa-
tion on the occurrence of these long-term sequelae, both for survivors of a stroke at 
young age as well as their caregivers and treating physicians. Furthermore, the associa-
tion of these symptoms with a poor functional outcome was determined.
The studies described in this thesis are based on data from the FUTURE study, a pro-
spective cohort study, including all consecutive patients with a TIA, ischaemic, and 
haemorrhagic stroke aged 18-50 years between 1980-2011. All patients visited the de-
partment of neurology of the Radboud University Nijmegen Medical Centre, the Neth-
erlands.
In this chapter, the most important methodological features of the studies in this the-
sis will be discussed first. Next, possible explanations for our main findings will be ex-
plored. Subsequently, we will discuss the challenges our findings may create for current 
daily practice, and formulate future research questions that need to be answered. 
Methodological considerations
Study design
We collected follow-up data from a cohort of all consecutive patients (n=1 005) with a 
stroke between 18 and 50 years, admitted to the Radboud University Nijmegen Med-
ical Centre since 1980. The cohort was identified, based on a prospective registry of 
stroke in young adults that has been kept at our neurology department since the late 
1970-ies. The general objective of the FUTURE study was to investigate aetiology and 
long-term prognosis after stroke at young age. For the studies in this thesis, outcomes 
(cognitive performance, presence of subjective cognitive complaints, depressive symp-
toms, anxiety, fatigue, and unemployment) were measured at 1 time-point during this 
observation period. This resulted in a variable length of follow-up for each individual 
patient, ranging from 0.5-31.0 years. 
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This very long maximum length of observation is a unique strength of this study and 
provides valuable information on long-term psychosocial consequences that patients 
with stroke at young age may encounter. Since we assessed outcome measures at only 
1 time-point during follow-up, we were not able to accurately assess the fluctuation 
over time of these consequences. However, the large variation in observation length al-
lowed us to compare prevalence of outcomes between different observation lengths, 
which gives us some insight into variation in frequencies of outcomes over time.
Another strength of the studies in this thesis is the inclusion of a stroke-free age-matched 
and sex-matched control cohort, for comparison of prevalence of outcome measures. 
Some outcome measures are known to be quite prevalent in the general popula-
tion.276-278 Therefore, the comparison with stroke-free controls is important, to assess the 
excess influence of the stroke at young age on the frequency of these symptoms.
Internal validity
The internal validity of a study reflects the reliability of the conclusions than can be 
drawn, based on the data collected. Results based on these data are always in a more 
or less extent vulnerable to bias. Three forms of bias can be distinguished: selection 
bias, information bias, and confounding. 
Selection bias occurs when the association between a certain determinant and out-
come is different in the population under study, than in the population from which 
these participants were drawn. Selection bias may occur when selection for participa-
tion in a study is dependent on the outcome, and not random.279 In our study, selec-
tion bias may have occurred, because the presence of neuropsychological complaints 
or employment status might have been related to participation. Obviously, outcome 
was only to be assessed in the patients alive at the time of follow-up, but also solely 
among participants. This might have led to an underestimation of the prevalence of 
psychosocial consequences of a stroke at young age, since the deceased patients prob-
ably had a more severe stroke, most likely leading to more post-stroke disabilities and 
psychosocial issues. The same may hold true for patients that refused to participate. 
Including these patients would have then increased the differences we found between 
patients and controls, but most likely would not have altered our conclusions. On the 
other hand, patients that refused to participate might also have recovered without any 
residual symptoms, not giving priority to participate in this study. In this case, our cur-
rent results would be an overestimation of the prevalence of outcomes. Probably, both 
explanations will have influenced participation in our study and it is therefore unlikely 
that this selection bias largely influences our results. However, we do not have any 
formal data on this issue.
Information bias arises when an error occurs in the measurement of a variable. For ex-
ample, this form of bias may be introduced when outcome measures are not clearly de-
fined or cannot be measured objectively, which may lead to misclassification.279 Some 
of our outcome measures (subjective memory complaints, depressive symptoms, anxi-
ety, and fatigue) were based on self-questionnaires and are therefore subjective. Some 
misclassification may have occurred due to the use of these subjective measures, which 
are more prone to misclassification than objective outcomes, such as mortality. How-
ever, all the questionnaires are well-validated, thereby limiting misclassification when 
previously defined cut-off values from these validation studies are used.183, 233, 241 For the 
measurement of unemployment, data from the Central Bureau of Statistics were used, 
which are objective data on whether a patient is receiving an unemployment benefit 
or not. Therefore, misclassification is not an issue in this study.
Another source of information bias could arise due to the fact that researchers were 
not blinded for a participant being a patient or a control, for example, due to visible 
physical post-stroke disabilities. However, all researchers were well-trained to use the 
structured questionnaires and tests in a pre-defined order, so these data were collect-
ed uniformly in all participants. 
Recall bias is another form of information bias that might have been introduced by the 
use of questionnaires. However, most outcomes are on psychosocial complaints in the 
past week or month, reducing the chance of recall bias. 
Finally, confounding is an important form of bias to consider. A confounder is a fac-
tor that is related to both the determinant and the outcome, without being part of 
the causal chain between determinant and outcome.279 In our studies, age, sex, ed-
ucational level, and socio-economic status may be important confounders. They are 
related to the risk of stroke at young age as well as cognitive impairment, depressive 
symptoms, or unemployment, etcetera. We tried to overcome confounding bias by 
adjusting for these confounding factor in the analyses. Moreover, patients and controls 
were matched for age and sex and controls were recruited from the same environment 
as the patients. Therefore, it is likely that socio-economic status between patients and 
controls is comparable. 
Precision
Precision indicates to what extent the findings deviate from the true value, due to ran-
dom (unknown) error.279 In the studies in this thesis, random error may have occurred, 
due to the fact that outcome measures, such as cognitive performance or the presence 
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of depressive symptoms may fluctuate over days. A patients’ performance during an 
extensive neuropsychological examination or answers on questions about feelings of 
depression probably depend on the presence of other variables, such as the quality of 
last night sleep or complaints from co morbidities. We tried to minimise the chance of 
this error, by including a large number of patients with a TIA (range between 160 and 
215 participants) and ischaemic stroke (range between 277 and 425 participants). How-
ever, we assessed neuropsychological symptoms in only 45 patients with an intracere-
bral haemorrhage, which may have resulted in diminished precision. Therefore, studies 
with larger sample sizes are needed to confirm findings from this particular study.
External validity
The extent to which results from the study sample can be generalised to patients out-
side the study sample is called external validity. Our study cohort is comparable to other 
young stroke cohorts with respect to mean age of approximately 40 years at the time 
of the event, but our study cohort has a lower proportion (<50%) of men than other 
young stroke cohorts (>55%).26, 43, 44 However, concordant with epidemiological data on 
stroke at young age, the higher proportion of women in our cohort probably reflects a 
true young stroke population.280 
With respect to stroke severity, our cohort consisted of patients who suffered from 
relatively mild strokes, with a median NIHSS-score on admission of 4, which seems 
somewhat less severe compared to 1 other study (mean NIHSS-score of 7.7, median not 
reported).131 However, another study reported a more or less comparable NIHSS-score 
on admission with our study with a median of 3,109 and other studies also described 
that neurological deficits on admission were minor to moderate in the majority of pa-
tients.203, 281 Therefore, with respect to stroke severity, our cohort seems comparable to 
other young stroke populations.
Our academic hospital serves as a tertiary referral centre for a large area in the eastern 
part of the Netherlands. Since most patients with a stroke at young age usually are 
referred to a university medical centre somewhere along the course of the disease, we 
most likely included the majority of patients in our catchment area.
To conclude, our study cohort has demographic and stroke characteristics, com-
parable to other young stroke cohorts. Moreover, our study cohort probably is a 
representative sample of all young strokes in our catchment area, despite being 
hospital-based instead of population-based. Therefore, we believe results from 
our studies can be generalised to other Dutch patients with a stroke at young 
age as well as to patients with a stroke at young age in other Western societies. 
General discussion of main findings
To date, a survivor of a stroke at young age was generally expected to regain pre-stroke 
activities in most cases. This expectation was based on previous studies, that found 
a relatively good motor recovery after a stroke under 50 years of age.118, 129 However, 
independent functioning in daily life requires more than only good motor recovery, 
for example adequate cognitive performance. The studies in this thesis show that im-
paired cognitive performance, and also other neuropsychological complaints were 
very common after very long-term follow-up after a stroke at young age. Subjective 
and objective cognitive impairment, depressive symptoms, anxiety, and fatigue were 
far more prevalent among survivors of a stroke at young age than among their peers 
in the control group. Moreover, we found that depressive symptoms, anxiety, and fa-
tigue were associated with a poor functional outcome. This functional outcome was 
assessed with the mRS, mainly a motor score, but also the with the IADL, which assesses 
more complex tasks in daily life functioning. Furthermore, fatigue was also associated 
with cognitive impairment on the domains of information processing speed and work-
ing memory.  
The recognition of long-term persistent ‘non-visible’ symptoms is one of the new insights 
provided by our studies due to the very long-term follow-up, since this was usually limit-
ed in previous studies that investigated neuropsychological outcomes.28-31, 34 The relation 
of these symptoms with a poor functional outcome stresses the importance of the rec-
ognition (and eventually treatment) of these symptoms in post-stroke care.
The negative influence of depressive symptoms, anxiety, and fatigue not only affects 
the individual patient and his or her direct social environment, but also places a burden 
to society as a whole. This is shown by our study on unemployment, in which we found 
a 2- to 3-fold increased risk of unemployment after a stroke at young age, compared to 
the general Dutch population. The highest risk was found in the population between 
35 and 44 years, which causes a major loss of years of productivity.
The high prevalence of long-term depressive symptoms, fatigue, and anxiety poses the 
question on which pathophysiological mechanisms underlie the occurrence and long-
term persistence of these symptoms, even for decades after the initial stroke. Possible 
underlying mechanisms will now be discussed.
First, a direct causal relationship between the stroke at young age and the long-term 
neuropsychological symptoms may exist. To increase the probability of a causal re-
lationship between 2 variables, a study needs to show that the risk factor is time- an 
dose-dependent, among other criteria.98 This requires a large, prospective cohort study. 
In our study, patients were divided into 3 groups, categorised by tertiles of length of 
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follow-up. We found that a stroke at young age was not related with psychological 
outcomes in a length of observation-dependent way. Depressive symptoms, anxiety, 
and fatigue were actually somewhat less prevalent or did not differ between the group 
with shortest length of follow-up (eg., first tertile of length of follow-up) and the group 
with the longest length of follow-up (eg., third tertile of length of follow-up), rather 
than being more prevalent. On the other hand, longer follow-up was associated with 
more cognitive impairment. It may be that the acute damage to the brain parenchyma 
causes neuropsychological symptoms on the short-term, whereas on the long-term 
other pathophysiological mechanisms come into play, such as accumulating neurode-
generative pathology in an ageing brain. 
According to the dose-dependent criterium (the more strokes, the more neuropsy-
chological sequelae), recurrent strokes would lead to a higher prevalence of neuropsy-
chological symptoms over time. This is indeed suggested by our finding that recur-
rent cerebrovascular events were related to the presence of fatigue in young ischemic 
stroke patients. However, recurrent strokes were not significantly related to depressive 
symptoms or anxiety. 
A direct causal relationship between the stroke and long-term neuropsychological 
symptoms may be suggested (although not proven), when symptoms only occur after 
lesions in specific parts of the brain. In the case of cognitive impairment, we found that 
cognitive performance was more affected by a left hemispheric strokes than a right 
hemispheric stroke, suggesting that lesion localisation may, at least partly, determine 
the extent of cognitive impairment. However, in the case of depressive symptoms, anx-
iety, and fatigue, we found no differences in prevalence by stroke localisation.
Findings from our studies clearly not uniformly point to a direct causal relationship 
between stroke and long-term neuropsychological symptoms, suggesting that there 
should be another explanation. We found that depressive symptoms, anxiety, and fa-
tigue were all related to a poor functional outcome in survivors of a stroke at young 
age. These young patients are in a demanding phase of life, with a young family and 
a career, and are suddenly confronted with a serious and often unexpected disease. 
Insufficient coping strategies may lead to an imbalance between physical and mental 
disabilities and high demands from the social environment. Most likely, patients be-
come trapped in a downwards helix of ever increasing neuropsychological symptoms, 
followed by more impairments in daily life, and vice versa.
Clinical relevance
Neuropsychological and social problems after a stroke at young age have received 
little attention in post-stroke care so far, reflected in scarce literature on the subject. 
Meanwhile, patients rate these topics among the top 10 list of research priority.48 An 
explanation may be that in the (sub)acute post-stroke care, the visible motor deficits 
probably attract more attention and these symptoms generally ameliorate in the first 
weeks or during the rehabilitation period. After the subacute and first rehabilitation 
phase, post-stroke care usually stops. However, it is only after this period that patients 
are being confronted with regular daily life, and only then the less visible psychosocial 
issues come into play.
Moreover, the importance of providing information to survivors of a stroke at young 
age on long-term prognosis lies in the fact that these young patients usually have a 
long life expectancy. These patients are often in the midst of an active social life, form-
ing new families and planning important career steps. The major impact of psycho-
social problems on daily life functioning is underlined by our finding that depressive 
symptoms, anxiety, and fatigue were associated with a poor functional outcome.
Current practice may therefore need to change, with a longer follow-up of patients, 
ideally in a multidisciplinary team, to evaluate both the important medical status, but 
also the equally relevant psychosocial issues. In our hospital, this multidisciplinary team 
is being formed currently for young patients with cerebrovascular disease. This teams 
actually consists of 2 subteams. One team contains a neurologist, cardiologist, vascular 
internal specialist, and a vascular surgeon, aiming to evaluate risk factors for the stroke 
and start secondary prevention. The other team consists of a medical psychologist, a 
nurse practitioner, and a social worker. They will offer the patient a ‘menu’ with possible 
neuropsychological or social difficulties. The young patient can then choose which 
topics need special attention in his or her individual situation, in order to regain pre-
stroke activities as much as possible. Examples include ‘fatigue’, ‘return to work’, and 
‘social interactions’. 
Education of the patient and his social environment, for example employers and col-
leagues, and thereby creating more understanding of difficulties a patient encounters, 
may be another method to alleviate psychosocial problems in patients.
We believe that recognition of these symptoms by clinicians, patients, and society may 
be the first step in initialising treatment. 
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Future directions
The combination of a rising incidence of stroke in young adults6 and the high preva-
lence of psychosocial consequences results in a considerable burden for patients and 
their direct social environment as well as for society as a whole. With results from the 
studies in this thesis, stroke physicians will now be able to better inform patients with a 
stroke at young age on long-term prognosis, and create more awareness for the recog-
nition of these symptoms. 
Although the recognition of problems in the neuropsychological and social domain 
in patients after a stroke at young age is the essential first step in treatment of these 
problems, an actual optimal treatment strategy is not available.160, 161 Clinical trials with 
medications, psychological interventions, and occupational therapy are needed to eval-
uate which treatment strategies can alleviate symptoms. To develop these treatment 
strategies however, we first need to learn more about the origin of these complaints. 
For example, are structural damage to brain networks or altered brain function causing 
these symptoms or are inadequate coping strategies or insufficient guidance from a 
social environment playing a role? 
Furthermore, trials should reveal whether there are certain high risk groups, for exam-
ple on the basis of medical or psychiatric history, stroke severity or subtype (including 
intracerebral haemorrhage) or recovery patterns, that would benefit from earlier, more 
intensive or different treatments than other patients.
This optimalisation of treatments and their adjustment to individual patients, based on 
their individual clinical characteristics may result in more cost-effective use of scarce 
health care budgets, with advantages for the individual patient and society as a whole.
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Nederlandse samenvatting
Een beroerte is wereldwijd een van de belangrijkste oorzaken van overlijden en han-
dicap. Beroerte wordt voornamelijk gezien als een ziekte van oudere mensen, maar 
ongeveer 10% van alle beroertes betreft jonge volwassenen, onder de leeftijd van 50 
jaar. Ondanks dit aanzienlijke percentage, is er maar weinig literatuur te vinden over 
deze jonge patiënten, zeker als het gaat om lange-termijn prognose. Voor hen is juist 
deze lange-termijn prognose van belang, omdat zij in het algemeen een lange levens-
verwachting hebben en omdat zij zich in een veeleisende fase van hun leven bevin-
den, waarin belangrijke beslissingen moeten worden genomen over bijvoorbeeld een 
carrière of het stichten van een eigen gezin.
In deel 1, hoofdstuk 2 van dit proefschrift geven wij een kritisch overzicht van de lite-
ratuur over oorzaken en gevolgen van een herseninfarct bij jonge volwassenen. In de 
bestaande literatuur tot nu toe ging de aandacht met name uit naar zeldzame risico-
factoren of onderliggende aandoeningen die een herseninfarct kunnen veroorzaken. 
Echter, de bewijslast hiervoor is relatief beperkt. Er wordt steeds vaker beschreven dat 
de traditionele cardiovasculaire risicofactoren frequent voorkomen bij deze jonge pa-
tiënten. De vraag is nu of de ziekte ‘herseninfarct bij jonge volwassenen’ als aparte 
ziekte-entiteit bestaat, los van een ‘herseninfarct op oudere leeftijd’. In dit hoofdstuk 
beschrijven wij dat, met betrekking tot de onderliggende oorzaak van een hersenin-
farct op jonge leeftijd, er eigenlijk meer sprake is van een heterogene aandoening. Er 
bestaat inderdaad een subgroep van hele jonge volwassenen (<35 jaar) die een zeld-
zame onderliggende aandoening heeft als oorzaak voor de beroerte, maar daarnaast 
ook een iets oudere subgroep (35-50 jaar) bij wie de cardiovasculaire risicofactoren een 
grote rol spelen in het ontstaan van de beroerte, zoals ook bij de oudere patiënten 
het geval is. Tot slot is er een subgroep van patiënten bij wie geen enkele oorzaak kan 
worden gevonden voor de beroerte.
De lange-termijn prognose wat betreft mortaliteit en cardiovasculaire comorbiditeit 
van patiënten die op jonge leeftijd een herseninfarct hebben gehad is slechter dan 
voorheen altijd werd gedacht. De mortaliteit is weliswaar lager dan bij oudere patiën-
ten met een beroerte, maar de cumulatieve mortaliteit ligt 2 tot 4 keer hoger dan bij 
volwassenen van gelijk geslacht en gelijke leeftijd, die géén beroerte hebben gehad. 
Het lange-termijn risico op het krijgen van cardiovasculaire aandoeningen was even-
eens hoog. 
Cognitieve beperkingen, depressieve symptomen, angst en vermoeidheid lijken na 
een beroerte op jonge leeftijd veel voor te komen. Echter, tot op heden zijn er maar 
weinig studies die deze uitkomsten onderzochten in deze populatie. Bovendien waren 
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de verrichte studies beperkt met betrekking tot duur van de follow-up periode of met 
betrekking tot het aantal geïncludeerde patiënten. Voorts zijn er nauwelijks gegevens 
over de invloed van deze symptomen op het algemeen dagelijks functioneren. 
Daarom werd de FUTURE studie uitgevoerd. In deel 2, hoofdstuk 3 beschrijven we 
de achtergrond en de opbouw van de FUTURE studie; een prospectieve cohortstudie, 
opgezet om de etiologie en lange- termijn gevolgen van een TIA, herseninfarct, of 
hersenbloeding op de leeftijd van 18 t/m 50 jaar te onderzoeken in 1 005 volwassenen 
die vanaf 1 januari 1980 tot 1 november 2010 patiënt onder behandeling zijn geweest 
in het Radboudumc te Nijmegen.
De studies in dit proefschrift beschrijven de neuropsychologische en sociale gevolgen 
op lange termijn van een beroerte op jonge leeftijd en de invloed van deze sympto-
men op de functionele uitkomst.
Neuropsychologische en sociale gevolgen op lange termijn 
na een beroerte op jonge leeftijd
In deel III, hoofdstuk 4, beschrijven we de cognitieve functies van patiënten met een 
herseninfarct. De patiënten presteerden slechter op de meeste cognitieve domeinen 
in vergelijking met 146 op leeftijd en geslacht gematchte controles zonder een be-
roerte. Na een gemiddelde follow-up duur van 11.0 (SD 8.2) jaar had zelfs de helft van 
de patiënten op sommige domeinen een benedengemiddelde score of cognitieve 
beperking. Een langere follow-up duur was geassocieerd met lagere testscores op de 
domeinen ‘korte-termijn geheugen’, ‘lange-termijn geheugen’ en ‘executieve taken’. 
De meeste afwijkingen werden gevonden in de cognitieve domeinen ‘snelheid van 
informatieverwerking’, ‘werkgeheugen’ en ‘aandacht’. Patiënten met een beroerte in 
de linkerhemisfeer van de hersenen presteerden het slechtst. In hoofdstuk 5 rappor-
teren we dat subjectieve geheugenklachten en subjectieve executieve stoornissen 
vaker vóórkomen bij patiënten met een TIA of herseninfarct dan bij de controlegroep 
(86.4% versus 67.7% en 67.4% versus 41.4%). Deze subjectieve klachten bleken niet sterk 
gerelateerd aan het daadwerkelijk vóórkomen van objectieve cognitieve stoornissen, 
wanneer deze werden getest tijdens een uitgebreid neuropsychologisch onderzoek. 
Bij patiënten en controles bleken de subjectieve cognitieve klachten wel geassocieerd 
met vermoeidheid. Deze vermoeidheid werd gemeten met de Checklist of Individual 
Strength vragenlijst. Deze vragenlijst bestaat uit items over zowel fysieke als mentale 
vermoeidheid.
Vervolgens onderzochten wij de lange-termijn prevalentie van depressieve symptomen 
en angst (hoofdstuk 6) en vermoeidheid (hoofdstuk 7). Al deze symptomen kwamen 
vaker voor bij patiënten (depressieve symptomen: 16.8%, angst: 23.0%, vermoeidheid: 
41.0%) dan bij controle-proefpersonen. De prevalentie van deze symptomen verschilde 
niet tussen de verschillende lokalisaties van de beroerte (links of rechts supratentorieel, 
of infratentorieel). Na een langere follow-up duur waren depressieve symptomen en 
angst wat minder prevalent dan in de eerste jaren na de beroerte. De prevalentie van 
vermoeidheid toonde eenzelfde trend, maar verschillen tussen korte- en lange-termijn 
follow-up waren niet statistisch significant na adjusteren voor leeftijd, geslacht, oplei-
dingsniveau, ernst van de beroerte en depressie in de voorgeschiedenis. Bij patiënten 
met een herseninfarct waren depressieve symptomen, angst en vermoeidheid allen 
geassocieerd met een slechte functionele uitkomst, gemeten met de modified Rankin 
Scale (mRS) en de Instrumental Activities of Daily Living-vragenlijst (IADL). Vermoeid-
heid was tevens geassocieerd met beperkingen in het cognitief functioneren op de 
domeinen ‘snelheid van informatieverwerking’ en ‘werkgeheugen’. 
In hoofdstuk 8 onderzochten we de prevalentie van cognitieve beperkingen, depres-
sieve symptomen, angst en vermoeidheid na een follow-up periode van 9.8 (SD 8.0) 
jaar bij 45 patiënten met een hersenbloeding en vergeleken dit met 45 op geslacht, 
leeftijd en opleidingsniveau gematchte controles. Subjectieve cognitieve klachten 
hadden een hogere prevalentie in patiënten dan in controles (93.9% versus 73.0%, 
p=0.02), evenals cognitieve beperkingen op de volgende domeinen: ‘Snelheid van in-
formatieverwerking’ (33.3% versus 5.4%, p=0.003), ‘werkgeheugen’ (29.4% versus 10.8%, 
p=0.049), ‘korte-termijn geheugen’ (26.5% versus 8.1%, p=0.04), and ‘lange-termijn 
geheugen’ (20.6% versus 2.7%, p=0.02). Er was een trend wat betreft vóórkomen van 
vermoeidheid (40.5% versus 22.2%, p=0.07). Er werden geen significante verschillen 
gevonden tussen patiënten en controles wat betreft de prevalentie van depressieve 
symptomen en angst.
Tot slot rapporteert hoofdstuk 9 over het percentage werkloosheid onder patiënten 
met een TIA, herseninfarct of hersenbloeding, gedefinieerd als het aantal mensen die 
een arbeidsongeschiktheidsuitkering ontvingen. Na een follow-up periode van ge-
middeld 8.1 (SD 7.7) jaar was 25.9%-43.9% van de patiënten tussen de 35 en 65 jaar 
werkloos. Patiënten hadden een hogere kans om werkloos te zijn dan de rest van de 
Nederlandse beroepsbevolking (vrouwen: OR 2.3, 95%-CI 1.8-2.9, mannen: OR 3.2, 95%-
CI 2.5-4.0). Een ernstigere beroerte en een langere follow-up duur waren geassocieerd 
met een hoger risico op werkloosheid. De patiënten in de leeftijdscategorie 35-44 jaar 
hadden het hoogste risico op werkloosheid (vrouwen: OR 4.7, 95%-CI 3.0-7.0, mannen: 
OR 9.4, 95%-CI 5.6-15.3).
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Conclusie
De studies in dit proefschrift beschrijven dat patiënten die op jonge leeftijd (18 t/m 
50 jaar) een beroerte doormaken vaak worden geconfronteerd met problemen op 
neuropsychologisch en sociaal vlak, zelfs na ongeveer 10 jaar follow-up. Dit spreekt de 
algemene gedachte onder neurologen en andere behandelaren tegen, dat de prog-
nose na een beroerte op jonge leeftijd relatief gunstig zou zijn. Deze klachten hebben 
gevolgen voor de patiënt zelf, maar ook voor zijn directe omgeving en de maatschap-
pij, gezien het feit dat deze neuropsychologische en sociale problemen gerelateerd 
bleken aan functionele afhankelijkheid en een kleinere kans om voormalige dagelijkse 
activiteiten, bijvoorbeeld werk, weer op te pakken.
De resultaten uit dit onderzoek maken het mogelijk voor artsen en andere beroeps-
groepen die betrokken zijn bij de zorg voor deze patiënten om betere informatie te 
kunnen geven over de mogelijke lange-termijn gevolgen die een beroerte op jonge 
leeftijd met zich mee kan brengen. In de toekomst is verder onderzoek nodig om de 
onderliggende pathofysiologische mechanismen verder te ontrafelen en behande-
lingsstrategieën te ontwikkelen.
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List of abbreviations
BI      Barthel Index
BMI      Body Mass Index
CBS      Central Bureau of Statistics
CFQ      Cognitive Failures Questionnaire
CIS      Checklist of Individual Strength questionnaire
FUTURE Study   Follow-up of Transient ischaemic attack and stroke patients and
      Unelucidated Risk factor Evaluation Study
HADS-a   Hospital Anxiety and Depression Scale, items on anxiety
HADS-d   Hospital Anxiety and Depression Scale, items on depressive
      symptoms
IADL      Instrumental Activities of Daily Living
ICH      Intracerebral haemorrhage
ILO     International Labour Organisation
IS       Ischaemic stroke
MMSE     Mini Mental State Examination
mRS      modified Rankin Scale
NIHSS     National Institutes of Health Stroke Scale
PPMST    Paper and Pencil Memory Scanning Test
RAVLT     Rey Auditory Verbal Learning Test
ROCF     Rey-Osterrieth Complex Figure
SDMT     Symbol-Digit Modalities test
TIA      Transient Ischaemic Attack
TOAST    Trial of Org 10172 in Acute Stroke Treatment
VSAT      Verbal Series Attention Test
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te bewaken.
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hadden hoe groot het was. We vormen samen een goed team en vullen elkaar aan 
waar nodig, al was het alleen al in het afwisselen van avonden en weekenden door-
werken om alle deelnemers te onderzoeken en te scannen. Dank voor deze samenwer-
king, maar vooral ook voor je vriendschap. Wat fijn dat je naast me staat als paranimf!
Lieve Linda, vanaf 4VWO hebben we altijd al samen kunnen sparren over carrière ambi-
ties, persoonlijke ontwikkeling, reizen, (gevraagde of ongevraagde) psychoanalyses, of 
onmogelijke biologieleraren. Dank dat jij naast me wil staan als paranimf!
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Renate, al vanaf het allereerste begin bij FUTURE betrokken, maar met nog een frisse 
blik begon je iets later aan je eigen promotietraject. Dank dat je de laatste loodjes van 
de dataverzameling mee op je hebt genomen, die wegen toch het zwaarst. 
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van je expertise vanuit de psychologie. 
Ook wil ik de medewerkers op de polikliniek hartelijk bedanken voor hun hulp bij de da-
ta-verzameling, Emely Klessens-Verkuylen als ‘full-time onderzoeksassistent’, maar ook 
Karin Kanselaar, Yvonne Cornelissen, Anneke Pelgröm, Sharon Romviel en alle stagaires 
die altijd flexibel waren om te ondersteunen wanneer nodig. Dank ook aan iedereen 
op de verschillende laboratoria en administratieve ondersteuning die van logistieke 
onmogelijkheden, logistieke uitdagingen wisten te maken (Sylvia Spaan, Paul Gaalman, 
medewerkers van de KNF, archiefmedewerkers, de studentassistenten, en iedereen die 
ik nog vergeten ben).
Alle mede-auteurs van de manuscripten wil ik hartelijk danken voor hun bijdrage aan 
de verschillende studies in dit proefschrift.
Mijn collega’s op de onderzoekerskamer op de tweede verdieping, Merel, Femke, Wil-
lemijn, Saskia, Karlien en tijdens het laatste staartje Michiel en Anke, en collega’s van de 
vasculaire groep (Mayte, Inge, Ellen, Frank, Anil, Joyce, Esther) dank ik voor hun gezellig-
heid en discussies over ‘de wetenschap’ en ‘de Mol’.  
Lieve familie, schoonfamilie en vrienden, hier ligt dan eindelijk een tastbaar resultaat 
van mijn onderzoek. Bedankt voor jullie nooit aflatende interesse en vertrouwen in de 
voortgang ervan. En dank voor het begrip voor alle keren dat jullie agenda’s moesten 
worden aangepast aan die van mij. 
Lieve Ja(n)-Pie(ter), grote broer /goede vriend, wat fijn dat ik altijd bij je terecht kan 
voor adviezen, goed gesprek, of gewoon een borrel in de tuin. Ik hoop samen met jou, 
Maura, Melle en Mirte nog veel te leren over dinosauriërs en nog veel meer.
Lieve papa en mama, eigenlijk horen jullie op de kaft van dit boekje, met ‘mede mo-
gelijk gemaakt door’. Jullie hebben mij geleerd dat er altijd een weg is om je dromen 
en ambities waar te maken. Bedankt voor jullie onvoorwaardelijke vertrouwen en trots. 
Lieve Danny,    “…let the music play…”
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